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ABSTRACT 
Shawn Michael Lyons: Post-Transcriptional Regulation of Histone mRNAs at the Level 
of Decay and 3’ End Processing (Under the Direction William F. Marzluff) 
 
Replication-dependent histone mRNAs are the only cellular eukaryotic mRNA 
which do not terminate in the canonical poly(A) tail.  Instead, they end in a conserved 26 
nucleotide stem-loop.  This structure consists of a 6 base pair stem topped by a 4 
nucleotide loop.  This cis-element is bound by two trans factors: (1) stem-loop binding 
protein (SLBP) and (2) 3’ to 5’ histone exonuclease (3’hExo/Eri1).  These two proteins 
play roles in regulating nearly all actions in the life cycle of histone mRNAs including 
direction of 3’ end cleavage of histone mRNA, nuclear export, translation and 
degradation of the mRNA.  Critical to this regulation is specific recognition of the histone 
stem-loop by these trans factors.  In this thesis, I show the sequence and structural 
determinants for SLBP and 3’hExo binding.  I then show how SLBP and 3’hExo are able 
to direct histone mRNA degradation by interaction with Lsm4, a component of the Lsm1-
7 complex.  Finally, I demonstrate that cells utilize polyadenylation signals downstream 
of a subset of histone mRNAs to continue expression of histone mRNAs outside of the 
confines of the cell cycle when SLBP is absent.     
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CHAPTER I: INTRODUCTION 
 
Overview 
 The genome of eukaryotes is composed of linear DNA molecules that are 
complexed with basic proteins called histones.  Together these two make up the 
chromosomes, which are composed of equal amounts of DNA and histone protein.  The 
primary function of histones is to compact DNA in the nucleus, but also a role in 
regulation of gene expression.  Collectively, the histone:DNA complex is known as 
chromatin, of which the main subunit is a nucleosome.  Each nucleosome is comprised of 
146 base pairs of DNA wrapped around a core octamer of histone protein.  A histone 
octamer contains two molecules each of the histone proteins H2A, H2B, H3 and H4.  A 
fifth histone protein, H1, is not part of the core octamer, but plays an enigmatic role in 
helping to further compact chromatin.  The globular central domains of histone proteins 
interact with each other to form the core of the nucleosome and are involved in 
compaction of the DNA into chromatin (Luger et al. 1997); however, histone proteins 
contain an unstructured N-terminal tail that may be modified in order to regulate gene 
expression (Strahl and Allis 2000).  Largely, this is accomplished by acetylation and 
methylation of lysine and arginine residues; however, mono-ubiquitination, 
phosphorylation and sumolyation of histone proteins has also been implicated in 
regulation of expression. 
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 As cells are preparing to divide into two daughter cells, they replicate their 
genome.  This newly synthesized genome must be rapidly packaged into chromatin in 
order to maintain genomic integrity.  To accomplish this, all eukaryotic cells rapidly 
upregulate the production of histone mRNAs in order to produce histone protein to 
package newly replicated DNA into chromatin.  Also, after the completion of DNA 
synthesis, the mRNAs encoding histone mRNAs are rapidly degraded.  My work aims to 
better understand the regulation of these mRNAs.  I will show what the mRNA sequence 
requirements are for two separate trans-factors (SLBP and 3’hExo) to bind the mRNA 
(Chapter 2).  I will show how these two proteins participate in the degradation of the 
message through interactions with general mRNA degradation factors (Chapter 3).  
Finally, I show how cells are able to continue to maintain appropriate levels of histone 
proteins after they have exited the cell cycle (Chapter 5).            
The Eukaryotic Cell Cycle 
  The growth and division of eukaryotic cells is governed by the eukaryotic cell 
cycle.  The cell cycle can be divided into 4 distinct phases: (1) G1-phase, (2) S-phase, (3) 
G2-phase and (4) M-phase.  Collectively G1- and G2-phases are known as “gap phases” 
and occur between the times when the genome is duplicated, S-phase, and when the cell 
divides, M-phase and cytokinesis.  Progression through the cell cycle is a highly 
regulated process controlled primarily by cyclin-dependent kinases (CDKs).  These are a 
group of serine/threonine kinases that are inactive on their own.  For activity, they must 
bind another set of proteins known as the cyclins.  The levels of cyclin proteins oscillate 
as the cell progresses throughout the cell cycle.  Binding of CDKs to particular cyclins, 
not only activates the CDKs, but also confers target specificity.  In mammals, there are at 
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least 8 CDKs and dozens of cyclins (although all do not change levels through the cell 
cell cycle).  CDK-inhibitors (CKIs), which fall into two families, CIP/Kip (p21, p27, p57) 
and Ink4 (p15, p16, p18, p19), can also bind CDKs and restrict their activity. 
 As the synthesis of large amounts of histone proteins is only required as the cell is 
duplicating its genome, the expression of these mRNAs is restricted to S-phase.  At least 
two cyclin/cdk complexes are directly involved in maintaining the proper regulation of 
these genes, Cyclin E/Cdk2 and Cyclin A/Cdk1.  CycE/Cdk2 is required for entry into S-
phase.  The kinase activity of Cdk2 is required for upregulation of histone mRNA 
synthesis at the G1/S boundary, which is accomplished by phosphorylation of the 
transcription factor NPAT.  CyclinA/Cdk1 phosphorylates SLBP, a critical histone 
mRNA specific trans-factor, at the completion of S-phase to promote proteasome-
mediated destruction of the protein.      
The Two classes of Histone Genes 
There are two classes of histone genes: (1) replication-dependent and (2) 
replication-independent.  As their names would suggest, the replication-independent 
histone genes are expressed constitutively throughout the cell cycle while the replication-
dependent histone genes are expressed during S-phase in order to help package the newly 
synthesized genome.  Nearly 95% of all of the histone in dividing cells is comprised of 
replication-dependent histone protein (West and Bonner 1980). 
In order to form the nucleosome, the basic unit of chromatin, 146 base pairs of 
DNA wraps around an octamer comprised of a histone H3-H4 tetramer and two histone 
H2A-H2B dimers.  Regulating the expression of these proteins such that the heterodimers 
form in the proper ratios is critical to maintaining genomic stability (Meeks-Wagner and 
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Hartwell 1986).  The 146 base pairs of DNA wraps itself 1.7 times around the octamer.  
Between one nucleosome and the next there a linker region of DNA of variable length 
and may involve the binding of the 5th canonical histone, H1.   
In all organisms, the different histone genes are clustered.  In mammals, the 
replication-dependent histones are expressed from multiple different non-allelic genes 
clustered across the mammalian genomes (Marzluff et al. 2002).  They are located in one 
major histone cluster (Hist1) and three minor histone clusters (Hist2, Hist3 and Hist4).  
The HIST1 cluster is located on chromosome 6 (6p21-22) in humans and 13 (13qA3.1) in 
mice and contains 55 and 51 genes, respectively.  Most of the H2A, H2B, H3 and H4 
genes and all of the H1 genes can be found in this cluster.  The Hist2 cluster is located on 
chromosome 1 (1q22) in humans and chromosome 3 (3qF2.1) in mice and contains 11 
and 10 genes, respectively.  The Hist3 cluster contains 3 genes in both humans and mice 
and is located on chromosomes 1 (1q24) and 11 (11qB1.3), respectively.  Finally, the 
Hist4 cluster is comprised of a single H4 gene and is located on chromosome 12 
(12p13.1) in humans and chromosome 6 (6qG1) in mice. 
The expression of this class of histone genes is tightly coupled to the cell cycle at 
the level of mRNA transcription, 3’ end processing, mRNA degradation and proteolysis 
of excess histones.  The mRNAs expressed from these genes contain a specialized 3’ end 
and are the only known cellular RNAs that are not polyadenylated.  Instead of ending in 
the canonical poly(A) tail, they end in a conserved stem-loop structure that is critical for 
regulation of expression.  The input of each of these processes and a more in depth 
description of the replication-dependent histone message 3’ end will be discussed in 
subsequent sections. 
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The expression of replication-independent histone genes is not tied to the cell 
cycle.  Instead, they are expressed at low levels throughout the cell cycle.  These genes 
are located throughout the genome and are expressed as normal polyadenylated mRNAs.  
These genes play two general roles in the cell.  The simplest task they may play is as 
replacement histones.  The primary example of this type of histone is H3.3.  This gene is 
expressed from a poly(A) encoding and intron containing gene.  The second role for 
replication-independent histone genes is to serve as variants that often play specialized 
roles in regulation of chromatin structure.     
Cell-cycle regulation of replication-dependent histone genes in mammals   
 The expression of replication-dependent histone mRNAs is tightly coupled to the 
cell cycle, as new histone protein is needed to package the newly synthesized genome 
(Figure 1).  Failure to couple these processes leads to S-phase arrest and subsequent 
genomic instability or cell death.  As cells approach S-phase, a Cyclin E dependent 
process allows for the upregulation of histone mRNA transcription.  Transcription of 
histone genes is constitutive throughout the cell cycle (DeLisle et al. 1983), but 
transcription is enhanced during S-phase by the phosphorylation of nuclear protein 
ataxia-telangiectasia locus (NPAT), which presumably acts as a transcription factor for 
the histone genes (Ma et al. 2000; Ye et al. 2003).  NPATs ability to activate transcription 
of histone genes is dependent upon phosphorylation by Cyclin E/CDK2 and interaction 
with the DNA binding factor Hinf-P (Miele et al. 2005). 
As cells enter S-phase, the levels of histone mRNAs increase 30 – 35 fold.  The 
increase in transcription only accounts for a 3-fold increase in histone levels.  The 
additional 10-fold increase in levels is due to the contribution of 3’ processing and 
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Figure 1.  Regulation of histone mRNAs and SLBP throughout the cell cycle.  Cell 
cycle effectors that regulate indicated processes are labeled in red. 
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mRNA stability (Harris et al. 1991a).  Specific regulation of histone mRNAs is 
attributable to a specialized 3’ end and a histone specific trans-factor, SLBP.  
The histone stem-loop and associated trans-factors 
 All eukaryotic mRNAs terminate in a polyadenosine (Poly(A)) tail except for the 
replication-dependent histone mRNAs (Adesnik and Darnell 1972; Adesnik et al. 1972).  
In order to add this tail, mRNAs are co-transcriptionally endonucleolytically cleaved and 
poly(A) polymerase (PAP) adds the poly(A) tail to the expose 3’ end..  After the addition 
of about 250 adenosines, polymerization will terminate as PAP can no longer 
communicate with a complex of proteins known as the cleavage and polyadenylation 
specificity factor (CPSF complex)(Wahle 1995). This tail participates in all stages in the 
life cycle of mRNAs.  It is required for mRNA export from the nucleus, enhances 
translation of poly(A) tailed mRNAs and protects the mRNA from degradation.   
 In order to perform these tasks, the poly(A) tail is bound by the RRM containing 
protein, polyadenylate-binding proteins (PABP).  There are two distinct poly(A) binding 
proteins, one that is cytoplasmic (PABPC1) and the other that is nuclear (PABPN1).  
During polyadenylation, the poly(A) tail is bound by PABPN1, which facilitates nuclear 
export.  Upon localization to the cytoplasm, PABPN1 exchanges with PABPC1 which 
allows for robust translation of its bound mRNA.   PABPC1 also interacts with 
eukaryotic release factor 3 (eRF3/GSPT1), an interaction that has been implicated in 
regulating both translation and mRNA degradation (Uchida et al. 2002; Hosoda et al. 
2003). 
 Replication-dependent histone mRNAs do not end in the canonical poly(A) tail.  
Instead, they terminate in a conserved 16 nucleotide stem-loop (Hentschel et al. 1980; 
	   9	  
Birchmeier et al. 1982), which serves many of the same functions that the poly(A) tail 
does in other mRNAs (Figure 2).  Like the poly(A) tail of other eukaryotic mRNAs, the 
histone stem-loop plays a critical role in regulating the life cycle of histone mRNAs.  The 
stem-loop is necessary for directing 3’ cleavage of histone messages, nuclear export of 
mRNAs, translation of histone mRNA and degradation of the mRNA.  The histone stem-
loop is the cis-element responsible for the post-transcriptional component of cell cycle 
regulation of the mRNAs (Harris et al. 1991a).   
 In mammals, the actions of the stem-loop are mediated by two trans-factors: (1) 
stem-loop binding protein (SLBP) and (2) 3’ to 5’ histone exonuclease (3’hExo/Eri1).  In 
humans, SLBP is a 31 kDa (270 amino acid) protein and 3’hExo is a 40 kDa (349 amino 
acid) protein (Figure 3).   
 SLBP was first identified in a yeast triple hybrid screen conducted simultaneously 
by Dr. Zeng-Feng Wang in the Marzluff lab and Dr. Frank Martin in the Schümperli lab 
(Wang et al. 1996; Martin et al. 1997) using the histone stem-loop as bait.  This protein 
contains a unique RNA binding domain located in the 73 amino acid region between 
amino acids 125 and 197 (Wang et al. 1996; Tan et al. 2013).  SLBP is the trans-factor 
primarily responsible for the mRNA regulation conferred by the histone stem-loop.  
SLBP is required for proper histone mRNA 3’ processing (Dominski et al. 2001) and 
mRNA export (Sullivan et al. 2009a), translation of the mRNA in the cytoplasm 
(Sanchez and Marzluff 2002) and, as this thesis will show, plays a direct role in histone 
mRNA degradation (This thesis, Chapter 3).  Unlike the exchange that occurs between 
PABPN1 and PABPC1 as the mRNA is exported from the nucleus, it is likely that a  
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Figure 2. Histone mRNAs have a unique 3’ end. (A) Cleavage by CPSF-73 between 
the histone stem-loop and histone downstream element (HDE) leads to message which is 
further trimmed by 3’hExo to produce the mature cytoplasmic mRNA.  (B) Histone 
mRNAs contain short 3’ and 5’ UTRs that are not spliced. 
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Figure 3. Histone mRNA metabolism.   
Histone mRNAs are upregulated at the G1/S boundary as a result of phosphorylation of 
NPAT by CycE/Cdk2 and by increased stability and 3’ end processing due to synthesis 
and binding of SLBP.  Endonucleolytic cleavage by CPSF-73 as directed by the U7 
snRNP produces the mature mRNA, which is exported from the nucleus to the cytoplasm 
in a TAP dependent manner.  Formation of a closed-loop translation complex is 
facilitated in the cytoplasm by bridging the 5’ and 3’ mRNPs by SLIP1.  Histone mRNA 
degradation is dependent upon ATR signaling from the nucleus.  During this process, 
translation termination becomes inefficient.  As a result, the NMD factor Upf1 is 
recruited which stimulates oligouridylation by a TUTase.  Lsm1-7 stimulates decapping 
of the mRNA which is subsequently degraded bidirectionally.  At the end of S-phase, 
SLBP is phosphorylated by CycA/Cdk1 to promote proteasome dependent degradation.      
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single SLBP protein remains associated with a single histone mRNA throughout the life 
of that mRNA as there are not distinct nuclear and cytoplasmic isoforms of SLBP.   
Cell Cycle Regulation of SLBP 
 Like histone mRNAs, the expression of SLBP is tied to the eukaryotic cell cycle.  
However, unlike histone message, whose regulation is dictated by mRNA 3’ end 
processing and mRNA degradation, SLBP protein expression is controlled by 
translational regulation and proteolysis. The levels of SLBP protein mirror that of histone 
mRNA.  Protein levels rapidly increases just before the cell enters S-phase and rapidly 
dissipate at the S/G2 border (Whitfield et al. 2000b).  At the end of S-phase, Cyclin 
A/Cdk1 binds SLBP at amino acids 95 through 98 (KRKL) and phosphorylates 
threonine-61 (Zheng et al. 2003a; Koseoglu et al. 2008a).  Following this 
phosphorylation, casein kinase 2 (CK2) phosphorylates threonine-60.  Phosphorylation of 
these two adjacent threonine residues is necessary for the proteasome-dependent cell 
cycle proteolysis of SLBP protein at the end of S-phase.   
 Unlike SLBP protein, SLBP mRNA levels change little throughout the cell cycle 
(Figure 1) (Whitfield et al. 2000b).  Dr. Lian-xing Zheng tested whether SLBP was 
rapidly degraded when the cell was not in S-phase or whether translation of SLBP mRNA 
was inhibited.  Cells were synchronized treated with MG132, an inhibitor of the 
proteasome, during G2-phase.  He found that SLBP did not accumulate which argued 
against rapid turnover by proteolysis.  By polysome gradient analysis, he showed that 
SLBP mRNA was found on polysomes during S-phase but during G2-phase, the mRNA 
shifted to lighter fractions.  These results indicated that SLBP was regulated not only at 
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the level of proteolysis, but by translational regulation of the mRNA through an as of yet 
undetermined mechanism.  
SLBPs Role in Translation of Histone mRNAs 
 The requirement of SLBP for efficient translation remains clear (Sànchez and 
Marzluff 2002).  SLBP can stimulate the translation of stem-loop containing mRNAs 
both in vitro and in vivo.  Dr. Ricardo Sanchez showed that the DWXSAVEE motif, 
located between amino acids 73 – 80 in humans, is required for the translation 
stimulation.  SLBP plays a similar role to PABPC1 in facilitating efficient translation.    
For polyadenylated mRNAs, efficient translation requires association of the 5’ and 3’ 
ends of the mRNA that form a closed-loop (Munroe and Jacobson 1990; Tarun and Sachs 
1996; Martineau et al. 2008).  It is thought that this configuration allows for more 
efficient recycling of translation factors, particularly ribosomes.  The association of three 
proteins spanning the 5’ and 3’ ends facilitates the formation of the closed-loop structure 
(Wells et al. 1998).  At the 5’ end, eukaryotic translation initiation factor 4E (eIF4E) 
binds the 7-methylguanosine cap of the mRNA.  eIF4E then interacts eukaryotic 
translation initiation factor 4G (eIF4G) forming the eIF4F complex along with the RNA 
helicase eIF4A.  To connect the ends of the mRNA, eIF4G directly interacts with 
PABPC1.  Using atomic force microscopy, the Sachs group was able to show that eIF4E, 
eIF4G and PABPC1 were sufficient to form a closed-loop of polyadenylated mRNA. 
(Wells et al. 1998).   
 While circularization of the mRNA is still necessary for efficient translation, this 
same configuration at the 5’ and 3’ ends is not possible for histone mRNAs due to the 
lack of a poly(A) tail.  The 3’ end of histone mRNAs does remain essential for translation 
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(Gallie et al. 1996).  For histone mRNAs, SLBP plays a critical role in the formation of 
the closed-loop complex along with eIF4F at the 5’ end of the message (Figure 4). SLBP 
remains bound to the stem-loop during translation (Whitfield et al. 2004).  However, 
SLBP does not interact directly with eIF4G as PABPC1 does.  To form the closed-loop, 
SLBP interacts with one or two accessory factors.  By a yeast two-hybrid screen, Dr. 
Nihal Cakmakci discovered a novel protein, which was termed SLBP interacting protein 
1 (SLIP1) (Cakmakci et al. 2008) that binds the sequence in SLBP required for efficient 
histone mRNA translation.  This protein also interacts with eIF4G allowing for bridging 
of the 3’ and 5’ ends of the mRNA.  Recently, a second protein, CBP80/20-dependent 
translation initiation factor (CTIF) has been implicated in assisting circularization the 
histone mRNAs through interaction with SLBP (Choe et al. 2013).  In this case, the 5’ 
cap is bound by cap binding protein 20 (CBP20) and cap binding protein 80 (CBP80).  
Additionally, CTIF binds SLIP1 (J. Trotman & S. Meaux, Unpublished data).  The exact 
contributions to SLIP1-dependent and CTIF-dependent histone mRNA translation are 
unclear and are currently being investigated in the Marzluff lab.    
3’hExo is the 2nd trans-factor that binds the histone stem-loop 
 3’hExo (also known as Eri1) is the second trans-factor that specifically interacts 
with the histone stem-loop.  While SLBP binds the proximal face of the stem-loop, 
3’hExo binds the distal face (Figure 5) (Tan et al. 2013).  To isolate 3’hExo, biotinylated 
histone stem-loop was incubated with cell extract and 3’hExo and SLBP were both 
obtained by their ability to specifically bind this stem-loop. (Dominski et al. 2003).  
3’hExo is a member of the DEDDh family of exonucleases, whose members include both 
deoxyribonucleases and ribonucleases (Zuo and Deutscher 2001).  This family of  
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Figure 4. Models of translation complexes.  (A) Histone mRNAs utilizing SLIP1 to 
form the closed circle translation complex (Cackmacki et al. 2008).  (B) Histone mRNAs 
utilizing CTIF to fort the closed circle translation complex (C) Steady state translation 
complex of poly(A) mRNAs 
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Figure 5. SLBP and 3’hExo bind the histone stem-loop 
Schematic of SLBP and 3’hExo binding to the stem-loop and recently solved crystal 
structure by Tan et al. 2013. 
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exonucleases is characterized by four invariant amino acids (three aspartates and one 
glutamic acid), which also give the group its name.  3’hExo is unique among other 
DEDDh exonucleases in that it also contains a 35 amino acid SAP domain.  The SAP 
domain was first identified as a DNA binding domain (Aravind and Koonin 2000); 
however, in 3’hExo, this domain is required for RNA binding along with the interdomain 
spacer region located C-terminal to the SAP domain (Yang et al. 2006).     
 Initially, the only activity described for 3’hExo was its ability to remove the last 
three nucleotides from the mature histone mRNAs.  In humans, after 3’ cleavage to form 
the mature message, 5 nucleotides (ACCCA) remain 3’ of the base of the stem.  Using in 
vitro nuclease assays in the presence of SLBP, Dr. Zbigniew Dominski determined that 
3’hExo would remove the final CCA leaving only two nucleotides (AC) after the base of 
the stem (Dominski et al. 2003).  If these experiments were done in the absence of SLBP, 
3’hExo was able to degrade the entire 3’ half of the stem to the loop.  Later, using 
circular RT-PCR, Dr. Thomas Mullen found that in the cytoplasm, histone mRNAs 
terminate in AC rather than the 5 nucleotide ACCCA formed after 3’ cleavage suggesting 
that 3’hExo is responsible for removing these nucleotides in vivo (Mullen and Marzluff 
2008).  Unfortunately, no role can be ascribed to the removal of the final 3 nucleotides. 
 More recently, the Heissmeyer lab was able to knockout the 3’hExo gene in mice, 
from which they derived fibroblasts for various experiments that they have used to 
elucidate many functions of the protein.  They have demonstrated that it has a role in 
ribosomal RNA processing as the 5.8S rRNA contains an extended 3’ end in the 
knockout mouse (Ansel et al. 2008).  They have also shown that it has a role in 
maintaining microRNA homeostasis (Thomas et al. 2012).  In terms of histone mRNAs, 
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they confirmed that 3’hExo is responsible for removing the final 3’ nucleotides from the 
3’ end of histone mRNAs as histone mRNAs in the knockout mouse end in ACCCA.  
More importantly, they demonstrated that 3’hExo functions in the initial steps of histone 
mRNA degradation (Hoefig et al. 2013).  They found that after inhibition of DNA 
synthesis by hydroxyurea (HU), histone mRNA degradation was slowed in 3’hExo 
knockout mouse cells.  Normal degradation kinetics could be restored by the transfection 
of wild type 3’hExo, but not by transfection of 3’hExo containing point mutants to the 
catalytic core.  
3’ end processing of polyadenylated mRNAs 
 All eukaryotic mRNAs except histone mRNAs end in a polyadenosine tail of 
about 200 nucleotides in humans.  An mRNA must be cleaved during transcription in 
order for the poly(A) polymerase to gain access to the 3’ hydroxyl to which the tail is 
added.  Two cis-elements direct the proper cleavage: the well conserved polyadenylation 
signal (AAUAAA) and the less conserved G/U rich element.  The poly(A) signal (PAS) 
was discovered shortly after the first genes were sequenced by comparing the sequences 
of only six different poly(A) mRNAs (Proudfoot and Brownlee 1976).  This sequence is a 
nearly invariant hexamer with the sequence AAUAAA.  It typically occurs 20 – 30 
nucleotides upstream of the cleavage site.  Drs. Nick Proudfoot and George Brownlee 
proposed that this hexamer sequence determined the site of polyadenylation.  This 
hypothesis was confirmed by studying SV40 PAS that had been mutagenized (Fitzgerald 
and Shenk 1981) and by studying naturally occurring mutations in the PAS in two 
different globin genes which lead to thalassemia (Higgs et al. 1983; Orkin et al. 1985).  
The second cis-element, known as the G/U rich element or downstream sequence element 
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(DSE), required for efficient polyadenylation is located downstream of the PAS and 3’ 
cleavage site.  As suggested by its name, it is particularly G/U rich with a consensus 
sequence of YGUGUUYY (Gil and Proudfoot 1984; McLauchlan et al. 1985).  Cleavage 
typically occurs between the AAUAAA and GU-rich element, about 20  - 30 nucleotides 
upstream of the GU-rich element following a CA dinucleotide (Chen et al. 1995b).   
 In order to make this cleavage, a large multisubunit protein complex must co-
transcriptionally assemble on the nascent mRNAs.  In mammals, there are 4 large 
multisubunit complexes that work to effect cleavage and polyadenylation: Cleavage and 
polyadenylation specificity factor (CPSF), Cleavage stimulatory factor (CstF), 
Mammalian cleavage factor I (CF Im) and Mammalian cleavage factor II (CF IIm) 
(Mandel et al. 2007).   
CPSF is a complex of six essential proteins: CPSF-160, CPSF-100, CPSF-73, 
CPSF-30, WDR-33 and Fip1.  While each of these is essential, the functions of CPSF-73 
and CPSF-160, are particularly noteworthy.  Using UV crosslinking, CPSF-160 was 
shown to recognize and directly binds the PAS (Christofori and Keller 1988; Murthy and 
Manley 1995).  Binding to the PAS is enhanced through interaction with CstF (Murthy 
and Manley 1992).  CPSF-73 is the endonuclease that performs the 3’ cleavage reaction 
(Ryan et al. 2004; Mandel et al. 2006).  This protein is a founding member of the β-
CASP protein family and contains a metallo-β-lactamase domain (Callebaut et al. 2002), 
a domain that is often found in nucleases. Interestingly, this same protein performs 
histone mRNA 3’ cleavage despite the fact that they are not polyadenylated (Dominski et 
al. 2005).  The role for this protein in maturation of histone mRNAs will be discussed in 
the following sections.    
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The CstF complex contains three individual proteins, CstF-50, CstF-64 and CstF-
77, that dimerize to form a hexameric complex.  CstF-64 is an RRM containing protein 
that has been shown to interact with the downstream G/U rich element by UV 
crosslinking (Wilusz and Shenk 1988).  The other components of CstF, CstF50 and 
CstF77, have been shown to interact with the C-Terminal domain (CTD) of the largest 
subunit of RNA polymerase II, likely coordinating transcription and 3’ end processing 
(McCracken et al. 1997).   
Symplekin, a HEAT-repeat contain protein (Kennedy et al. 2009), is also a critical 
component in cleavage and polyadenylation despite not being contain specifically in 
either CPSF or CstF (Zhao et al. 1999).  Symplekin is thought to function as a scaffold 
that coordinates the interaction between CstF and CPSF (Takagaki and Manley 2000). 
3’ end processing of histone mRNAs  
 As histone mRNAs are not polyadenylated and contain no introns, the only 
enzymatic reaction needed to create the mature mRNA is 3’ cleavage.  Histone mRNAs 
also utilize two cis-elements to direct 3’ end cleavage.  Rather that the PAS and G/U rich 
region, the histone downstream element (HDE) and the previously discussed histone 
stem-loop direct histone mRNA cleavage.  The mammalian HDE is a loosely conserved 
11 nucleotide sequence with the consensus of AAAAGAGCTGT (Marzluff et al. 2002) 
(Figure 2).   
 One of the many unique features to histone mRNA 3’ end processing is the 
requirement for a small nuclear RNA (snRNA), U7.  The dependence of histone mRNA 
cleavage on a then unidentified small RNA was first shown in frog oocytes and sea 
urchins (Galli et al. 1983; Strub et al. 1984).  Later, it was shown that this RNA is in a 
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complex with an unknown set of Sm-proteins, contains the trimethylated cap 
characteristic of snRNAs and is required for the endonucleolytic cleavage of mammalian 
histone genes as well (Gick et al. 1986; Strub and Birnstiel 1986).  Characterization of 
the U7 snRNA revealed that it contains a stem-loop at its 3’ and a single stranded region 
at its 5’ end.  This single stranded region is complementary to the HDE and binding 
between the two in necessary of directing endonucleolytic cleavage (Schaufele et al. 
1986; Bond et al. 1991).  The location of the binding of U7 to the HDE acts as a 
molecular ruler by directing the location of endonucleolytic cleavage (Scharl and Steitz 
1994; Scharl and Steitz 1996; Yang et al. 2009c).   
 For years, the composition of the protein component of the U7 snRNP remained 
elusive.  However, while a graduate student working in the lab of Dr. Dani Shümperli, 
Dr. Ramash Pillai was able to purify the Sm-proteins associated with the U7 snRNA 
(Pillai et al. 2001).  He first isolated the U7 snRNP by biochemical fractionation of HeLa 
cell extracts followed by affinity purification using biotinylated U7 snRNA.  He found 
that he was able to purify five members of the canonical Sm-core: SmB/B’, SmD3, SmE, 
SmF, and SmG.  However, SmD1 and SmD2 were absent from biochemical purifications 
of the U7 snRNP.  In his initial study, Dr. Pillai identified Lsm10 as a novel protein that 
replaces one of the two missing Sm proteins in the U7 snRNP (Pillai et al. 2001).  He was 
later able to identify Lsm11 as the second replacement subunit in the U7 snRNP (Pillai et 
al. 2003).  Thus, the U7 snRNP contains a heptameric ring of Sm-proteins similar to the 
sliceosomal snRNPs; however, in the U7 snRNP, Lsm10 and Lsm11 have replaced 
SmD1 and SmD2.   
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 While both are unique to histone mRNA metabolism, the majority of study has 
focused on Lsm11, as it is the largest subunit and the primary subunit that interacts with 
specific processing factors in the U7 snRNP.  Lsm11 is a unique Sm-protein in that it 
contains two separate Sm folds that are separated by a linker region.  Also, it contains a 
long N-terminal extension, but no C-terminal extension.  Lsm11 has a predicted 
molecular weight of 36 kDa in contrast to other Sm-proteins that typically range from 10 
– 15 kDa.  In mammals, the U7 snRNP is stabilized on the HDE by an interaction 
between Lsm11 and SLBP that is mediated by another histone specific protein, ZFP100 
(Dominski et al. 2002; Azzouz et al. 2005; Wagner and Marzluff 2006).  ZFP100 
interacts with helix B in the SLBP RNA binding domain.  This region had been shown to 
be required for efficient 3’ end processing of histone messages.  ZFP100 also interacts 
with N-terminal domain of Lsm11.   
 Lsm11 also interacts with FLASH, a protein originally identified as a pro-
apoptotic protein associated with Caspase-8 (Imai et al. 1999; Yang et al. 2009a).  The 
first indication that FLASH was involved in histone mRNA metabolism came when it 
was shown that it localizes with the histone genes (Barcaroli et al. 2006).  This study 
showed that FLASH was required for efficient histone expression, but concluded that the 
reduction in histone mRNA levels was a transcription defect.  In fact, the decrease in 
expression was likely due to inefficient 3’ processing, which led to degradation of the 
misprocessed mRNAs.  FLASH’s involvement in 3’ end processing of histone mRNAs 
was first shown by its interaction with Lsm11, first by yeast two-hybrid screen and then 
by GST pulldown (Yang et al. 2009a).  Furthermore, nuclear extracts depleted of FLASH 
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fail to process histone mRNA in vitro and depletion of the Drosophila homolog of 
FLASH results in misprocessed histone mRNA in vivo. 
 After assembling the U7 snRNP complex with SLBP and ZPF100, the histone 
mRNA is cleaved after a CA dinucleotide in the same manner as with poly(A) mRNAs.  
Surprisingly, the same enzyme, CPSF-73, performs both endonucleolytic cleavages 
(Dominski et al. 2005).  By using RNAs containing phosphothioates to slow the cleavage 
reaction, Dr. Zbigniew Dominski was able to crosslink CPSF-73 to the histone pre-
mRNA and showed that it was necessary for both cleavage (Dominski et al. 2005; Yang 
et al. 2009b).  Purification of the heat labile factor provided even more connections 
between histone mRNA processing and poly(A) mRNA processing.  The heat labile 
factor was characterized by as being absolutely required for histone processing but 
distinct from the U7 snRNP and being susceptible to heat inactivation (Gick et al. 1987; 
LÅscher and SchÅmperli 1987; Luscher and Schumperli 1987).  By biochemical 
fractionation, Dr. Nikolay Kolev partially purified the activity of the heat labile factor 
(Kolev and Steitz 2005).  They confirmed the results from Dr. Dominski by showing that 
CPSF-73 was contained within the HLF, but also found that the polyadenylation factors 
CPSF-100, CPSF-160, CPSF-30, Fip1, CstF64, CstF-77, and Symplekin, which proved to 
be the factor susceptible to heat treatment.  They later confirmed that a complex of CPSF-
73, CPSF-100 and Symplekin was able to cleave histone mRNAs and this was also 
shown to be true in Drosophila (Kolev et al. 2008; Sullivan et al. 2009b).  Further 
investigations showed that this complex could be purified from nuclear extract by using a 
preassembled complex of Lsm11 and FLASH as bait (Yang et al. 2013), and that a 
complex of polyadenylation factors is associated with the U7 snRNP.      
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General Mechanisms of Eukaryotic mRNA Degradation 
Historically, mRNA transcription was assumed to be the primary contributor in 
establishing the abundance of mRNAs in a cell.  However, the steady state levels of 
mRNA are a product of both the rate of transcription and rate of mRNA degradation.  As 
the relative rates of transcription between various genes can be different, the rates of 
degradation between different mRNAs also vary (Perry and Kelley 1973; Singer and 
Penman 1973).  The half-life of an mRNA is determined by cis-elements in the mRNA 
and RNA binding proteins and miRNAs that interact with the mRNA.  
The pioneering studies of Dr. Roy Parker and coworkers have elucidated the 
pathways and factors involved in mRNA degradation in the budding yeast Saccromycces 
cerevisiae.  Mammalian cells contain orthologs of the yeast factors, which play important 
roles in mRNA degradation (Figure 6).   
Deadenylation 
The initial step in mRNA degradation involves transition from the closed-loop 
translation complex to the active degradation complex that facilitates efficient translation 
of an mRNA.  In this state, PAPBC1 is bound to the poly(A) tail and interacts with the 
eIF4F complex to form a closed loop.  The first step in initiation mRNA degradation is  
deadenylation, which serves to disrupt the closed-loop translation complex and, as the 
poly(A) tail is a key element in maintaining stability, begins to destabilize the mRNA.  
Three deadenylases have been identified in humans: (1) Pan2-Pan3, (2) Ccr4-Not 
Complex, (3) PARN [reviewed in (Wahle and Winkler 2013)].  As with many RNA 
degradation enzymes, the Pan2-Pan3 deadenylase was first identified in yeast (Sachs and 
Deardorff 1992).  Pan2-Pan3 appears to function doing the initial trimming of the  
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Figure 6. Outline of Cellular degradation pathways 
(A) Deadenylation dependent decay relies on removal of the poly(A) tail by one of the 
three deadenylases.  Decay can then continue in a 5’ to 3’ direction after binding of 
Lsm1-7 stimulates decapping by a NUDIX fold containing protein, of which Dcp2 is the 
most well-studied member.  Removal of the cap deprotects the 5’ end, leaving a 5’ 
phosphate that Xrn1 can use as a substrate for 5’ to 3’ exonucleolytic degradation.  
Alternatively, following deadenylation, the exosome may degrade the mRNA in a 3’ to 5’ 
direction.  Mounting evidence in mammalian systems indicates that these two pathways 
are not mutually exclusive and bidirectional decay may be commonplace.   
(B) Endonucleolytic cleavage dependent mRNA decay relies on one of many cellular 
endonucleases to cleave within the body of the mRNA.  This occurs by Dicer during 
siRNA mediated decay, by Smg6 during NMD or by PMR1 in specific cases.  Following 
cleavage, the 5’ and 3’ fragments are degraded by the exosome or Xrn1, respectively.    
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poly(A) tail which is then completed by Ccr4-Not, the major deadenylase in eukaryotic 
cells. (Yamashita et al. 2005).  Pan2 contains a DEDD nuclease domain that has poly(A) 
nuclease activity, while Pan3 contains a PABC1-interacting domain (PAM2 domain).  
Pan3 will interact with the poly(A) tail through its interaction with PABPC1 while the 
Pan2 subunit will begin to hydrolyze the poly(A) tail.  Pan2-Pan3 has a lower affinity for 
the poly(A) tail after removal of about 100 adenosines because of the reduction in 
PABPC1 molecules coating the tail.  At this point, the Ccr4-Not complex will finish the 
deadenylation reaction.   
 The major deadenylase in all organisms is Ccr4-Not.  It is a multisubunit complex 
of which five members are considered canonical: (1) Ccr4, (2) Caf1/Pop2, (3) Not1, (4) 
Not2, (5) Not3/5 (Albert et al. 2000; Temme et al. 2010).  Both Ccr4 and Caf1 possess 
deadenylase activity with Ccr4 containing an EEP domain that coordinates two essential 
Mg2+ ions and Caf1 containing a DEDD exonuclease domain similar to the active site of 
Pan2.  The HEAT domain containing protein Not1 acts as a scaffold upon which the 
other subunits of Ccr4-Not assemble.  It also coordinates interactions with trans-factors 
that target specific mRNAs.  For example, during AU-rich element (ARE) mediated 
degradation (AMD) (discussed in following sections), tristetraproline (TTP) binds to 
target mRNA and then directly interacts with Not1 to trigger deadenylation dependent 
degradation of ARE-containing mRNAs (Sandler et al. 2011). 
 The third vertebrate deadenylase is Poly(A)-specific ribonuclease (PARN), which 
is also a DEDD family exonuclease (Wu et al. 2005).  PARN is unique in that it not only 
has affinity for the poly(A) tails of mRNAs, but also has an affinity for the 7-
methylguanosine cap (Gao et al. 2000) (Dehlin et al. 2000).  The ability to bind the cap is 
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thought to help target PARN to non-translating mRNAs as the cap of translating mRNA 
should be bound by translation initiation factors such as eIF4E. 
Nucleases and accessory factors involved in mRNA degradation 
 Following deadenylation, mRNAs can be degraded in a 5’ → 3’ direction, a 
3’→5’ direction or bidirectionally.  In special cases, degradation can be initiated as a 
result of cleavage by an endonuclease followed by degradation of the resulting two RNA 
fragments. 
 The multisubunit exonuclease complex called the exosome degrades mRNAs in 
the 3’ → 5’ direction and also has roles in RNA maturation (Mitchell et al. 1997).  The 
core exosome, called Exo9, consists of 9 invariant subunits, six of which – Rrp41, Rrp42, 
OIP2 (Rrp43), PM/Scl-75 (Rrp45), Rrp46 and Mtr3 – form a hexameric torus.  The 
remaining three core subunits – Rrp4, Rrp40 and Csl4 – form a trimeric cap atop of the 
hexameric base.  The subunits contained within the trimeric cap contain S1 RNA binding 
domains and KH RNA binding domains, while the subunits of the hexameric ring contain 
RNAse PH domains.  However, none of the subunits have ribonuclease activity due to 
mutations in the active sites of the RNAse PH domains.  Instead, the ribonuclease activity 
of the exosome is conferred by the addition of auxiliary subunits, Dis3 (Rrp44) and 
Pm/Scl-100 (Rrp6), which, added to the Exo-9 complex, forms the Exo-10 exosome (Liu 
et al. 2006; Dziembowski et al. 2007).  Dis3 is located on the opposite side of the 
hexameric ring as the trimeric cap.  RNA is fed through center of the barrel shaped Exo-9 
spanning at least 25 nucleotides (Makino et al. 2013).  As the RNA exits the barrel, it 
comes into contact with the exonucleolytic active site of Dis3, which degrades the RNA 
processively.  In addition to the exonuclease activity, Dis3 also possesses endonucleolytic 
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activity conferred by the PIN domain located at the N-terminus (Lebreton et al. 2008; 
Schaeffer et al. 2009; Schneider et al. 2009).  The Exo-10 complex may also interact with 
a second exonucleolytic subunit, Pm/Scl-100 (Rrp6), in order to form the Exo-11 
complex.  Pm/Scl-100 sits on the opposite side of the exosome barrel from Dis3.   
 In order to degrade mRNAs 5’→3’, the 5’ 7-methylguanosine cap must be 
removed.  The most well studied protein that accomplishes this is the protein Dcp2, 
which is found in a stable complex with Dcp1.  Dcp2 was originally identified using 
yeast genetics (Dunckley and Parker 1999) and later confirmed to be a decapping enzyme 
in humans as well (Wang et al. 2002).  Subsequent biochemical characterization of Dcp2 
showed that is has the ability to release a m7GDP molecule from capped messages and 
that this activity is greatly enhanced by the binding of Dcp1 (Steiger et al. 2003; Cohen et 
al. 2005).  The active site of Dcp2 is found in the nudix fold that is characterized by an α-
helix/β-sheet/α-helix fold.  Subsequent genomic analyses in humans have identified 
many other proteins that contain this same fold.  In mammals, Dcp2 is differentially 
expressed in different tissues, leading to the hypothesis that there must be additional 
decapping enzymes to fill various roles (Song et al. 2010a).  Additionally, Dcp2 has 
affinity for some RNAs over others, indicating that there may target specific mRNAs for 
decapping rather than being a general decapping factor (Li et al. 2008; Li et al. 2009).  
Global analysis of mRNA stability following transcription arrest showed that lack of 
Dcp2 activity only stabilized a subset of mRNAs, indicating that Dcp2 dependent 
decapping is not required for all mRNAs (Song et al. 2010b).  Nudt16 was the second 
decapping enzyme discovered, originally in Xenopus but then in humans (Ghosh et al. 
2004; Taylor and Peculis 2008).  Nudt16 expression was found to be more ubiquitous in 
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mammals, but inactivation of the protein still only stabilized a subset of mRNAs, albeit, a 
different subset as was stabilized with Dcp2 inactivation (Song et al. 2010a). More 
recently, six additional nudix containing proteins – Nudt 2, Nudt3, Nudt15, Nudt 17, 
Nudt19 – have been identified and confirmed to contain decapping activity, bringing the 
total number of decapping enzymes in mammals to eight (Song et al. 2013). 
 Decapping activity is enhanced by a variety of accessory proteins such as the Edc 
proteins.  However, the critical complex in initiating degradation is the Lsm1-7 complex 
and this complex will be the most germane to the work presented in this thesis.  This 
complex is a heptameric ring that is restricted to the cytoplasm (Bouveret et al. 2000; 
Tharun et al. 2000).  Each protein in the ring contains a canonical Sm-fold for which they 
are named.  The Sm-fold is characterized by 5 β-sheets and a single terminal α-helix.  
This structure is sufficient to bind RNA.  Since most Lsm proteins are relatively small, 
often, the majority of the protein is contained within the Sm-fold.  There are a few 
notable exceptions that contain longer N-terminal or C-terminal extensions, which will be 
particularly relevant to my work.  Six proteins in the Lsm1-7 complex are shared with the 
nuclear Lsm2-8 complex, which is a component of the U6 snRNP and plays major roles 
in RNA splicing as well as roles in nuclear RNA turnover (Salgado-Garrido et al. 1999).  
 The Sm-folds of the individual Lsm proteins provide the RNA-binding site.  
Lsm1-7 has strong affinity for both oligoadenylated and oligouridylated RNA.  
Interestingly, Lsm1-7 has an intrinsic ability to distinguish between polyadenylated and 
oligoadenylated RNA that is dependent upon residues in Lsm1 (Chowdhury et al. 2007; 
Chowdhury and Tharun 2008).  This is important because deadenylation typically leaves 
short adenosine tail of about 10 nucleotides that has affinity for Lsm1-7 through an 
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unknown mechanism.  The ability to distinguish between oligo(A) and poly(A) tails  
prevents Lsm1-7 from aberrantly targeting poly(A) tail containing messages for 
degradation.  In yeast, deletion of Lsm1 impairs the rate of RNA degradation without 
affecting deadenylation, confirming that Lsm1-7 targets deadenylated mRNAs (Boeck et 
al. 1998; Schwartz and Parker 2000).  Furthermore, mRNAs that contain an unadenylated 
3’ end generated by ribozyme cleavage are not targets for 5’→3’ degradation mediated 
by Lsm1-7 and are instead degraded in a 3’ → 5’ direction by the exosome (Meaux and 
van 2006; Chowdhury and Tharun 2008).   
 The Lsm1-7 complex is typically considered to be in a stable complex with the 
protein Pat1b in yeast; however, a thorough biochemical investigation of this interaction 
has not been completed at this point, and no studies have been done on proteins bound to 
Lsm1-7 in mammalian cells.  Pat1 is an activator or decapping as its deletion in yeast 
results in a partial defect in decapping.  However, Pat1 may play a more important role in 
facilitating translational repression prior to the initiation of degradation.  Pat1 
coimmunoprecipitates with translation factor eIF4E and PABP in a RNA-dependent 
manner and a portion of the protein can be found on polysomes, which suggests that it 
interacts with the mRNA while it is still being actively translated and plays a role in 
mediating the transition from actively translated mRNA to one which is targeted for 
degradation (Tharun et al. 2000; Wyers et al. 2000).   
It interacts directly with other members of the decapping and deadenylation 
complex.  A complex consisting of the proteins Hedls, Rck/p54 (Dhh1) and hEdc3 is 
critical in decapping and degradation (Fenger-Gron et al. 2005).  Rck/p54 is a DEAD-box 
helicase that functions to shut down translation as an mRNA transitions from being 
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translationally competent to being targeted for degradation.  Pat1 acts to coordinate this 
complex with Lsm1-7 at the 3’ end of the mRNA (Braun et al. 2010; Ozgur et al. 2010).  
The Rck/p54, Hedls, hEdc3 complex can also include Dcp1and Dcp2 (Fenger-Gron et al. 
2005).  Thus, Pat1 may function to connect the decapping activity with deadenylation by 
coordinating Lsm1-7 binding to the 3’ end of deadenylated mRNAs with the decapping 
activity of Dcp2 at the 5’ end of mRNAs. 
Following decapping, mRNAs are rapidly degraded in the 5’ → 3’ direction by 
Xrn1 (Hsu and Stevens 1993; Muhlrad and Parker 1994).  The active site of Xrn1 
requires coordination of at least one Mn2+ ion for activity (Chang et al. 2011).  In 
mammals, Xrn1 is the major 5’→3’ exonuclease and is structurally and functionally 
related to the nuclear Xrn2/Rat1, which degrades downstream cleavage products in a 
5’→3’ direction following 3’ cleavage (Luo et al. 2006).  Utilization of Xrn1 in addition 
to the exonucleolytic activity of the exosome allows for mRNAs to be degraded by either 
decapping and 5’ to 3’ degradation, deadenylation followed by 3’ to 5’ degradation or a 
combination of the two processes.   
Decay via mRNA surveillance pathways Nonsense Mediated Decay  
In order to protect itself from possibly cytotoxic proteins produced from 
malformed mRNAs, the cell has various surveillance mechanisms to ensure that mRNAs 
are properly formed.  The best studied of these is nonsense mediated decay (NMD), 
which promotes the degradation of mRNAs that contain a premature termination codon 
(PTC) also known as a nonsense codon.  As many as one-third of congenital human 
disorders are caused by mutations that result in mRNAs harboring premature termination 
codons(Holbrook et al. 2004).  Translation of PTC-containing mRNAs could lead to the 
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production of C-terminally truncated proteins that might act as dominant negatives.  
These PTC containing mRNAs may arise from retained introns, errors in splicing, 
chromosomal rearrangements or mutations in genes.  Additionally, it has been reported 
that 3 - 20% of mRNAs contain features that make them natural targets for NMD (Karam 
et al. 2013).  In particular, the levels of many RNA binding proteins are autoregulated by 
coupling NMD with alternative splicing.  For example, the polypyrimydine tract binding 
protein alters spicing of its own mRNA creating an mRNA sensitive to NMD.  
 In mammals, the creation of an NMD sensitive mRNA results from the location of 
deposited exon junction complexes (EJCs) in relation to the stop codons along the body 
of the mRNA.  Following splicing of an mRNA, a multisubunit complex is deposited 24 
nucleotides upstream of where two exons where joined together marking a successful 
splicing event.  This core of this complex contains the proteins Y14, Magoh, eIF4III and 
RNPS1.  Normal mRNAs or those that are not natural targets for NMD contain their stop 
codons within their last exon.  Therefore, the presence of an EJC more than 50 
nucleotides downstream of a stop codon indicates a premature termination codon and 
makes the mRNA a target for NMD.  This is because this EJC is not removed by a 
translocating ribosome during translation.  Additionally, translation termination at PTC 
appears to mechanistically different than at normal termination codons indicating that 
PTC dependent termination is inefficient.  Toe print analysis of human β-globin mRNA 
that had a normal termination codon or a premature termination codon demonstrated that 
the NMD targets contained a toe print at the termination codon while normal termination 
did not (Peixeiro et al. 2012).  These ribosome toe prints indicated that there was 
ribosome pausing at PTCs but not at normal termination codons demonstrating that PTCs 
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were not as efficient at translation termination.  Additionally, the drug ataluren (PTC124) 
preferentially causes read-through of PTC but not of normal termination codons, again, 
indicating a mechanistic difference between translation termination at PTC versus normal 
termination codons (Welch et al. 2007). 
 The primary effectors of NMD are the Upf proteins, which were originally 
discovered in yeast as suppressors of nonsense mutations, and later shown to be 
conserved in humans.  There are three main Upf proteins, Upf1, Upf2 and Upf3, with 
there also being a second Upf3 variant, Upf3x.  All three Upf proteins can form a 
complex on the EJC with Upf3 being bound to the EJC, Ufp1 being recruited to PTC and 
Upf2 bridging the two proteins by interacting with both of them.  Upf1 is a large protein 
(130 kDa) consisting of two major domains: a zinc-finger domain (CH domain) and a 
helicase domain (Cheng et al. 2007; Chakrabarti et al. 2011).  Both domains are required 
for activating NMD (Weng et al. 1996; Bhattacharya et al. 2000).  The helicase domain is 
required to “push” protein components off of the mRNA to be degraded (Franks et al. 
2010).  In cells with an ATPase-dead Upf1 protein, NMD mRNA intermediates are 
unable to be degraded due to NMD proteins remaining bound to the 3’ fragment of the 
mRNA.  Upf1 also participates in other mRNA degradation pathways, particularly, 
histone mRNA degradation (Kaygun and Marzluff 2005a) and staufen- (stau1) mediated 
degradation (SMD) (Kim et al. 2005).  In SMD, stau1 recognizes inter- and 
intramolecular dsRNA helices and recruits Upf1 to target certain mRNAs for 
degradation.   
 The other set of proteins that play an integral role in NMD are the Smg proteins, 
which consist of smg1, smg 5 – 9.  The majority of these proteins serve to regulate the 
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phosphorylation and dephosphorylation of Upf1.  Smg1 is a kinase that phosphorylates 
many residues in the N-terminal and C-terminal domains of Upf1 (Denning et al. 2001; 
Pal et al. 2001; Yamashita et al. 2001).  The kinase activity of Smg1 is regulated by its 
two binding partners Smg8 and Smg9 (Yamashita et al. 2009).  Smg5 and Smg7 regulate 
Upf1 dephosphorylation by recruiting protein phosphatase 2a (PP2a) (Chiu et al. 2003; 
Fukuhara et al. 2005).  The role of this dephosphorylation is poorly understood, but 
presumably functions to recycle NMD components.  Phosphorylation of threonine-28 
provides a platform for Smg6 binding, which is unique among the Smg proteins (Okada-
Katsuhata et al. 2012).  Rather than affecting the phosphorylation of Upf1, Smg6 contains 
an endonucleolytic PIN1 domain like the one found in Dis3 (Glavan et al. 2006).  
Experiments by the Lykke-Andersen and Izaurralde labs have demonstrated that Smg6 
cleaves mRNAs targeted for NMD in both humans and Drosophila (Huntzinger et al. 
2008; Eberle et al. 2009).  Following this endonucleolytic cleavage, the two resulting 
halves of mRNA are degraded by Xrn1 in a 5’→3’ direction and the 3’→5’ direction by 
the exosome. 
No-Go Decay and Non-Stop Decay 
  While NMD is the best studied mRNA surveillance mechanism, two other 
equally important surveillance mechanisms are No-Go decay (NGD) (Van Hoof et al. 
2002), which targets mRNAs that lack termination codons, and Non-Stop decay (NSD) 
(Doma and Parker 2006), which targets mRNAs with stalled ribosomes typically due to 
secondary structures in mRNA ORFs.  Both of these mechanisms require recognition of 
the ribosome.  In NGD, a ribosome stalled at the 3’ end of an mRNA is recognized by 
Ski7, which then enters the unoccupied A-site and facilitating ribosome release by 
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mimicking eRF1 and eRF3.  Following ribosome release, the mRNA is targeted for 
degradation.  In NSD, which has only been identified in S. cerevisiae, the unoccupied A-
site of the stalled ribosome is recognized by the Hbs1/Dom34 complex.  In this case, 
Hbs1 mimics eRF3 to promote ribosome release and Dom34 endonucleolytically cleaves 
the mRNA, allowing for degradation of the two halves of the mRNA by Xrn1 and the 
exosome.   
Decay via cis-element mediated degradation 
 The half-life of every mRNA is determined by sequences in the mRNA, usually 
by its 3’ untranslated region.  In addition, it is often necessary to regulate the half-lives of 
particular messages by either stabilizing them or initiating degradation.  This task is 
accomplished by alteration of the trans-factors that interact with the cis-elements 
encoded in the mRNA sequences.  One of the best-studied examples of regulated mRNA 
stability by cis-elements is A+U rich element (ARE) mediated degradation (AMD).  
AREs are characterized by 50 – 150 nucleotide stretches of sequence that are particularly 
rich in adenosine and uridine residues and contain multiple AUUUA motifs.  They are 
typically in the 3’ UTRs of target genes.  The first characterized ARE was in the 
granulocyte-macrophage colony stimulating factor (GM-CSF) mRNA (Shaw and Kamen 
1986).  They inserted a 58 bp sequence containing the suspected mRNA sequence 
element into the 3’ UTR of a recombinant rabbit β-globin gene.  After transcriptional 
shut off by treatment with actinomycin D the ARE containing β-globin gene had a half-
life of less than 30 minutes, while β-globin constructs containing mutations to the 
AUUUA motif were stable over the two-hour time-course.  Later studies confirmed these 
results without the use of actinomycin D, which can cause off target effects (Xu et al. 
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1998).  Shaw and Kamen also pointed out that many genes that code for proto-oncogenes, 
lyphokines and cytokines contain similar AU-rich sequences in their 3’UTRs.  
Subsequent studies have determined that many of these initial candidates are bone fide 
AMD targets including TNF-α (Lai et al. 1999), c-fos (Chen et al. 1995a), p21 and 
interleukin-2 (Bhattacharya et al. 1999).  Some estimates suggest that between 5 – 8% of 
transcripts contain AREs (Halees et al. 2008). 
 The ARE cis-elements function through a variety of trans-factors, often referred 
to as ARE-binding proteins (AUBPs).  Some of these AUBPs function to promote 
degradation of ARE containing messages such as AUF1/hnRNP D or TTP.  However, 
binding of some factors, such as HuR has been shown to stabilize ARE-containing 
mRNAs and binding of T-cell intracellular antigen 1 (TIA-1) or TIA-1-related protein 
(TIAR) functions to modulate translation.  These situations are further complicated by the 
fact that a single ARE may bind multiple AUBPs, thus fine-tuning the expression of the 
target gene.   
 A less studied though equally intriguing cis-element that modulates mRNA 
stability are GU-rich elements (GREs).  As their name suggests, these elements are 
similar to AREs except they contain guanosine and uridine residues as opposed to 
adenosine and uridine residues.  They have a 11 nucleotide cis-element: 
UGUUUGUUUGU (Vlasova et al. 2008).  This element binds members of the CUGBP 
(CELF) family, which has at least 6 members (CELF1 – 6) (Vlasova and Bohjanen 
2008). 
 The histone stem-loop is the cis-element that regulates the stability of histone 
mRNAs.  While it is also necessary for proper 3’ end processing, export and translation, 
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the stem-loop is both necessary and sufficient for histone mRNA degradation (Pandey 
and Marzluff 1987).  In fact, as AREs can be moved to non-ARE containing genes and 
alter their stability, the histone stem-loop can be inserted at the 3’end of reporter genes to 
regulate their half-lives (Pandey and Marzluff 1987; Su et al. 2013).   
Histone mRNA degradation 
 The degradation of histone mRNAs utilizes many of the same factors used in 
general mRNA degradation; however, as their degradation is cell cycle dependent and 
required that there not be a poly(A) tail, there are some surprising aspects unique to 
histone mRNA degradation.   
Histone mRNAs are rapidly degraded at the end of S-phase (Harris et al. 1991b; 
Morris et al. 1991) or when DNA synthesis is inhibited (Sittman et al. 1983; Baumbach et 
al. 1984; Graves and Marzluff 1984).  This disappearance of these mRNAs is largely due 
to a change in the half-life of the messages (DeLisle et al. 1983; Sittman et al. 1983; 
Graves and Marzluff 1984).  Following the inhibition of DNA synthesis by hydroxyurea, 
the half-life of histone mRNAs changes from 45 – 60 minutes to about 10 minutes.  The 
initiation of degradation of these mRNAs occurs 5 – 10 minutes after the addition of HU 
(Graves and Marzluff 1984; Su et al. 2013).   
The relationship between histone mRNA stability and translation of the mRNA 
was appreciated early on in the investigation of histone mRNAs.  The earliest evidence 
came nearly 40 years ago when it was demonstrated that histone mRNA degradation was 
inhibited when protein synthesis was inhibited (Butler and Mueller 1973; Breindl and 
Gallwitz 1974; Stahl and Gallwitz 1977).  In fact, histone mRNAs are able to accumulate 
after the inhibition of DNA synthesis (Graves and Marzluff 1984; Graves et al. 1987; 
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Kaygun and Marzluff 2005b) or during G1-phase (Stimac et al. 1984; Harris et al. 1991a) 
if protein synthesis has been inhibited.  The first direct evidence for translation being 
necessary for histone mRNA degradation came from the work of Dr. Reed Graves and 
colleagues (Graves et al. 1987).  Their work outlined three critical findings that would 
help underpin our knowledge of histone mRNA degradation.  Using chimeric histone 
genes transfected into mouse tk- L cells, they confirmed previous work showing that the 
histone stem-loop is the critical determinant for directing histone mRNA degradation 
(Alterman et al. 1985; Luscher et al. 1985; Pandey and Marzluff 1987).  When histone 
mRNAs ended in poly(A) tails instead of stem-loops, their degradation was not regulated.  
Furthermore, this stem-loop needs to be at the 3’ end of the mRNA.  If an mRNA 
contained a stem-loop but terminated in a poly(A) tail, it was not subject to degradation.  
By removing coding regions of the histone mRNAs in 100 nucleotide blocks, they also 
determined that there are not sequences within the open reading frame of the histone 
mRNA.  This observation was particularly useful, as later studies would swap the histone 
ORF with ORFs of other genes to use as a reporter.   
Previous work had shown that general protein synthesis was necessary for histone 
mRNA degradation.  In these previous studies, global protein synthesis was inhibited by 
the addition of cycloheximide (CHX).  While these approaches provided initial insight 
into the requirements for histone mRNA degradation, they did not definitively implicate 
the translation of histone mRNAs themselves as needing to be translated.  It was possible 
that CHX treatment inhibited the translation of an additional factor that was needed for 
degradation or that degradation was activated by synthesis of excess histone proteins.  By 
making mutations that created a stop codon at codon 43, they were able to determine that 
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translation of the histone message itself, rather than protein synthesis in general, was 
required for histone mRNA degradation.   
Dr. Handan Kaygun followed up these experiments 20 years later by utilizing the 
iron response element (IRE) to modulate histone mRNA translation (Kaygun and 
Marzluff 2005b).  The IRE is a cis-element consisting of a 30-nucleotide stem-loop 
structure found in the 5’ UTRs of ferritin mRNAs that binds aconitase 1 (Aco1/IREB1).  
Binding of Aco1 to the ferritin mRNA inhibits translation of the bound mRNA and the 
ability of Aco1 to bind is dictated by the intracellular levels of iron.  By inserting an IRE 
in the 5’ UTR of a recombinant histone mRNA and varying the intracellular levels of iron 
by treatment with deferoxamine, an iron chelator, or hemin, an iron-containing porphyrin 
molecule, Dr. Kaygun was able to modulate the translation of particular histone mRNAs.  
As suggested by previous work, the stability of an individual histone mRNAs is 
dependent upon whether or not it is being translated.  Furthermore, transfection of a 
mutant of SLBP that is not capable of maintaining translation (SLBP-SAVEE) stabilized 
histone message if endogenous SLBP mRNA what knocked down by RNAi.   
Dr. Kaygun further explored the role of the distance between the stop codon and 
the stem-loop.  If the stem-loop was moved within 11 nucleotides of the stop codon, the 
histone mRNA was constitutively unstable.  Conversely, if the stem-loop was moved far 
from the stop codon (505 nts in this case), the histone mRNA was constitutively stable.  
These data argued that interactions with the terminating ribosomes or release factors 
might be needed for proper regulation of the mRNA.  This situation would be analogous 
to that found in NMD where an EJC present 20 – 40 nucleotides downstream of a stop 
codon is a trigger for degradation (Maquat 2004).   
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This led her to investigate whether NMD factors might be required for histone 
mRNA degradation and she showed that Upf1 was required for histone mRNA 
degradation (Kaygun and Marzluff 2005a).  Knockdown of Upf1, but not Upf2, led to 
stabilization of histone mRNA after the inhibition of DNA synthesis and during a normal 
cell cycle.  She also confirmed that the helicase and ATP binding domains of Upf1 were 
necessary for its functions in histone mRNA degradation.  She also determined that Upf1 
was a direct player in histone mRNA degradation through her immunoprecipitation 
experiments.  She transfected haemagglutinin (HA)-tagged SLBP and performed 
immunopreciptiation experiments before and after HU treatment.  Immunoprecipitates 
were tested by western blot for the presence of Upf1 and she found that after the initiation 
of histone mRNA degradation, Upf1 associates with SLBP indicating that it is directly 
associated with histone mRNAs during degradation.  In contrast to NMD, other Upf 
proteins are not involved in histone mRNA degradation.  However, Smg1, the kinase that 
phosphorylates Upf1, is necessary (Tom Mullen, unpublished data).   
Dr. Tom Mullen’s work provided an even more unexpected revelation about 
histone mRNA degradation (Mullen and Marzluff 2008).  By RNAi, he showed that the 
Lsm1-7 complex was necessary for efficient histone mRNA degradation.  This result was 
puzzling as Lsm1-7 typically binds the short oligo(A) tail remaining after deadenylation 
of poly(A) messages.  Since histone mRNAs are not polyadenylated, what was Lsm1-7 
binding?  Dr. Mullen interrogated the 5’ and 3’ ends of the degrading mRNA by circular 
RT-PCR (cRT-PCR).  Briefly, this method involves intramolecular ligation of the 5’ and 
3’ ends of a mRNA followed by RT-PCR and sequencing across the ligation junction.  
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He found that the 3’ end often contained a short non-genomically encoded oligo(U) tail 
(Figure 7).  He hypothesized that this oligo(U) tail provided a binding site for Lsm1-7.   
The addition of non-templated oligo(U) tails to a specific subset of mRNAs was a 
particularly novel finding.  However, at the time of Dr. Mullen’s work, there were some 
other reports of uridylation being involved in RNA degradation.  In Arabadopsis 
thaliana, the addition of non-templated oligo(U) tails had been reported on the 5’ mRNA 
fragment after miRNA mediated cleavage (Shen and Goodman 2004).  Oligoadenylation 
had also been seen as a post-transcriptional regulator of gene expression.  In the nucleus, 
addition of short oligo(A) tails by the TRAMP complex is a trigger for degradation of 
aberrant RNAs (Allmang et al. 1999; van Hoof et al. 2000; Kuai et al. 2004; LaCava et 
al. 2005).  The oligouridylation of histone mRNAs to trigger degradation also bears some 
similarity to the general mechanism of degradation in bacteria.  Bacterial mRNAs 
typically end in a stem-loop structure.  Their degradation is triggered by the addition of 
an adenylate tail that provides a platform for binding of Hfq, a hexameric ring which is 
homologous to the eukaryotic Sm-proteins (Hajnsdorf and Regnier 2000; Le Derout et al. 
2003).  Following the publication of Dr. Mullen’s work, cellular uridylation has become a 
much more highly investigated topic particularly in the field of miRNA biogenesis.  In 
particular, the Let7 miRNA has been shown to be uridylated as both a mature miRNA 
and as a pre-miRNA (Heo et al. 2008; Heo et al. 2009; Newman et al. 2011).   
The identity of the enzyme that adds the uridyl tails has been a much-debated 
topic.  In Dr. Mullen’s original research, he identified 7 proteins that might contain uridyl 
transferase activity based on their similarity to the U6 snRNA terminal uridyl transferase 
(TUTase) and Cid1, a characterized TUTase in S. pombe (Trippe et al. 2006; Kwak and 
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Wickens 2007).  These were subsequently named Tut1 – Tut7.  Using siRNAs directed to 
each putative Tutase, Dr. Mullen determined that knockdown of both Tut1 and Tut3 
(PAPD5) resulted in stabilization of the histone message after inhibition of DNA 
synthesis.  Following this study, Tut4 (ZCCHC11) was suggested as a possible effector 
of histone mRNA uridylation (Schmidt et al. 2011).  This study also reported that 
knockdown of either Tut1 or Tut3 had no effect of histone mRNA stability.  Additionally, 
immunofluorescence of endogenous Tut3 showed that this protein was primarily nuclear 
and contained adenylation activity only (Rammelt et al. 2011).  Follow up work in our 
lab has indicated that the mRNA stabilization seen by Tut1 knockdown was likely due to 
a cytotoxic effect or cell cycle defect and not due to a direct effect on histone mRNAs 
(Patrick Lackey, unpublished data).  Following this contradictory data, a third study 
demonstrated that knockdown of Tut4 has stabilizing effects on histone mRNAs (Su et al. 
2013).  However, this study demonstrated that Tut4 was required for histone mRNA 
degradation in the absence of hydroxyurea treatment.  Much more work is required to 
determine the exact molecular events that occur leading to uridylation of the histone 
mRNA, but, it seems likely that multiple TUTases may play combinatorial or redundant 
roles.   
The other interesting finding from Dr. Mullen’s investigation of histone mRNA 
degradation was that an individual molecule was subject to both 3’→5’ and 5’→3’ 
degradation.  Knockdown of either Xrn1 or components of the exosome (Pm/Scl-100 or 
Rrp41) stabilized histone mRNAs as did knockdown of Lsm1-7.  More intriguingly, cRT-
PCR of the Hist2H2aa3 gene demonstrated that a single molecule was degraded 
simultaneously from the 5’ and 3’ ends.  Using an invader assay, Schoenberg lab  
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presented data that ARE containing messages are degraded bidirectionally (Murray and 
Schoenberg 2007).  Combined, these data suggest that in mammals, bidirectional decay 
may be the typical mechanism of degradation as opposed to yeast, which typically 
degrade mRNAs 5’ → 3’.  
 In this thesis, I will present data that will demonstrate the sequence and structural 
requirements for SLBP and 3’hExo binding as determined by utilizing two high 
throughput techniques, RNA-MITOMI and HITS-CLIP.  Then, I will demonstrate that in 
addition to facilitating histone 3’end processing, export and translation, SLBP directs 
histone mRNA degradation after the inhibition of DNA synthesis.  This is through direct 
interaction with the C-terminal tail of Lsm4.  Finally, I will show how cells are able to 
keep producing histone proteins after they exit the cell cycle in terminally differentiated 
mouse tissue. 
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Figure 7. The initial step in histone mRNAs is oligouridlylation of the 3’ end.  (A) 
Schematic of circular RT-PCR (cRT-PCR) protocol.  (B) Electropherogram of 
oligouridylated 3’ end ligated to 5’ end.  (C) Knockdown of Lsm1 stabilizes the 
degradation of histone mRNAs 
Adapted from Mullen & Marzluff 2008.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
	   50	  
 
 
 
 
	   51	  
 
 
 
CHAPTER II: SEQUENCE ELEMENTS REQUIRED FOR BINDING OF SLBP 
AND 3’hEXO TO THE HISTONE STEM-LOOP 
 
Introduction 
 The histone stem-loop is the critical cis-element that governs all aspects of the 
histone mRNAs life cycle.  The two proteins that bind this structure, SLBP and 3’hExo, 
directly act on the histone mRNAs or provide both a platform for other proteins to act on 
these mRNAs.  As these interactions are highly specific, the sequence and structural 
elements of the stem-loop that govern binding must be specifically organized.  In fact, the 
remarkable evolutionary conservation of the stem-loops in the 65 individual replication-
dependent histone genes in not only the human genome, but in all metazoans except for a 
single change in C. elegans, is a testament to this fact.  Both SLBP and 3’hExo were 
isolated by their abilities to interact directly and specifically with the histone stem-loop 
(Wang et al. 1996; Martin et al. 1997; Dominski et al. 2003).  However, prior to the 
discovery of the identity of these trans factors, the RNA sequences required for mature 
histone mRNA formation had been well studied.  The sequence requirements for SLBP 
binding had been studied for nearly a decade before SLBP was identified.   
 Dr. Niranjin Pandey expressed recombinant histone genes in Chinese Hampster 
Ovary (CHO) cells (Pandey et al. 1991; Pandey et al. 1994) and found that reversing the 
stem prevented expression of the histone mRNAs presumably by rapidly degrading 
unprocessed message.  He found that alterations to the 1st and 3rd nucleotides in the loop 
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as well as flipping the two base pairs at the base of the stem also prevented accumulation 
of the histone mRNAs.  Finally, he showed that a C-G base pair at the top of stem as 
opposed to the conserved A-U base pair reduced the expression of histone mRNAs.  He 
determined that the failure to express these recombinant mRNAs was due to an inability 
to properly process the mRNA at the 3’ end.   
 Dr. Anthony Williams followed up this work as he demonstrated by UV 
crosslinking that a protein with an apparent size of 45 kDa, which would later be 
identified as SLBP, would bind the stem-loop in both nuclear and cytoplasmic extracts 
(Pandey et al. 1991; Williams et al. 1994; Williams and Marzluff 1995).  Building on Dr. 
Pandey’s work, he showed that the stem-loop mutants that did not express in CHO cells 
were defective in binding to SLBP by EMSA.  He also determined that the upstream 
flanking region of the stem-loop was necessary for binding to SLBP.  Mutation of the 
conserved adenosine nucleotides 5’ to the stem reduced SLBP binding to the stem-loop.  
An indepth study of SLBP’s binding affinity for the histone stem-loop was conducted 
2001 by Dr. Dan Battle while in the laboratory of Dr. Jennifer Doudna (Battle and 
Doudna 2001).  He determined that SLBP has subnanomolar affinities for the wild-type 
histone stem-loop and first demonstrated that the  2nd base-pair in the stem (G2-C15) 
drastically reduced affinity for SLBP for the stem-loop.  
 Dr. Zbigniew Dominski identified 3’ hExo by its ability to interact specifically 
with the histone stem-loop and not with the reverse-stem stem-loop (Dominski et al. 
2003).  He also tested a number of mutations in the stem-loop for their ability to bind 
3’hExo by pulling down in vitro translated 3’hExo with biotinylated stem-loop mutants.  
He found that reversing the 2nd and 3rd base pairs together and the 4th and 5th base-pairs 
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together reduced 3’hExo’s affinity for the stem-loop.  He also found that the 3’ flanking 
region was more important for 3’hExo binding that the 5’ flanking region.  Note that the 
importance of the flanking regions are opposite for SLBP and 3’hExo.  High affinity 
binding required that the final nucleotide be an adenosine and that there be 5 nucleotides 
following the base of the stem.     
 While these initial investigations of the stem-loop sequence requirements that 
allow for binding of SLBP and 3’hExo provided several important insights, an 
investigation of the full sequence space has not been completed.  No more than 16 
different mutations of the stem-loop have ever been tested, which is a small percentage of 
the mutations possible to a 26-nucleotide sequence (> 45,000 variants).  A more in depth 
analysis of the contribution of each nucleotide to binding of both SLBP and 3’hExo may 
yield insights into the structure and function of these two proteins as well as in the 
evolution of the histone 3’ end.  To this end, I participated in two high throughput 
investigations of RNAs that could bind SLBP (RNA-MITOMI) and the RNAs that 
interact with SLBP in vivo (HITS-CLIP).  These allowed us to investigate SLBP binding 
to the stem-loop both in vitro and in vivo.  Using RNA-MITOMI, we were able to make 
many non-obvious and surprising observations about the SLBP recognition of the stem-
loop RNA.   
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Materials and Methods 
RNA-MITOMI  
 The protocol for Mechanically Induced Trapping of Molecular Interactions 
(MITOMI) was modified to allow for measurements of protein binding to RNA rather 
than DNA (Maerkl and Quake 2007; Gerber et al. 2009).  This modified protocol was 
termed RNA-MITOMI (Martin et al. 2012).  An in-depth description of RNA-MITOMI 
along with validation of the technique can be found in Martin et al. 2012.  The RNA-
MITOMI experiments were carried out in Dr. Howard Chang’s laboratory at Stanford 
University by Lance Martin using recombinant proteins that I provided.  Lance and I 
designed the RNA motif library we used and I subsequently validated the results by 
mobility shift experiments.     
 Briefly, on a 640-well wafer, stem-loop mRNAs were transcribed using T7 RNA 
polymerase (Figure 8).  The stem-loops were extended on the 3’ end to contain a A24-
tail.  This oligo(A) tail was used to capture the RNA in the well via an oligo(dT) DNA 
oligo labeled with FAM-fluorophore.  The oligo(dT) capture DNA was biotinylated on 
it’s 5’ end to allow for attachment to the well RNA capture.  RNA capture was confirmed 
by lack of quenching after flowing an oligo(dA) primer covalently linked to an Iowa 
Black dark quencher.  If RNA was effectively captured through its oligo(A) stretch, the 
Iowa Black-d(A) primer would not bind the oligo(dT) and there would not be quenching. 
 To measure binding of SLBP to the stem-loops, GST-SLBP that had been pre-
incubated to TxRed-α-GST was flowed over captured RNA.  After washing, fluorescent 
intensity of TxRed was measured to determine the amount of protein bound.  The 
efficiency of binding was determined as the ratio between TxRed/FAM fluorescence (i.e.  
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Figure 8. RNA-MITOMI workflow.  (A) An RNA motif library is designed to test 
protein binding against (B) A cDNA microarray of templates that each serve as a 
template for RNA expression are spotted. (C) A microfluidic device is placed on top of 
the microarray such that each cDNA spot is compartmentalized in a unique champber. 
(D) A FAM-labeled poly(T) DNA capture probe is immobilized to the microarray surface 
in each chamber.  The probe is complimentary to the poly(A) tail on each transcribed 
RNA.  In vitro transcription of RNA is performed from the spotted cDNA templates in 
each chamber and the resulting RNA molecules are captured by the probe. (E)A 
Quencher probe is flowed across the array in order to quantify the abundance of 
immobilized RNA in each chamber. (F) A Tx-Red labeled protein is flowed across the 
array and allowed to equilibrate with each RNA.  Unbound proteins are washed off of the 
chip. (G) The array is scanned in order to quantify protein pull down to each motif.         
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protein/RNA).  Relative affinity was then calculated by setting the protein:RNA ratio of 
SLBP:SLWT interaction to 1.   
HITS-CLIP of SLBP 
HITS-CLIP was completed as described in (Licatalosi et al. 2008) by Lionel Brooks III in 
Dr. Mike Whitfield’s lab at Dartmouth University.  HeLa-S3 cells were grown in 
monolayer to 80 percent confluency on 100 mm polystyrene culture plates. Prior to UV 
crosslinking, cells were washed with 10 ml ice-cold PBS. The washed plates were then 
placed on ice and irradiated with 7400 mJ of 254 nm UV light. Cells were immediately 
lysed in NP-40 lysis buffer (0.5 % NP-40, 150 mM NaCl, 10 mM Tris [pH 7.5]) and 
concurrently exposed to micrococcal nuclease and DNase. The micrococcal nuclease 
digestion was stopped by chelation of Ca2+ ions by the addition of EGTA.  Polyclonal α-
SLBP antibody was used for immunoprecipitation of SLBP complexes.  As a negative 
control, α-GFP was used.  Three α-SLBP IPs were performed and three negative control 
IPs were performed.  Adapter ligation and RNA fragment purification were performed as 
according to manufacturers instructions except illumina sRNA adapters were used. The 
CLIP libraries were sequenced at the UNC genomics core facility on a GAII to yield 36 
base pair single-end reads. 
In vitro transcription of stem-loop substrates for crosslinking assays and 
electrophoretic mobility shift assays (EMSAs) 
 Stem-loops used in electrophoretic mobility shift assays (EMSA) and crosslinking 
studies were made by in vitro transcription.  Probes used in EMSAs were uniformly 
labeled with [α-32P]-CTP.  Oligonucleotide sequences were ordered from Integrated 
DNA Technologies (IDT) containing the reverse complement of the histone stem-loop 
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with the reverse complement of the T7 promoter (Milligan et al. 1987; Pandey and 
Marzluff 1987).  These oligonucleotides were annealed to an oligonucleotide which 
coded for the T7 promoter by mixing 10 pmol of each in a 10 µL solution containing 
10mM Tris-HCl [pH 7.9], 10 mM MgCl2, 50 mM NaCl, 1 mM DTT.  The reaction was 
heated to 100oC for 10 minutes and then placed on ice for 10 minutes.  The resulting 
DNA product is shown below and transcription initiates at the underlined G and extends 
to the end of the template:  
 
   5’ TAATACGACTCACTATAGGG 3’ 
 3’ ATTATGCTGAGTGATATCCC GGGTTTTCCGAGAAAAGTCTCGGTGGGT 3’ 
 
 
To this annealed DNA template, 5 µL of 10X Transcription buffer (40 mM Tris [pH 7.9], 
6 mM MgCl2, 10 mM DTT, 2 mM spermidine), 5 µL of 10 mM rATP, rGTP, rUTP (3.3 
mM each), 10 µL of 3.3 µM [α-32P]-3000 Ci/mmol-CTP, 1 µL of Ribolock (40U/µL) 
(Fermentas), 2 µL of 50U/µL T7 RNA polymerase (New England Biolabs) and 17 µL of 
dH2O were added on ice.  The transcription reaction mixture was incubated at 37oC.  
After 2 hours, DNA template was removed by adding 1 µL of 1U/µL RQ1 DNAse 
(Promega) for 15 minutes.  Unincorporated nucleotides were removed by running the  
total reaction through Illustra G-25 sephadex microspin columns (GE Healthcare 
lifesciences).  Eluate was ethanol precipitated with 1 µL of 15 mg/mL glycoblue 
(Ambion).  RNA pellet was resuspended in 20 µL of RNA loading dye (98% Formamide, 
0.2 mM ETDA, 0.25% SDS, 0.01% Bromophenol Blue, 0.01% Xylene Cyanol) and 
loaded onto 15% Urea-Acrylamide gel (acrylamide:bis-acrylamide was 19:1).  Following 
electrophoresis, the wet gel was exposed to film for 2-5 minutes to visualize radioactive 
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transcription products.  Products were excised from gel and frozen for 1 hour at -80oC.  
Transcription products were eluted from gel overnight in RNA elution buffer (20 mM 
Tris, 250 mM Sodium Acetate, 1 mM EDTA, 0.25% SDS) at room temperature while 
rotating.  The following day, the liquid phase was removed to a new eppendorf tube and 
extracted with phenol/chloroform followed by ethanol precipitation.  The pellet was 
resuspended in 50 µL of dH2O.  Concentration was calculated following determination of 
cpm on scintillation counter.  
 For stem-loops used in crosslinking studies, protocol was the same except, in the 
transcription reaction, 10 µL of 3.3 µM [α-32P]-3000 Ci/mmol-UTP was used in place of 
CTP, 10mM rATG, rGTP, rUTP (3.3 µM each) mix was replaced with 10 µM rATG, 
rGTP, rCTP (3.3 µM each) and 100 µM rCTP was replaced with 100 µM rUTP.  This 
resulted in stem-loops labeled with UTP rather than CTP.   
Expression and purification of recombinant SLBP and 3’hExo from Sf-9 cells 
 Full-length SLBP, RNA binding domain (amino acids 125 – 223) of SLBP and 
full length 3’hExo was cloned into pFastBac HTa.  To produce bacmid, these pFastBac 
was transformed into DH10BAC E. coli and grown for 48 hours at 37oC on LB-agar 
plates supplemented with 10 µg/ml tetracycline, 7 µg/ml gentamicin, and 50 µg/ml 
kanamycin 40 µg/ml of IPTG and 100 µg/mL Bluo-gal (Invitrogen).  Incorporation of 
plasmid DNA into bacmid was monitored by blue/white screening.  Individual white 
colonies were picked and grown overnight at 37oC.  Bacmids were recovered by alkaline 
lysis followed by phenol/chloroform extraction and ethanol precipitation.  Positive 
bacmids were screened by PCR.  To produce viral particles, bacmids were transformed 
into Sf-9 cells grown in a monolayer using Cellfectin II (Invitrogen).  P1 viral particles 
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were harvested from media 2 days post-transfection.  The P1 virus was amplified by 
adding 500 µL of virus to 50 mL of Sf-9 cells at 2 x 106 cells/mL.  P2 viral particles were 
harvested from media 3 days post-secondary infection.   
 For large scale protein expression, 1 L of Sf-9 cells at 2 x 106 cells/mL were 
infected with 10 mL of P2 virus and grown for 72 hours at 27oC while shaking.  Cells 
were collected by centrifugation and lysed in 5 cell volumes of Sf-9 Lysis buffer (50 mM 
Tris [pH 7.5], 1% NP-40, 5 mM β-mercaptoethanol and 1X protease inhibitors-EDTA 
Free (Roche)) for 10 minutes on ice.  Insoluble material was pelleted by centrifugation 
for 10 minutes at 12000 x g.  Clarified lysate was transferred to a falcon tube containing 1 
mL of pre-equilibrated Ni-NTA agarose (Qiagen) and rotated for 3 hours at 4oC.  Ni-
NTA agarose was pelleted by centrifugation and washed with 25 mL of Buffer A (20 mM 
Tris [pH 8.0], 500 mM KCl, 1 mM β-mercaptoethanol, 10% glycerol) and then 5 mL of 
Buffer B (20 mM Tris [pH 8.0], 1 M KCl, 1 mM β-mercaptoethanol, 10% glycerol).  
Recombinant protein was eluted from column with 5 mL Buffer C (20 mM Tris [pH 8.0], 
100 mM KCl, 5 mM β-mercapotethanol, 10% glycerol, 150 mM imidazole) in 10 0.5-mL 
fractions.  Purification was checked on SDS-PAGE gel followed by coommassie staining.  
Recombinant protein was quantified using Qubit-IT. 
Electrophoretic mobility shift assays 
10 femtomoles of uniformly labeled RNA was incubated on ice with various amounts of 
purified recombinant protein in 10 mM HEPES [pH 7.60], 50 mM KCl, 0.1 mM EDTA, 
10% glycerol, 1 µg/µL yeast tRNA, 0.1 µg/µL, BSA.  For shifts with 3’hExo, yeast 
tRNA was omitted from shifts.  Reactions were directly loaded onto 6% native 
polyacrylamide gel (acrylamide:bisacrylamide was 29:1 in 1X TBE buffer) without any 
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loading dyes.  Gels were fixed in 45% methanol/10% acetic acid, dried and then 
visualized by autoradiography on phosphor screen and film.  Images were analyzed by 
ImageQuant. 
Crosslinking Assays 
 For crosslinking assays, in 10 µL, 1 pmol of recombinant protein was incubated 
with 10 fmol of stem-loop probes uniformly labeled with 32P-uridine in 10 mM HEPES 
[pH 7.60], 50 mM KCl, 0.1 mM EDTA, 10% glycerol, 1 µg/µL yeast tRNA, 0.1 µg/µL 
BSA for 30 minutes on ice.  Yeast tRNA was omitted for experiments using 3’hExo.  
RNA:protein complexes were crosslinked for 10 minutes on ice using stratalinker 
(Stratagene) with 254 nm UV bulbs.  An equal volume of 2X SDS-loading buffer (4% 
SDS, 10% β-mercaptoethanol, 0.125 M Tris [pH 6.8], 20% glycerol, 0.2% Bromophenol 
Blue) was added to the crosslinked proteins and boiled for 10 minutes before loading 
onto a 12% SDS-PAGE gel (acrylamide:bis-acrylamide was 37.5:1).  Gels were dried and 
visualized by autoradiography and analyzed using ImageQuant.  
 
Results 
Sequence requirements for SLBP binding to the histone stem-loop 
 RNA-MITOMI was adapted from the MITOMI protocol originally designed by 
Maerkl and Quake (Maerkl and Quake 2007; Maerkl and Quake 2009).  MITOMI was 
designed to measure interactions between transcription factors and DNA.  Modifications 
to the protocol were made to allow for measurements of protein:RNA binding 
interactions.  The modified protocol was termed RNA-MITOMI.   
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 While individual nucleotides have been tested for their effect on SLBP binding 
(Pandey et al. 1994; Williams et al. 1994; Williams and Marzluff 1995; Battle and 
Doudna 2001), prior to my arrival in the lab, a thorough investigation of each nucleotides 
contribution to SLBP binding had not been conducted.  Using the high-throughput nature 
of the RNA-MITOMI platform, we were able to interrogate each nucleotide for its effect 
on binding to SLBP (Table 1).  GST-SLBP that had been pre-incubated with α-GST 
coupled to Texas Red fluorophore was allowed to bind to a panel of 57 stem-loop 
mutants.  In this panel, every nucleotide was changed to each of the other 3 possible 
nucleotides to test for the contribution the chemical nature of each residue.  Additionally, 
for each point mutant in the stem, the corresponding base pair on the opposite side of the 
stem was mutated to restore base pairing in order to determine the effect structure has at 
each position in the stem.   
 Results obtained by RNA-MITOMI interrogation of individual stem-loop 
nucleotides reveal a surprising pliability in SLBP’s binding requirements (Figure 10).  
Largely, individual nucleotides provide little contribution to binding of SLBP, but rather, 
structure is the overriding determinant at any single position in the stem (Figure 10c).  
The exception to this found at G2 (for numbering nomenclature, see Figure 9).  Changing 
this guanine to any other nucleotide completely abolished binding to SLBP.  
Furthermore, this lack of binding was not abrogated by making any compensatory 
mutation to the 3’ side of the stem at C15.  These data indicated that the chemical nature 
of guanine at this position was absolutely necessary for interaction with SLBP.   
At every other position in the stem, if a single point mutant disrupted binding, 
binding could be rescued by making the compensatory mutation on the opposite side of  
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Figure 9. Numbering convention of histone stem-loop.  Schematic of stem-loop 
indicating numbering convention used in experiments. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
	   64	  
 
 
 
 
	   65	  
Table 1. RNA motif library.  Motif library used in RNA-MITOMI experiments.  
Mutations for a given stem-loop variant are indicated in red. 
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the stem (Figure 10c).  This indicated that the amino and carbonyl radical groups found 
at other positions provided no interactions with SLBP groups.  For example, the C3A 
mutation abolished binding to SLBP, presumably because of the inability of the 
adenosine nucleotide to interact with the guanine nucleotide opposite it, creating a bulge 
in the stem that prevents binding.  However, by making the compensatory mutation 
(G14U), creating an A-U base pair in place of the original C-G base pair, SLBP binding 
was restored to wild-type levels.   
 Of the point mutations that disrupted SLBP binding, all were found on the 5’ side 
of the stem.  This is consistent with the model that SLBP binds to the 5’ side of the 
histone stem-loop.  Recently, this has model has been confirmed by solving the crystal 
structure of SLBP in complex with stem-loop RNA and 3’hExo (Tan et al. 2013).  
Further connections between this new crystal structure and RNA-MITOMI data will be 
examined in the discussion of this section.  The only positions on the 3’ half of the stem 
that were particularly susceptible to point mutations were at the top and bottom of the 
stem (A11 and C16) with disrupting base pairing at the top of the stem being particularly 
deleterious to SLBP binding.  However again, binding could be rescued to near wild-type 
levels by the mutations of the corresponding base pair (Figure 10A).   
These experiments led me to speculate on the inability of the reverse stem-loop 
(SLRS) to bind SLBP.  This is a stem-loop in which the base pairs in the stem have been 
reversed but the loop and flanking regions remain the same.  Structure appears to be the 
dominant determinant for SLBP at each position in the stem except for at the 2nd base pair 
from the bottom of the stem.  SLBP binding requires that position 2 in the stem is a 
guanine.  Therefore, I hypothesized that the main reason for lack of binding to SLRS  
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Figure 10. Binding of SLBP to histone stem-loop motif library.  (A) SLBP affinity for 
variant stem-loops as measured by RNA-MITOMI.  SLBP:stem-loop ratio was measured 
by Tx-red/FAM fluorescent intensity.  The binding of each variant was compared to 
binding of SLWT, which was arbitrarily set at 1.  Point mutants are shown in red and 
compensatory mutations are shown in blue.  (B) Strategy for assigning function to 
specific features of stem-loop sequence and structure. (C) The scatter plot of relative 
binding for each point mutant with respect to each double compensatory mutant is 
separated into mutants that have a low effect on binding (regime 1), deleterious mutants 
that are rescued by restoring RNA secondary structure (regime 2), and mutants that 
cannot be rescued (regime 3). 
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might not be due to the reversed stem in general, but rather to the alteration of the 2nd 
nucleotide to a cytosine. Therefore, perhaps I could make SLRS bind SLBP if by 
switching the back only the 2nd base pair to G-C.  I in vitro transcribed this stem-loop 
named SLRS(GC2Comp) and tested its ability to bind SLBP alongside SLWT and SLRS 
by EMSA.  This construct was not able to bind SLBP stably at any of the concentrations 
tested (Figure 11C).  This data indicated that while base pair structure is able to rescue 
SLBP at any one position, it is not able to rescue binding at all positions, consistent with 
the fact that specific base pairing pattern in the stem has been conserved in evolution.  
 More surprising than the ability of compensatory mutations to rescue SLBP 
binding were the wide array of point mutations that did not have an effect on SLBP 
binding, but did affect canonical Watson-Crick base pairing.  Many point mutants in the 
stem resulted in bulges that we would have predicted would have prevented binding to 
SLBP, particularly at this important position that will not tolerate a C-G base pair in place 
of a G-C base pair.  However, many retained near wild type binding affinities (Figure 
11A).  Most strikingly, the C15A mutation resulted in a G – A base pair at the 2nd position 
in the stem.  Our prediction would be that this pyrimidine:pyrimidine  “base pair” would 
disrupt the structure of the stem such that it would not be able to bind SLBP.   However, 
RNA-MITOMI determined that this stem-loop was able to bind with no change in 
affinity.  Likewise, the C5G mutation resulted in reduced binding, but still had affinity for 
SLBP despite creating a two opposing guanine nucleotides.  Due to these surprising 
results, I confirmed them by EMSA (Figure 11B).  In each case, the EMSA data 
corroborated the RNA-MITOMI data (Figure 11C).  Thus, there is a much broader range 
of sequences that bind SLBP than expected, although, none of these mutations are found 
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in histone mRNAs.  HITS-CLIP of SLBP shows that it only interacts with histone 
mRNAs in vivo.           
The four-nucleotide loop of the histone stem-loop has sequence requirements for 
both SLBP and 3’hExo 
 
 High throughput sequencing of RNA isolated by crosslinking 
immunoprecipitation (HITS-CLIP) was done using α-SLBP in HeLa-S3 cells.  This was 
a follow up of a previous study completed in 2006 where RNA immunoprecipitation 
followed by hybridization to a microarray (RIP-CHIP) using α-SLBP (Townley-Tilson et 
al. 2006).  There was significant overlap between the two studies; however, HITS-CLIP 
allows for the mapping of crosslinking sites to the genome as a method to determine 
protein:RNA contacts (Ule et al. 2003; Zhang and Darnell 2011).  Following 
immunoprecipiation, crosslinked proteins are digested by proteinase K; however, the 
crosslink is not reversed, so there is a single amino acid adduct covalently attached to the 
immunoprecipitated RNA.  Reverse transcriptase often reads through this crosslinked 
nucleotide with the amino acid adjunct, creating an insertion, point mutation or, most 
commonly, a deletion (indel).  The location of this indel is inferred to be the site of 
protein:RNA contact and confirms a bone fide protein:RNA interaction (Zhang and 
Darnell 2011).           
 The histone stem-loop consists of a 4-nucleotide loop that has the consensus 
sequence of UUU(C/A) (Figure 12).  However, there are some naturally occurring 
variation located in this loop.  The 1st and 3rd uridines are 100% conserved in all 
metazoan histone mRNAs except C. elegans.  On the other hand, there are significant 
naturally occurring polymorphisms in the loop at positions 2 and 4 (LU2 and LC4) and  
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Figure 11. Confirmation of binding by conventional gel shift. (A) Gel shifts of mutant 
stem-loops by recombinant SLBP.  For each shift, 0.0, 0.01, 0.1, 1.0, or 10.0 pmol of 
SLBP was used to shift 10 fmol of stem-loop RNA uniformly labeled with 32P-CTP.  (B) 
RNA-fold predictions of mutant stem-loops. (C) Correlation between SLBPs affinity for 
mutant stem-loops as gathered by traditional EMSA and RNA-MITOMI. (D) G2 is not 
sufficient to restore binding to SLRS. 
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changes to the 4th position do not affect binding.  The most common loop variant is 
UUUA, which is found in 14% of the histone stem-loops (9/65).  The other two variants, 
UUUU and UCUC, occur in 8% (5/65) and 5% (3/65) of histone stem-loops, 
respectively.  Interestingly, 42% (6/14) of H2B genes contain a variant in the loop, while 
only 21% (11/51) of all other genes contain loop variants.  
 Analysis of HITS-CLIP data revealed that of the UCUC variants (Hist1H3E, 
Hist1H2BI and Hist1H4L), none of them contained indels at the LU2 position.  Note that 
because of the string of four U’s in the other stem-loops, it was not possible to precicely 
assign the position of the indel.  Unfortunately, only one of these genes is expressed in 
HeLa cells, based on high throughput sequencing of the ENCODE project.  My initial 
hypothesis was that LU2 was required for interaction with SLBP or that it was the site of 
crosslinking.  To test this hypothesis, I in vitro transcribed wild-type stem-loop probes 
(SLWT), a stem-loop containing a reversed stem (SLRS), which has been shown not to 
interact with SLBP and a stem-loop containing the UCUC loop variant (LU2C).  
Electrophoretic mobility shift assays were completed using these probes.  SLBP showed 
no difference in affinity for SLWT as compared with LU2C (Figure 13A cf. Lanes 1-5 
and 16 - 20), in agreement with the RNA-MITOMI results.  However, it was still 
possible that despite having no effect on its ability to bind, it may still be the crosslinking 
site.  Therefore, I conducted an in vitro crosslinking assay in which I attempted to 
crosslink SLBP to both SLWT and LU2C.  First, I determined that I was able to 
effectively crosslink SLBP to the stem-loop in vitro.  SLBP was incubated with 32P-
labeled SLWT or SLRS RNA crosslinked for different times over the span of 10 minutes.  
I was able to effectively crosslink SLBP to the SLWT construct, but not to the SLRS  
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Figure 12. Human histone stem-loops are well conserved.  (A) Histone stem-loops 
from all human histone genes aligned using ClustalW2 
(http://www.ebi.ac.uk/Tools/msa/clustalw2/) Note changes in loop nucleotides, 
particularly the UCU(A/C) variants found in Hist1H3E, Hist1H2BE and Hist1H4L.  (B) 
Consensus sequences of human histone stem-loops as assigned by WebLogo 3.2 
(http://weblogo.berkeley.edu/).  
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construct (Figure 13B). Recombinant SLBP was crosslinked to 32P-stem-loops for 10 
minutes using 254 nm UV light.  There was no change in the ability of SLBP to crosslink 
to the stem-loops containing the consensus UUUC loop vs. the UCUC loop (Figure 13C, 
cf. Lane 3 & 9) demonstrating that LU2 is not the major site of SLBP crosslinking. 
 I therefore interrogated the other loop positions containing uridyl groups to 
determine if any provided sites for crosslinking.  Previous work by Dr. Anthony 
Williams, as well as RNA-MITOMI data, demonstrated that LU1 and LU3 are critical 
determinants for SLBP binding.  Additionally, there are no naturally occurring stem-loop 
variants that contain changes to either LU1 or LU3 (Figure 12).   I made 32P-labeled stem-
loops with U>C transitions at loop positions 1 (LU1C), position 3 (LU3C) and both 
(LU1,3C) as well as the previously tested LU2C, SLWT and SLRS.  First, I tested these 
mutants by EMSA (Figure 13A).  Stem-loops harboring mutation at LU1, proved 
detrimental to SLBPs ability to bind the stem-loop (Figure 13A, Lanes 11 – 15), but 
LU3C and LU1,3C were nearly incapable of binding (Figure 13A, Lanes 21 – 30), 
emphasizing the importance of the U at position 3.  I next determined if SLBP was able 
to crosslink to any of these loop variants.  Interestingly, SLBP was able to crosslink to 
any of the single point mutants (LU1C, LU2C, LU3C), although, crosslinking efficiency 
was reduced in the LU3C mutant.  However, in the double loop mutant, LU1,3C, there was 
no crosslinking to SLBP (Figure 13C, Lane 15 & D).  These data suggest that SLBP 
makes contacts with both LU1 and LU3.  If one of these uracils is changed to a cytosine, 
SLBP is still able to make contact with the second and exposure to UV still allows for 
crosslinking.  However, the mutation of both eliminates the contacts.  The reduction of 
SLBP binding to these mutants in an EMSA confirms their necessity for binding.   
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Figure 13. L1 and L3 are required for SLBP binding.  (A) EMSAs using stem-loop 
probes harboring indicated mutations.  For each shift, 0.0, 0.01, 0.1, 1.0 or 10 pmol of 
recombinant SLBP-RPD (a.a. 127 – 220) were used to shift 10 fmol of in vitro 
transcribed stem-loops uniformly labeled with 32P-CTP.  Note that SLWT (Lanes 1 – 5) 
and LU2C (Lanes 16 – 20) have similar affinities, but other mutations to LU1C and LU3C 
reduce affinity for SLBP.  (B) Optimization of UV crosslinking reaction using SLWT 
(Lanes 1 – 6) and SLRS (Lanes 7 – 12).  For each experiment, 1 pmol of SLBP-RBP was 
incubated with 10 fmol of given probe and irradiated with 256 nm UV light for indicated 
times.  Crosslinked RNA-protein complexes are indicated with arrow. (C) Crosslinking 
of SLBP-RBP to stem-loop mutations indicate that both LU1 and LU3 are able to 
crosslink to SLBP.  Only when both are mutated does SLBP fail to crosslink (Lane 15). 
(D) Quantification of SLBP crosslinking.   
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While these experiments did shed light on the requirements of SLBP binding to 
the stem-loop and indicated nucleotide-amino acid contacts, they did not show why 
UCUC loop variants was not immunoprecipitated in the HITS-CLIP experiment.  I 
reasoned that if SLBP is not is not affected by the LU2C variant, perhaps 3’hExo was.  
Therefore, I tested the affinity of 3’hExo for the wild-type stem-loop as compared to the 
LU2C variant.  By EMSA, the LU2C variant had greatly reduced affinity for 3’hExo 
compared to SLWT (Figure 14A).  Then, I completed crosslinking assays to determine if 
the LU2C RNA was able to crosslink to 3’hExo.  Changing 2nd nucleotide in the loop 
from U to C abolished crosslinking of 3’hExo to the stem-loop (Figure 14B & C), 
indicating that the U at position 2 was a critical binding determinant for 3’hExo, while 
the U’s at position 1 and 3 were critical for SLBP binding.   
Finally, I sought to determined the effect of the UCUC loop on the formation of 
the ternary SLBP:3’hExo:RNA complex.  I performed EMSAs using SLWT and LU2C 
probes by prebinding the RNA to SLBP and then increasing the concentration of 3’hExo 
and monitoring the formation of higher mobility ternary complexes (Figure 14D).  In this 
experiment, I was able to identify 3 different complexes: (1) SLBP:RNA, (2) 
3’hExo:RNA and (3)SLBP:3’hExo:RNA.  The formation of the highest mobility 
complex, SLBP:3’hExo:RNA was not altered between the SLWT and LU2C stem-loops 
(Figure 14D, cf. Upper band Lane 7 & 14).  Thus, binding of SLBP removed the 
dependence of 3’hExo binding to the stem-loop on LU2.  This is consistent with previous 
data showing that SLBP and 3’hExo synergistically bind the histone stem-loop (Yang et 
al. 2006).  I then performed crosslinking assays to determine if 3’hExo was able to 
crosslink to the LU2C stem-loop when bound in this ternary complex.  Despite being able  
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Figure 14. L2 is required for binding to 3’hExo.  (A) LU2 is required for 3’hExos 
affinity to the histone stem-loop.  Gel shifts were completed using 0.0, 50.0, 150.0, 200.0 
or 250.0 pmol of 3’hExo in 2 µg/µL yeast tRNA using the same conditions as previously 
described. (B) 3’hExo is not able to crosslink to LU2C.  Crosslinking was done for 10 
minutes using 256 nm UV light.  LU2C is able to weakly interact with LU2C (Figure 1), 
but mutation of this nucleotide prevents crosslinking (c.f. Lane 3 & 6).  (C) 
Quantification of 3’hExo crosslinking data.  (D) Formation of tertiary complex is not 
impaired by LU2C.  Gel shifts were completed as previously described.  In Lanes 2 – 7 & 
9 – 14, 1 pmol of SLBP-RPB and 0.0, 0.01, 0.1, 1.0, 10.0 or 50.0 pmol of 3’hExo.  
Formation of binary and tertiary complexes are indicated by arrows.  (E) SLBP is able to 
crosslink to LU2C after formation of tertiary complexes (c.f. lower band, lane 3 & 6), but 
3’hExo is not (c.f. upper band, lane 3 & 6).  (F) Quantification of tertiary complex 
crosslinking  
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to bind the RNA, 3’hExo was not able to crosslink to the stem-loop if the 2nd uridine was 
changed to a cytidine (Figure 14 E & F).  Again, there was no effect on SLBP’s ability 
to crosslink to the LU2C stem-loop.  Since UV crosslinking occurs primarily through the 
binding of U to the protein, this result strongly supports the conclusion that LU2 is the 
crosslinking site for 3’hExo.    
SLBP and 3’hExo binding is not inhibited by oligouridylation          
In mammals, the initial cleavage of histone pre-mRNA in the nucleus occurs 5 
nucleotides after the stem-loop (Scharl and Steitz 1994), and SLBP remains bound to the 
processed RNA and participates in export to the cytoplasm (Sullivan et al. 2009a).  The 
cytoplasmic histone mRNA ends 2-3 nucleotides after the stem-loop as a result of 
exonucleolytic trimming by the 3’hExo (Hoefig et al. 2013), which forms a stable ternary 
complex (SLBP:SL:3’hExo) with SLBP and the stem-loop (Yang et al., 2006;Tan et al., 
2013).  The initial intermediate in histone mRNA degradation is oligouridylation of the 3’ 
end of histone mRNA (Su et al., 2013). Removal of SLBP and possibly also 3’hExo is 
likely required for complete 3’ to 5’ digestion of histone mRNA, since once the integrity 
of the stem-loop is destroyed, 3’hExo has a greatly reduced affinity for the RNA (Yang et 
al., 2006)(Tan et al. 2013).  It is possible that uridylation plays a direct role in the 
removal of 3’hExo or SLBP from the 3’ end of the RNA.  Previously, Dr. Zbigniew 
Dominski and Xiao-cui Yang demonstrated that a 3’ extension of the stem-loop reduced 
3’hExo binding.  Therefore, I asked whether SLBP and/or 3’hExo can interact with the 
oligouridylated RNA.  I also asked whether Lsm1-7, an activator of decapping, can 
interact with the stem-loop at the same time as SLBP, 3’hExo or both.  Dr. Thomas 
Mullen had proposed that uridylation served as a platform for association with Lsm1-7.  
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To determine whether oligouridylation affects the ability of SLBP or 3’hExo to bind the 
histone stem-loop, I prepared stem-loop constructs which mimic the cytoplasmic histone 
mRNA ending in 2 nts after the stem loop followed by 0, 5 or 10 uridines (SLWT, SL5U, 
SL10U) (Figure 15A).  The SLBP RNA processing domain (RPD, aa 127-220) was used 
in these experiments to facilitate resolution of the complexes. Proteins used in these 
experiments are shown in Figure 15B.  Mobility shift experiments showed that 
baculovirus expressed SLBP-RPD bound to all three probes and the presence of uridyl 
groups at the 3’ end of the stem-loop did not alter the affinity of SLBP-RPD for the stem-
loop structure (Figure 15C & D).  I also tested whether 3’hExo would bind the 
uridylated stem-loops, since previous experiments suggested that 3’hExo did notn bind 
the histone pre-mRNA.  Surprisingly, uridylation did not decrease the affinity of 3’hExo 
for the stem-loop (Figure 15 E & F) consistent with the finding that 3’hExo is required 
for initial degradation of histone mRNAs and may be responsible for degrading the 
oligo(U) tail  
To determine whether the triple complex consisting of SLBP, stem-loop RNA and 
3’hExo (SLBP:SL:hExo) also forms with the same efficiency regardless of whether or 
not the 3’ end is uridylated, I incubated the radiolabeled stem-loop (Figure 15G, lanes 1-
6), the stem-loop with 5 uridines added (lanes 7-12) or with 10 uridines added (lanes 13-
18) with increasing amounts of 3’hExo.  The RPD was added in a constant amount in 
lanes 4-6, 10-12 and 16-18.  3’hExo bound to each of the probes with similar affinity, and 
the addition of the SLBP-RPD resulted in efficient formation of a triple complex with all 
three probes.  Thus, uridylation does not dramatically alter the affinity of SLBP, 3’hExo 
or the triple complex for the histone stem-loop.    
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Figure 15. Uridylation does not affect mRNP formation of the histone stem-loop. (A) 
Stem-loop constructs used in mobility shift experiments.  (B)  The purified proteins used 
in these experiments were analyzed by SDS-gel electrophoresis.  The purified His-SLBP-
RPD and His-3’hExo were resolved on a 10% SDS-polyacrylamide gel (left) and the 
Lsm1-7 proteins were resolved on a 15% SDS-polyacrylamide gel (right). (C) 
Electrophoretic mobility shift assays (EMSA) were carried out using increasing amounts 
(0.01, 0.1,1 and 10 pmol) of recombinant SLBP-RPD with 10 fmol of the uniformly 
labeled histone stem-loop probes.  Lanes labeled (-) had no added protein. Complexes 
were analyzed on an 8% polyacrylamide gel.  (D) The data in Fig. 1B was quantified as 
percent of probe in complex versus unbound probe: (u) SLWT(-CCA), (n) SL5U, (Δ) 
SL10U (n = 3).  (E) EMSAs using recombinant 3’hExo under the same conditions except 
tRNA was omitted.  Each reaction was done with 10 fmol of the indicated uniformly 
labeled histone stem-loop probe and increasing amounts, (0.1, 1.0 and 10 pmoles) of 
3’hExo. (F) The data was quantified as in Fig. 1D: (u) SLWT(-CCA), (n) SL5U, (Δ)  
SL10U (n = 3). (G) EMSA’s with 3’hExo, SLBP RPD or mixtures of the two proteins.  
Increasing amounts (1 or 10 pmoles) of 3’ hExo were incubated with (lanes 
5,6,11,12,17,18) or without (lanes 2,3,8,9,15,16) 1 pmole of SLBP-RPD as indicated 
above each lane.  The probes used were SLWT (lanes 1-6), SL5U (lanes 7-12) or SL10U 
(lanes 13-18).  Complexes were analyzed on a 6% polyacrylamide gel.  The monomer 
and heterodimer complexes formed are indicated. Complex components are indicated by 
h (3’hExo), S (SLBP) or R (RNA). (H) The indicated probes were incubated without 
(lanes 1-3, 7-9, 13-15) or with (4-6, 8-10, 16-18) 1 pmole of SLBP RPD and either 24 
pmoles (lanes 2,5,8,11,14,17) or 48 pmoles (lanes 3,6,9,12,15,18) of Lsm1-7. Complexes 
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were analyzed on a 6% polyacrylamide gel. Complexes components are indicated by L 
(Lsm1-7), S (SLBP) or R (RNA). (I) The SLWT (lane 1-4) or SL10U probe (lanes 5-8) 
were incubated with 1 pmole of SLBP-RPD (lane 2 and 6); SLBP and 10 pmoles 3’hExo 
(lanes 3 and 7); or SLBP, 3’hExo and 48 pmoles of Lsm1-7 (lanes 4 and 8). Complexes 
were analyzed on a 6% polyacrylamide gel. Complexes components are indicated by L 
(Lsm1-7), S (SLBP), h (3’hExo) or R (RNA).    
 
 
 
 
 
 
 
 
 
 
	   87	    
	   88	  
Lsm1-7 has a similar affinity for both oligo(A) and oligo(U) tails at the 3’ end of 
RNAs (Chowdhury et al. 2007; Song and Kiledjian 2007).  Since the Lsm1-7 complex is 
required for histone mRNA degradation after inhibition of DNA synthsis (Mullen and 
Marzluff 2008), presumably by binding the oligouridylated RNA, we tested whether the 
presence of SLBP and/or 3’ hExo affected the binding of Lsm1-7.  If SLBP remains 
bound to the stem-loop following uridylation, its presence may not hinder the binding of 
Lsm1-7 to allow for activation of degradation.  To determine the conditions under which 
Lsm1-7 could bind the histone stem-loop, I performed mobility shift experiments with 
recombinant Lsm1-7 and the SLBP-RPD.  Lsm1-7 was not able to bind the normal stem-
loop (Figure 15G, lanes 2 and 3) and had weak affinity for SL5U (Figure 15H, lanes 8 
and 9), but formed a stable complex with the SL10U RNA (Figure 15H, lane 14 and 
15).  When both Lsm1-7 and SLBP were added to the SL10U RNA, formation of a 
ternary complex was readily detected (Figure 15H, lanes 17 and 18).   
I then determined whether a quaternary complex containing SLBP-
RPD:SL:3’hExo:Lsm1-7 could form in vitro on uridylated histone mRNA.  Using the 
mobility shift assay, we were able to detect higher mobility complexes forming on 
SL10U RNA (Figure 15I, lane 8), but not on the SL RNA (Figure 15I, lane 4).  These 
complexes resulted from Lsm1-7 interacting with the ternary SLBP:3’hExo:stem-loop 
complex;, however, an unambiguous determination of components of the individual 
complexes was not possible.  These results show that oligouridylation likely also does not 
disrupt the SLBP:3’hExo:histone mRNA complex, but does facilitate the association with 
Lsm1-7. 
 
	   89	  
Discussion 
SLBP’s binding is more pliable than previously suspected 
  The histone stem-loop has been defined as a 6 base pair stem with a 4 nucleotide 
loop in addition to a consensus CCAAA 5’ of the base of the stem, followed by an 
ACCCA (vertebrates) or ACCA (invertebrates) 3’ of the stem.  To produce the mature 
stem-loop, cleavage of the mammalian pre-mRNA occurs 5 nucleotides 3’ of base of the 
stem following a “CA” dinucleotide.  This 3’ end is necessary and sufficient for regulated 
metabolism of histone mRNAs, which is mediated through the binding of SLBP (Harris 
et al. 1991a).  In metazoans, the histone stem-loop is remarkably conserved which 
suggests a narrow set of binding requirements for SLBP.  In humans, within the sequence 
of the stem, only one (Hist1H2AK) of 65 histone genes deviates from the consensus 
where the 5’ half of the stem is GGC(U/C)CU and the 3’ half of the stem is 
AG(A/G)GCC.  As SLBP is the major player in histone mRNA metabolism, it was 
expected that the ability of SLBP to bind this sequence has been the primary constraint in 
preventing divergence of this sequence in the 65 human histone genes. 
 Therefore, I was surprised to find that SLBP has near wild-type affinity for a wide 
array of alternative histone stem-loops.  Using RNA-MITOMI, we interrogated each 
nucleotide in the stem-loop and each base pair in the stem.  SLBP was remarkably adept 
at binding stem-loops with a number of single point mutations that are predicted to 
destroy the integrity of the stem-loop (Figure 10).  For example, via prediction with 
RNAfold software (http://rna.tbi.univie.ac.at/cgi-bin/RNAfold.cgi), the G12A substitution 
reduces the stem to only 4 base pairs and creates an 8-nucleotide loop (Figure 11B).  
However, this stem-loop variant was still able to bind SLBP with near wild-type affinity 
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(Figure 11A and 10A).  Others, such as U4A and G14A resulted in bulges in the center 
of the stem; however, these had little effect on binding of SLBP. 
 Additionally, these data demonstrate that despite the high conservation of 
sequence of the stem, the structure of the stem-loop, rather than the sequence is the major 
contributor to SLBP binding, save for three nucleotides, G2, LU1 and LU2.  For any single 
nucleotide change in the stem that disrupted binding of SLBP to the stem-loop, wild-type 
levels of binding could be restored by making compensatory mutations to the opposing 
nucleotide in the base pair except for base-pair 2 (G-C) and to a lesser degree at the top  
of the stem at position 6 (U-A).  For example, the C3A mutation proved to be particularly 
detrimental to SLBP binding, presumably because of the inability to force a A-G “base 
pair” into an conformation that would allow SLBP binding.  However, the combination 
of the C3A mutation with the compensatory G14U mutation restored near wild-type 
binding.  This was true throughout the body of the stem, except for at base pair 2, 
demonstrating that RNA structure rather sequence it the primary contributor to SLBP 
binding.  Again, this is puzzling, as these compensatory changes, which support SLBP 
binding are not seen in nature.  The only example of this is with the H4 genes in which 
the 4th base pair in the stem has switched from the U-A base pair seen in H1, H2A, H2B 
and H3 genes to a G-C base pair (Figure 11B), and this pattern is conserved in 
vertebrates.  These data show that the intermediate step required to arrive at this change, 
that is, either a U-C or G-A base pair would have supported SLBP binding, perhaps for 
long enough for a compensatory change to the G-C base pair to have restored structure at 
this position.  This change must have occurred before further diversion between H4 
genes, as every H4 has the G-C base pair at position 4.     
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 The only position in the stem at which compensatory mutations did not restore 
wild-type binding was at the 2nd position.  Dr. Dan Battle had previously demonstrated 
the importance of this base pair in the stem-loop (Battle and Doudna 2001).  However, 
these data demonstrate that it is not the G-C base pair that is critical, but rather the 
guanine on the 5’ side of the stem.  Disrupting the base pair by changing C15 to either an 
adenosine or uridine does not greatly reduce binding, but alteration of G2 to any other 
nucleotide completely abolishes binding.  Shortly after the completion of this work, Dr. 
Dazhi Tan in the lab of Dr. Liang Tong at Columbia University solved the crystal 
structure of SLBP RNA binding domain in complex with the stem-loop RNA and 3’hExo 
in collaboration with our lab.  His data shows that G2 of the stem is the only nucleotide 
that forms a direct interaction with SLBP.  They were able to show that the guanidinium 
group of arginine-181 forms two hydrogen bonds with this nucleotide.  In the crystal, 
other interactions between SLBP and RNA in the stem were with the phosphodiester 
backbone.  This indicates why compensatory mutations preserving structure had little 
effect on SLBP binding, but again, does not answer why these changes are not seen in 
nature.     
 The most likely reason that there is not increased variation in naturally occurring 
stem-loops is likely due to selective pressure due to requirements of 3’hExo binding.  We 
are currently undertaking collaborations which will expand our knowledge of 3’hExo 
binding requirements, but, the solved crystal structure does not show any contacts 
between the amino acids of 3’hExo and any of the nucleotides in the stem of the stem-
loop, although the 3’hExo does not bind to the SLRS mutant.  Instead, all interactions are 
mediated through interactions with the phosphodiester backbone, nucleotides found in the 
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loop (to be discussed below) and in the final 5 nucleotides of the RNA after the base of 
the stem. 
 Additionally, data presented here demonstrate that RNA-MITOMI is a powerful 
technique that allows one to screen RNA space in an unbiased manner for potential 
discovery of many non-obvious binding sites for RNA binding proteins.  The time 
consuming and low throughput nature of the traditional EMSA technique precludes 
testing the full sequence space of a potential RNA binding site, even a binding site as 
well defined as the histone stem-loop.  The ability to gain new insights into such a well-
studied interaction is a testament to the power of this technique.   
HITS-CLIP of SLBP suggests narrow binding constraints 
 As demonstrated by the above work, the pliability for SLBP’s binding sites makes 
it is possible that SLBP binds a wider suite of RNAs in cells. To investigate this 
possibility, I performed HITS-CLIP analysis in collaboration with Dr. Lionel Brooks in 
Dr. Michael Whitfield’s Lab at Dartmouth University.  Data generated by Dr. Brooks 
during initial HITS-CLIP analysis found that 5 non-histone transcripts were enriched in 
SLBP HITS-CLIP experiments.  However, sequences from these 5 transcripts showed 
poor read coverage and did not contain any cross linking induced mutations characteristic 
of bone fide targets, and hence were not statistically significant.  Thus, despite the 
potential ability to bind many more mRNAs than previously thought, it seems that 
histone mRNAs are indeed the only natural substrate for SLBP in cultured cells.        
Resolving ambiguities in HITS-CLIP derived CIMs as a result of homopolymer 
stretches and overlapping binding sites 
 
 Analysis of crosslinking induces mutations (CIMs) demonstrated that the stretch 
of uridines at the top of the stem and in the loop were potential sites of contact for SLBP.  
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CIMs are produced when an amino acid adduct remains attached to crosslinked 
nucleotide and reverse transcription of this RNA leads to skipping of the crosslinked 
nucleotide.  This results in a single base deletion of the nucleotide that made contact with 
the RNA binding protein and can provide valuable insights into sequences required for 
binding.  This is in contrast to the mutations that are characteristics of crosslinking in 
PAR-CLIP where, upon reverse transcription, the crosslinked nucleotide undergoes a T to 
C converstion in the cDNA.   
 The CIMs resulting from traditional UV crosslinking with 254 nm light lead to 
ambiguities if crosslinking occurs in a stretch of repeated nucleotides.  This proved true 
in the case of histone mRNAs.  Starting at the top of the stem through the 1st three 
positions of the loop, there are four contiguous uridine residues in most histone mRNAs.  
UV crosslinking and reverse transcription led to deletion of a single uridine within this 
stretch, resulting in the reduction of this homopolymer from 4 uridines to 3 uridines.  
Thus, it was not possible to determine precisely the site of crosslinking through analysis 
of HITS-CLIP data alone. 
 Clear determination of crosslinking site required further biochemical techniques, 
by which I was able to determine that the 1st and 3rd uridines in the loop made contact 
with SLBP while the 2nd uridine made contact with 3’hExo.  This highlights another 
potential pitfall of high throughput crosslinking based assays, including HITS-CLIP, 
PAR-CLIP and CRAC, used to determine the RNAs that interact with particular RNA 
binding proteins that they primarily probe uridine residues for crosslinking .  The ability 
of multiple proteins to bind at a single purported binding site can obscure the identity of 
the actual binding site for each protein.  It is clear that 3’hExo was interacting with the 
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histone stem-loop simultaneously with SLBP.  Exposure to UV light likely led to 
crosslinking of both SLBP and 3’hExo to the stem-loop.  Immunoprecipitation with α-
SLBP could then lead to co-precipitation of crosslinked 3’hExo, which is a similar size to 
SLBP.  Upon digestion of bound proteins and reverse transcription, it was impossible to 
unambiguously determine which CIMs resulted from crosslinking to SLBP and which 
resulting from crosslinking to 3’hExo.  This situation may arise any time a multisubunit 
complex assembles on an mRNA as is the case during spliceosome assembly or 
translational repression due to miRNA binding.  Data derived from analysis of CIMs in 
these situations should be analyzed with this possibility in mind.   
The histone stem-loop as a platform for assembling multi-subunit complexes 
 The importance of the ability of SLBP to faithfully recognize the histone stem-
loop is clear.  It is also critical that other proteins are able to assemble on the stem-loop 
during the histone mRNAs life cycle.  3’hExo in particular must also be able to 
specifically recognize the histone stem-loop as it is required to facilitate histone mRNA 
degradation at the end of S-phase or when DNA synthesis is inhibited.  In addition to 
these two factors, other proteins are able to assemble on the histone stem-loop to direct 
action.  Here, I show that Lsm1-7 is able to assemble on the histone stem-loop after 
uridylation of the 3’ end of the mRNA.  This uridylation is critical for Lsm1-7 binding 
but does not alter the ability of SLBP to bind the stem-loop.  In terms of uridylation and 
3’hExo, I had hypothesized that uridylation would evict 3’hExo from the stem-loop as 
previous data demonstrated that 3’hExo was not able to efficiently bind the histone pre-
mRNA.  However, as I demonstrate here, uridylation does not reduce 3’hExo’s affinity 
for the stem-loop; in fact, mobility shifts demonstrate that uridylation increases the 
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affinity of 3’hExo for the stem-loop (Figure 15 F).  It is possible then that 3’hExo is not 
bound to the histone stem-loop throughout the life cycle of the histone mRNA.  Rather, it 
is possible that 3’hExo is only recruited to the stem-loop following uridylation of the 
mRNA.   
 This truly seems to be the case with Lsm1-7.  Previous studies have demonstrated 
that Lsm1-7 has affinity for oligo(A) and oligo(U) RNAs.  I show that Lsm1-7 does 
indeed have affinity for oligouridylated histone stem-loop.  But, what is particularly 
striking is that it is able to bind the stem-loop concurrently with SLBP and 3’hExo.  This 
leads to a complex of 9 individual proteins bound to an mRNA only 31 nucleotides long.  
In the following chapter, I will investigate how protein:protein interactions between 
Lsm4, a subunit of the Lsm1-7 complex, with both SLBP and 3’hExo facilitate this 
complex formation and direct histone mRNA degradation.  
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CHAPTER III:  THE C-TERMINAL EXTENSION OF LSM4 DIRECTLY 
INTERACTS WITH THE 3’ END OF HISTONE mRNP AND IS REQUIRED FOR 
EFFICIENT HISTONE mRNA DEGRADATION  
 
Introduction 
The final step in mRNA metabolism is degradation of the mRNA and rapid 
degradation of mRNA is the most effective way of stopping protein expression.  
Regulation of mRNA half-life is an important component of regulation of gene 
expression.  The pathways for degrading polyadenylated mRNAs are relatively well 
understood. The initial step in degradation is deadenylation (shortening the poly(A) tail to 
about 10 nts).  The cytoplasmic Lsm complex, Lsm1-7, binds the oligo(A) tail, and also 
recruits the degradation factors, although the molecular details of how Lsm1-7 function 
are not known.   The Lsm1-7 complex is found in a complex with the translation inhibitor 
Rck/p54 (in yeast dhh1) (Cougot et al., 2004) and also recruits the decapping complex, 
hDcp1 and hDcp2, (see Parker and Song, 2004 for review).  Following decapping the 
mRNA can be degraded 5’ to 3’ by the processive exonuclease, Xrn1.  After 
deadenylation, the mRNA can also be degraded 3’ to 5’ by the exosome, a complex of 
10-12 polypeptides that contains Rrp44, a processive 3’ to 5’ exonuclease (Liu et al., 
2006;Makino et al., 2013). 
For some mRNAs, degradation is initiated by an endonucleolytic cleavage, 
followed by degradation of the two fragments.  In NMD, the Smg6 endonuclease cleaves 
the mRNA (Huntzinger et al., 2008;Eberle et al., 2009), and Xrn1 degrades the 3’ 
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fragment.  The molecular details of degradation of the 5’ fragment are not clear (Franks 
et al., 2010), but they are dependent upon exosome mediated degradation (Gatfield and 
Izaurralde, 2004;Huntzinger et al., 2008;Eberle et al., 2009).  The endonuclease PMR1 
has been shown to initiate the degradation of some mRNAs, and the mechanism of 
degradation of the 5’ fragment is not known (Schoenberg, 2011).  Finally, in 
Chlamydomonas reinhardtii and Arabadopsis thaliana, following cleavage of mRNAs by 
an siRNA/argonaute protein complex, the 5’ fragment can be oligouridylated or 
oligoadenylated and could then potentially bind Lsm1-7 (Shen and Goodman, 
2004;Ibrahim et al., 2006) as part of its degradation pathway.  In metazoans, particularly 
Drosophila, degradation of the 5’ fragment following siRNA directed cleavage requires 
the exosome and depletion of Xrn1 does not alter the half-life of these fragments (Orban 
and Izaurralde 2005). How the exosome is recruited to the 5’ fragment is not understood.   
The Lsm1-7 ring consists of seven polypeptides that form a ring as a result of 
interactions between their core Sm-domains.  In addition, there are extensions on both the 
N- and C-terminus of several Lsm proteins.  The Lsm1-7 ring can bind either oligo(A) or 
oligo(U) tails (Chowdhury et al., 2007;Song and Kiledjian, 2007).  The specific role(s) of 
individual Lsm proteins in interacting with factors involved in mRNA degradation and 
translational inhibition is not known, although mutations in yeast Lsm1 that reduce 
binding to oligoadenylated mRNA stabilize yeast mRNAs (Chowdhury and Tharun, 
2008).  It is not known whether Lsm1-7 is recruited to specific deadenylated mRNAs by 
components of the mRNP.  
Metazoan replication-dependent histone mRNAs are unique among eukaryotic 
mRNAs in that they are not spliced and terminate in a conserved 26 nucleotide sequence 
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containing a stem-loop rather than the canonical poly(A) tail (Marzluff et al., 2008).  The 
levels of these mRNAs are tightly coupled with DNA synthesis, as histone proteins are 
needed to immediately package the newly replicated genome.  Precise regulation of new 
histone protein synthesis is critical for proper chromatin assembly during DNA 
replication.  Following the completion of S-phase or the inhibition of DNA synthesis by 
pharmacological agents, histone mRNAs are rapidly degraded (Sittman et al., 
1983;Heintz et al., 1983).  The half-life of these messages decreases from 45-60 minutes 
to approximately 10 minutes.  The stem-loop at the 3’ end of histone mRNA is the cis-
element that is responsible for histone mRNA degradation (Pandey and Marzluff, 1987), 
ensuring that all five classes of histone mRNAs are regulated coordinately.  The stem-
loop is bound by the stem-loop binding protein (SLBP) which participates in all steps in 
histone mRNA metabolism.  It also interacts specifically with a 3’ to 5’ histone 
exonuclease, 3’hExo (ERI1) which together with SLBP can form a ternary complex at the 
3’ end of histone mRNA (Yang et al., 2006;Dominski et al., 2003;Tan et al., 2013). 
During the past several years, members of the Marzluff lab have defined several 
features of histone mRNA degradation.  Drs. Reed Graves and Handan Kaygun has 
demonstrated that efficient histone mRNA degradation requires active translation of the 
histone mRNA.  As such, the mechanism by which active translation transmits signals 
that direct degradation is not known.  Active translation is also required for efficient 
degradation of NMD substrates as the failure to clear EJCs signals an aberrant mRNA to 
the mRNA decay machinery.  However, no such analogous complex has been identified 
for histone mRNAs.  Following on work done in yeast, I explored the possibility of two 
proteins being the effectors of translation dependent histone mRNA degradation in 
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human cells. In Saccharomyces cerevisiae, Tpa1p was identified as a protein that 
influenced translation termination and mRNA stability.  As Dr. Handan Kaygun’s work 
suggested that inefficient termination triggers the degradation of histone mRNAs, I 
investigated whether the human ortholog of this protein played a role in the degradation 
of histone mRNAs.  Additionally, work in yeast has shown that there is an interaction 
between poly(A) binding protein and the eukaryotic release factor 3 (eRF3) and that 
modulation of this interaction affects mRNA stability.  Again, owing to its role in 
translation termination and mRNA degradation, I investigated if there was an analogous 
interaction between human eRF3 and  components of the histone mRNP.  Histone mRNA 
degradation requires the nonsense-mediated decay (NMD) factor, Upf1, suggesting that 
translation termination may become inefficient as part of triggering initiation of histone 
mRNA degradation (Kaygun and Marzluff, 2005b;Kaygun and Marzluff, 2005a).  The 
initial biochemical step in degradation is covalent alteration of the histone mRNA by 
addition of an oligo(U) tail to the 3’ end (Mullen and Marzluff, 2008;Su et al., 2013).  
Knockdown of Lsm1 inhibits degradation of histone mRNA consistent with Lsm1-7 
being recruited to the oligo(U) tail.  Knockdown of either components of the exosome or 
the decapping enzyme each partially stabilized histone mRNA, suggesting that both 5’ to 
3’ and 3’ to 5’ degradation pathways are involved in degrading histone mRNA.  
Consistent with this observation, molecules that had been decapped and partially 
degraded from both the 5’ end and 3’ end were detected by circular RT-PCR (Mullen and 
Marzluff, 2008).   
Since histone mRNA degradation requires that the histone mRNA be translated 
(Kaygun and Marzluff, 2005b;Graves et al., 1987), it is likely that SLBP is associated 
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with the histone mRNP when degradation is initiated.  Consistent with this possibility, we 
detected the association of SLBP with both Upf1 and Lsm1 after treatment of cells with 
inhibitors of DNA replication (Kaygun and Marzluff, 2005a;Mullen and Marzluff, 2008) 
suggesting that the oligo(U) tail is added to the histone mRNA while it is still associated 
with polyribosomes.  I have previously shown in Chapter 2 that uridylation does not evict 
either SLBP or 3’hExo from the mRNP.  3’hExo (Eri1), which specifically binds the 
stem-loop and forms a stable ternary complex with the 3’ end of histone mRNA (Yang et 
al., 2006;Tan et al., 2013), is also required for rapid degradation of histone mRNA 
(Hoefig et al., 2013).   
The molecular details of how histone mRNA is degraded are not known.  In 
particular, we do not understand how the degradation factors are recruited to histone 
mRNA.  The Lsm1-7 ring is required for degradation of both histone mRNA and 
polyadenylated mRNA.  Given the many targets of Lsm 1-7 and the widely varying half-
lives of individual mRNAs, it is not known whether Lsm1-7 simply recognizes the 
oligo(A) or oligo(U) tail mRNA or whether binding to the tail involves other components 
of the mRNP. It is likely that the amount of Lsm1-7 may be limiting relative to its 
potential target mRNAs, and that efficient mRNA metabolism may require additional 
sequence elements other than simply binding to the oligo(A) or oligo(U) homopolymer.  
In particular for the rapid degradation of histone mRNAs when DNA replication is 
inhibited, efficient recruitment of Lsm1-7 to target message is essential.  Here I 
demonstrate that the C-terminal tail of Lsm4 interacts directly with both SLBP and 
3’hExo and show that this interaction is necessary for rapid histone mRNA degradation.  
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I propose that this interaction is an example of a more general mechanism that may 
function to help target Lsm1-7 to specific sets of mRNAs.  
 
Materials and Methods 
Protein purification    
Baculovirus was produced as described in Chapter 2.   Sf-9 cells cultured in suspension in 
Sf-900 II media supplemented with 10% FBS and Pen/Strep at 27oC.  Ten milliliters of 
baculovirus was added to 1 L of Sf-9 cells at 2 x 106 cells/mL and allowed to express 
recombinant protein for 72 hours.  Cells were pelleted by centrifugation and washed with 
PBS.  Cells were lysed in 50 mM Tris [pH 7.5], 1% NP-40, 5 mM β-mercaptoethanol and 
1X protease inhibitors-EDTA Free (Roche) for 10 minutes on ice.  Clarified lysate was 
produces by pelleting insoluble material at 12000 x g for 10 minutes.  Lysate was rotated 
at 4oC  with 1 mL of Ni-NTA agarose (Qiagen) for 3 hours.   Ni-NTA agarose was 
pelleted by centrifugation and washed with 25 mL of Buffer A (20 mM Tris [pH 8.0], 
500 mM KCl, 1 mM β-mercaptoethanol, 10% glycerol) and then 5 mL of Buffer B (20 
mM Tris [pH 8.0], 1 M KCl, 1 mM β-mercaptoethanol, 10% glycerol).  Recombinant 
protein was eluted from column with 5 mL Buffer C (20 mM Tris [pH 8.0], 100 mM 
KCl, 1 mM β-mercapotethanol, 10% glycerol, 150 mM imidazole) in 10 0.5-mL 
fractions.  Purification was checked on SDS-PAGE gel followed by coommassie staining.  
Pure recombinant protein was quantified using Qubit-IT.  Lsm1-7 complexes were 
purified and assembled as described in Zajac and Kambach 2008. 
Lsm4 recombinant proteins were cloned into pET42a between EcoRI and HindIII.  
Proteins were expressed in BL-21 (DE3) E. coli after induction by 1 mM IPTG.  Bacteria 
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were resuspended in 30 mL of E. coli lysis buffer 50 mM NaH2PO4, 300 mM NaCl, 10 
mM imidazole.  Lysozyme was added to a final concentration of 1 mg/mL and allowed to 
incubate for 30 minutes on ice.  Cells were further lysed by sonication for six 10-second 
bursts.  Clarified lysate was produced by pelleting insoluble material by centrifugation 
and removing supernatant.  Recombinant proteins were purified from clarified lysate in 
the same manner as with proteins expressed in Sf9 cells.     
Transcription and purification of stem-loop probes 
To anneal T7 promoter oligo to an oligo containing reverse complement to T7 oligo with 
coding strand of stem-loop, 10 pmol of each were incubated in 10 µL of 1X NEBuffer 2 
for 10 minutes at 100oC and then placed on ice.  To the 10 µl of annealed oligos, 5 µl of 
10X NEB transcription buffer, 5 µL of 10 µM rA,G,U mix, 12.5 µL of 100 µM rCTP, 5 
µL of [α-32P]-rCTP (Perkin Elmer), 1 µL of Ribolock RNAse inhibitor (Fermentas), 1 µL 
of T7 RNA polymerase (NEB), and 10.5 µL of water was added.  Transcription reactions 
were incubated at 37oC for 2 hours.  To stop reaction, 1 µL of RQ1 DNAse (Promega) 
was added and allowed to incubate for 15 minutes at 37oC.  Unincorporated nucleotides 
were removed by running reaction through G-25 column (GE Lifesciences).  The RNA 
was ethanol precipitated and resuspended in 20 µL of Formamide Loading dye (98% 
deionized formamide, 0.2 mM EDTA) and run on a 15 % Urea-Acrylamide gel (19:1 
acrylamide:bisacrylamide in 1X TBE and 8M urea).  RNA was visualized by exposing 
wet gel to film for 5 minutes and then excising radioactive stem-loops.  Gel slices were 
incubated overnight while rotating in 400 µL of Gel elution buffer(20 mM Tris, 250 mM 
Sodium Acetate, 1 mM EDTA, 0.25% SDS).  The following day, the supernatant was 
removed and checked by Geiger counter for radioactivity.  These supernatants were 
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phenol/chloroform extracted, ethanol precipitated and resuspended in 50 µL of dH2O.  
Purified probes were counted on scintillation counter and concentration was determined. 
Electrophoretic Mobility Shift Assay 
10 femtomoles of uniformly labeleld RNA was incubated on ice with various amounts of 
purified recombinant protein in 10 mM HEPES [pH 7.6], 50 mM KCl, 0.1 mM EDTA, 
10% glycerol, 1 µg/µL yeast tRNA, 0.1 µg/µL, BSA.  For shifts with 3’hExo, yeast 
tRNA was omitted from shifts.  Reactions were directly loaded onto 6% native 
polyacrylamide gel (acrylamide;bisacrylamide was 29:1 in 1X TBE buffer) without any 
loading dyes.  Gels were visualized by autoradiography on phosphor screen and film.  
Images were analyzed by imageQuant. 
siRNA Knockdown 
 Double hit siRNA knockdown was done as described in Wagner and Garcia-
Blanco 2002.  Double stranded siRNAs were ordered from Dharmacon/Thermo Scientific 
which targeted eRF1, eRF3, OGFOD1, Lsm1 or Lsm4 or a control siRNA.  These 
siRNAs were resuspend at a concentration of 20 µM in dH2O.  On day 1, cells were 
seeded in a 24-well dish at 8.5 x 104 cells/mL.  The following day 3 µL of 20 µM siRNA 
was incubated with 47 µL of OPTI-MEM (Gibco) and 3 µL of Lipofectamine 2000 
(Invitrogen) was incubated for 12 µL of OPTI-MEM (Gibco) and incubated for 10 
minutes at room temperature.  Following this incubation, the two mixtures were added 
together and incubated at room temperature for 25 minutes.  Then, 35 µL of OPTI-MEM 
was added and the 100 µL mixture was added to cells and incubated overnight.  On day 
3, cells were split to 6-well plates.  On Day 4, the siRNA transfection procedure was 
completed exactly as on day 2 without adjusting volumes.  For experiments utilizing 
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reporter constructs, they were transfected on Day 5 using Lipofectamine (Invitrogen) 
instead of Lipofectamine 2000.  If no reporter was used, the cells were allowed to grow 
on this day.  On day 7, cells were harvested for protein extraction or HU treated for and 
RNA was extracted.    
GST Pulldown assay 
5 µg of recombinant GST proteins were incubated at 4oC with pre-equilibrated 
glutathione-sepharose resin (GE lifesciences) in 100 µl of TEN100 buffer (20 mM Tris 
[pH 7.5], 0.1 mM EDTA, 100 mM NaCl).  In vitro translation was carried out using 
Promega’s TNT coupled rabbit reticulocyte or Wheat germ extract kit. Unbound protein 
was removed by washing 2X with 250 µL TEN100.  10 µL of in vitro translated protein 
was added to beads along with 10 uL of 10X TEN100 buffer, 14 µL of GDB buffer (10% 
Glycerol, 10 mM DTT, 0.05 mg/mL BSA) and 76 µL of dH2O.  Proteins were allowed to 
bind for 2 hours at 4oC while rotating.  Glutathione beads were washed 4 times with 1 mL 
of TEN100 buffer.  25 µL of 2X SDS loading dye (4% SDS, 10% β-mercaptoethanol, 
0.125 M Tris [pH 6.8], 20% glycerol, 0.2% Bromophenol Blue) was added to beads and 
boiled for 10 minutes.  The supernatant was loaded onto an SDS-PAGE gel.  Gels were 
stained with commassie blue to confirm pulldown of recombinant GST protein.  Gels 
were dried and visualized by autoradiography. 
Cloning of Flag vectors 
Lsm4 cDNA was cloned into pcDNA-Flag between BamHI and XhoI.  This vector 
contains a single N-terminal FLAG tag (DYKDDDDK).  It is driven by the CMV 
promoter, contains a beta-globin intron and the bGH polyadenylation signal.  Mutations 
were introduced by PCR and recloned between BamHI and XhoI.   
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For all in vitro translation assays, proteins were cloned into pxFRM between NcoI and 
XbaI.  This vector contains a synthetic poly(A) tail to aid in translation.   
Production of Lentivirus for RNAi 
 For each shRNA lentivirus to be produced, hairpin DNA was cloned into pLKO.1 
between AgeI and EcoRI.  For each target sequence, two oligos were ordered from IDT 
and annealed.  For each target sequence, oligos were ordered such that:  
 Forward: 
 5’ CCGG – 21 bp sense – CTCGAG – 21 bp antisense – TTTTTG 3’ 
 Reverse: 
 5’ AATTCAAAAA – 21 bp sense – CTCGAG – 21 bp antisense 3’ 
Following cloning, 1.0 µg of pLKO.1-shRNA, 0.75 µg of pNRF and 0.25 µg of pVSVG 
were transfected into HEK293T cells using Lipofectamine 2000 (Life Technologies) 
according to manufacturer’s instructions.  The following day, media was removed from 
cells and discarded and 2 mL of fresh media was added to each dish.  Cells were returned 
to 37oC incubator overnight.  The following day, media containing lentiviral particles was 
harvested.  For long-term storage, this media was stored at -80oC.  This process was 
repeated for one additional day.    
Immunoprecipitation 
HeLa cells were cultured in DMEM supplemented with 10% FBS and Pen/Strep.  Cell 
were trypsinized and washed 1 time with PBS.  Cell pellets were lysed in hypotonic lysis 
buffer (10 mM Tris [pH 7.5], 10 mM NaCl, 2 mM ETA, 0.1% Triton-X) on ice for 10 
minutes and then brought to 150 mM NaCl.  Cell debris was removed by centrifugation.  
Cell lysate was quantified by Bradford assay.  For each immunoprecipitation, 0.5 mL of 
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1.0 mg/mL lysates were used.  Lysates were precleared with 25 µL of Protein G 
Sepharose (GE Lifesciences) for 1 hour at 4oC.  For immunoprecipitation, 1 µL of 1 
mg/mL antibody was added to each sample and rotated overnight at 4oC.  The following 
day 50 µL of 1:1 protein G Sepharose slurry was added and rotated at 4oC for 4 hours.  
Following incubation, Protein G Sepharose was washed 4 times with hypotinic lysis 
buffer supplemented to 150 mM NaCl.  For co-immunoprcipitation experiments, Protein 
G Sepharose was resuspended in 25 µL of 2X SDS loading buffer and boiled for 10 
minutes.  Resulting supernatant was loaded on SDS-PAGE gel.  For RNA 
immunopreciptation experiments, Protein G Sepharose was resuspended in 100 µL of 
SDS extraction buffer (20 mM Tris [pH 7.5], 1 mM EDTA, 0.5% SDS) and incubated at 
65oC for 15 minutes and then phenol/chloroform extracted and ethanol precipitated.  
RNA was resuspended in Formaminde loading dye and run on an 8 M Urea-Acrylamide 
gel.   
Histone mRNA degradation assay 
Exponentially growing HeLa cells were grown until ~50% confluent.  Three hours prior 
to addition of hydroxyurea (HU), cells were refed.  Cells were treated with hyroxyurea to 
a final concentration of 5 mM for indicated times.  Cells were washed with PBS and 
extracted using TriZol (Invitrogen).  RNA was resuspended in 50 µL of dH2O and 
concentration was checked on Nanodrop spectrophotometer.     
 
Results 
OGFOD1 is involved in Poly(A) but not histone mRNA metabolism 
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 In 2006, the Bedwell lab identified a novel protein in S. cerevisiae which they 
termed Tpa1 (for Translation and polyadenylation 1) (Keeling et al. 2006).  They 
determined that this protein was involved in translation termination and mRNA turnover.  
As histone mRNA degradation relies on translation termination, I wanted to determine if 
this protein had any role in histone mRNA metabolism.  By BLAST analysis, I identified 
the human homolog of Tpa1 as 2-oxoglutarate and iron-dependent oxygenase domain 
contain 1 (OGFOD1) (Figure 16).  These two proteins contain 39% sequence similarity.  
Later, a separate study confirmed that this was the mammalian homolog of yeast Tpa1 
(Wehner et al. 2010).   
 To begin, I designed siRNAs that targeted OGFOD1 as well as the translation 
termination factors eRF1 and eRF3.  Using 293T cells, I knocked down each of the three  
proteins individually using the two hit RNAi protocol (Figure 17 A & B) (Wagner and 
Garcia-Blanco 2002) followed by transfection of GFP reporter constructs containing 
either a histone stem-loop or polyadenyation signals (Figure 17C).  The poly(A) 
construct was driven by a CMV promoter and the histone reporter was driven by the 
mouse Hist2h2aa1 reporter.  The effect on expression was determined by the expression 
of GFP by western blotting.  As compared to cells transfected with a control siRNA (C2), 
expression of this histone reporter was greatly reduced upon knockdown of both eRF1 
and eRF3 (Figure 17 D, Lane 1 & 2).  Dilution series of C2 siRNA knockdown shows 
that GFP is expressed at about 25% of control levels.  The knockdown of eRF1 had a 
slight effect on the expression of poly(A) reporter as levels were reduced about 50%.  
However, eRF3 knockdown had little effect on the levels of the poly(A) reporter (Figure 
17 E, Lane 1 & 2).  These data further demonstrate the role that translation termination  
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Figure 16. OGFOD1 is the human ortholog of S. cerevisiae Tpa1.  Sequence 
comparison of human 2-oxoglutarate and iron-dependent oxygenase domain containing 
protein 1 (OGFOD1) and S. cerevisiae Translation and Polyadenylation 1 protein (Tpa1) 
using ClustalW2 (http://www.ebi.ac.uk/Tools/msa/clustalw2/)   
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Figure 17. OGFOD1 is not involved in histone mRNA metabolism but is involved in 
poly(A) mRNA metabolism. (A) Knockdown of eRF1 using siRNAs (Dharmacon).  
Two-hit siRNA knockdowns were completed as described in Wagner & Garcia-Blanco 
2002.  Western blotting using antibodies specific to eRF1 was used to confirm 
knockdown of eRF1 (c.f. Lane 1 & 4) and loading is shown by probing with antibody for 
PTB.  Note also that knockdown of eRF3 does not codeplete eRF1 (Lane 2).  (B) 
Knockdown of eRF3 by two hit siRNA treatment as confirmed by western blotting using 
antibody specific for eRF3 and using antibody specific for SLBP as a loading control.  
(C) Schematic of reporters used in following assays.  Both reporters contain a 
destabilized green fluorescent protein (d4GFP) ORF.  The histone reporter is driven by 
the mouse H2a promoter and 3’ UTR and downstream sequences.  The poly(A) reporter 
is driven by the CMV promoter and bGH poly(A) signal and downstream sequences.  (D) 
Histone reporter reveals knockdown of eRF1 and eRF3 are particularly detrimental to 
histone expression.  Following knockdown of indicated proteins by two hit siRNA 
transfection, HEK293T cells were transfected with histone reporter and expression was 
measured by western blotting with antibody specific to GFP.  Equal loading was 
confirmed by western blotting for PTB.  Knockdown of eRF1 and eRF3 reduced 
expression of the histone reporter to ~25% of the control samples (compare Lane 1 & 2 to 
lane 6).  OGFOD1 knockdown has no effect on expression of histone reporter (Lane 3).  
(E) Poly(A) reporter experiments were conducted as described for histone reporter 
experiments.  Knockdown of eRF1 reduces expression of poly(A) reporter to ~50% of 
control.  Knockdown of eRF3 has little effect on expression of poly(A) reporter.  
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Knockdown of OGFOD1 reduces levels to ~25% of control indicating that it plays a 
discrete role in metabolism of polyadenylated mRNAs. 
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has in histone mRNA expression and perturbation of translation termination has a more 
detrimental effect on histone expression than on poly(A) tail containing mRNAs.  
 Knockdown of OGFOD1 has no effect on the expression of the histone reporter 
construct.  Transfection of siRNAs against this protein resulted in no change in the 
expression of the histone reporter construct (Figure 17 D, Lane 3).  On the other hand, 
levels of the poly(A) reporter were significantly reduced by knockdown of OGFOD1 
(Figure 17E, Lane 3).  This is in agreement with data presented by the Bedwell lab and 
confirms that OGFOD1 is the human homolog of S. cerevisiae Tpa1.  These data confirm 
that OGFOD1 is involved in the metabolism of polyadenylated mRNAs in humans, but 
suggest that it is not involved is histone mRNA metabolism.   
eRF3 and SLBP directly interact 
 Given the effect seen in knockdown of eRF1 and eRF3 on the translation of 
histone mRNAs, I tested if these proteins formed an interaction with members of the 
histone mRNA translation complex.  eRF1 recognizes the stop codons and has a similar 
structure to tRNAs.  It binds in the A site ofthe ribosome and facilitates with release of 
the nascent polypeptide chain along with its binding partner, eRF3.  Other groups have 
shown that eRF3 form directly interacts with PABPC1 on polysomes and that the 
modulation of this interaction may direct the degradation of poly (A) messages (Hoshino 
et al. 1999).  As SLBP can be thought to be analogous to PABPC1 in terms of histone 
mRNAs, I sought to determine if there was also an interaction between SLBP and eRF3 
or eRF1.  
 Using recombinant GST-SLBP, I performed GST pulldown assays to demonstrate 
that SLBP and eRF3 were able to form an interaction in vitro, but that SLBP and eRF1 
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did not interact (Figure 18 A).  As a positive control, SLIP1 was able to interact with 
SLBP as shown previously (Cakmakci et al. 2008) and to interact with itself (von Moeller 
et al. 2013).  The N-terminus of eRF3 contains a PABP-interacting motif (PAM) that 
complexes with PABPC1.  I tested whether this N-terminal region also contained the 
domain that interacted with SLBP.  Surprisingly, the N-terminus of eRF3 did not interact 
with SLBP, but the C-terminus did (Figure 18 B).  Thus, the eRF3:SLBP interaction is 
mediated by a different region of the protein than the eRF3:PABPC1 interaction.  In 
order to further narrow down the region of eRF3 that interacts with SLBP, I made further  
truncations of eRF3 and tested them for interaction with GST-SLBP.  Two separate  
regions of eRF3 showed interaction with SLBP: amino acids 307 – 433 and amino acids 
501 – 637, showing an unusual bipartite binding domain (Figure 18 B & C).  It is 
possible that in the tertiary structure of eRF3, these two domains are adjacent, but, since 
the crystal structure of this protein has not been solved, I was unable to confirm this 
hypothesis.   
I also wanted to show the region of SLBP that interacted with eRF3.  To this end, 
I expressed GST-tagged truncations of SLBP in baculovirus.  These GST proteins were 
tested for their interaction with eRF3 labeled with 35S-methionine.  Using a panel of six 
truncations, I showed that eRF3 interacts between amino acids 91 and 127 of SLBP 
(Figure 18 D & E).      
However, attempts to show that this interaction is differentially regulated by 
hydroxyurea in vivo were ambiguous.  More work is needed to show that this interaction 
plays a role in regulating the half-life of histone mRNAs in a similar way as the 
PABPC1:eRF3 interaction does.     
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Figure 18. eRF3 interacts SLBP. (A) 5 µg of recombinant GST or GST-SLBP was 
bound to glutathione sepharose resin for 2 hours at 4oC followed by incubation with 8 µL 
of the indicated 35S-methionine labeled eRF3, eRF1 and SLIP1 protein in reticulocyte 
lysate in a 100 ml total volume for 2 hours at 4oC.  Glutathione beads were washed with 
TEN100 buffer, and the proteins were eluted by boiling in SDS, resolved on a 10% SDS-
PAGE gel, dried and visualized on a PhosphorImager. (B) GST pulldowns were done as 
previously described.  Truncations were made by PCR and translated in rabbit 
reticulocyte lysate in the presence of 35S-Met.  Pulldowns indicate two separate regions of 
interaction with SLBP.  (C) Domains of eRF3 demonstrating interactions with different 
proteins. (D & E) eRF3 interacts with the region of SLBP near the RNA binding domain.   
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SLIP1 remains in the initial RNA degradation complex 
 SLBP-interacting protein 1 (SLIP1) was identified in a yeast two-hybrid screen by 
its ability to interact directly with SLBP (Cakmakci et al. 2008).  Dr. Nihal Cakmakci 
determined that SLIP1 functioned in enhancing translation of histone mRNAs perhaps by 
facilitating the formation of a closed-loop translation structure by interacting with both 
SLBP and the translation initiation complex.  Since active translation is a critical step in 
triggering degradation of histone mRNAs, I hypothesized that SLIP1 may play a role in 
transitioning the histone mRNA from a translation competent complex to a complex 
primed for degradation.  The most likely mode of action for this model would be removal 
of SLIP1 from the translating histone mRNP, thereby making translation inefficient and 
triggering degradation.    
 To test this hypothesis, I utilized hydroxyurea (HU), which inhibits DNA 
synthesis by blocking ribonucleotide reductase, to trigger the degradation of histone 
mRNAs.  I immunoprecipitated Lsm1 before and after HU treatment and tested for the 
presence of SLIP1 in the precipitate.  Lsm1 had previously been shown to be in a 
complex with SLBP upon initiation of histone mRNA degradation by 
immunoprecipitation (Mullen and Marzluff 2008), presumably as a result of binding the 
oligo(U) tail (Chapter 2).  If SLIP1 were removed from the translating histone mRNA 
upon initiation of degradation, we would not expect to see association with Lsm1.  
However, I was able to show that following HU treatment, Lsm1 and SLIP1 were 
associated with each other, but not before (Figure 19 A).  I then completed the reciprocal 
IP in which I immunoprecipitated HA-tagged SLIP1 and tested for its association with 
Lsm1 after HU treatment.  Under these conditions, I was able to co-immunoprecipitate 
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Lsm1 and SLIP1 before HU treatment, but the association was increased following 
treatment (Figure 19 B).  Finally, I performed the immunoprecipitation of Lsm1 with 
lysate treated with RNAse A to determine if this interaction was RNA dependent.  I saw 
no change in the ability to immunoprecipitate SLIP1 with α-Lsm1 (Figure 19 C).  These 
data show that SLIP1 remains in the initial histone mRNA degradation complex and 
suggests the formation of an RNAse-insensitive on the 3’ end of the histone mRNA 
between members of the histone mRNP and degradation factors.     
Lsm4 interacts directly with the RNA binding domain of SLBP. 
Since, I showed that Lsm1 was in an RNAse-insensitive complex with SLIP1 and 
Drs. Tom Mullen and Handan Kaygun had demonstrated that a large multisubunit 
complex could form on the oligo(U) mRNA, I sought to determine if there were any 
protein:protein interactions between members of the Lsm1-7 ring and members of the 
histone 3’ mRNP.  To this end, I, with the assistance of Adele Ricciardi, an 
undergraduate student working in the lab at the time, cloned each member of the ring, 
labeled them with 35S-methionine by in vitro translation and tested their ability to interact 
with GST-SLBP expressed in baculovirus or GST-SLIP1 expressed in E. coli.  Of the 
seven Lsm proteins, only Lsm4 interacted with recombinant full length GST-SLBP in 
vitro (Figure  20 A) and none of the members interacted with SLIP1 (Figure 20 B).   
To confirm these interactions, I purified recombinant GST-Lsm4 from E. coli and 
tested its interaction with SLBP and SLIP1 labeled with 35S-methionine by in vitro 
translation in rabbit reticulocyte lysate.  These experiments confirmed that Lsm4 
interacted in vitro with SLBP and not with SLIP1 (Figure 20C).  To determine the region 
of SLBP that interacts with Lsm4, I purified both N- and C-terminal truncations of SLBP  
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Figure 19. SLIP1 remains in an RNAse-insensitive complex after the initiation of 
histone RNA degradation.  (A) Asynchronously growing HeLa cells were treated with 5 
mM HU for indicated times.  Cell lysates were prepared and immunoprecipitated with 
Lsm1 antibody.  Immunoprecipitate was tested for presence of SLIP1.  Lsm1 interacts 
with SLIP1 following HU treatment.  (B) Asynchronously growing HeLa cells were 
treated with 5 mM HU for indicated times.  Cell lysates were prepared and 
immunoprecipitated with SLIP1 antibody.  Immunoprecipitate was tested for presence of 
Lsm1. Reciprocal immunoprecipitation confirms the SLIP1/Lsm1 interaction.  (C) 
Asynchronously growing HeLa cells were treated with HU for 15 minutes and cell 
lysates were prepared with or without RNAse A.  Lsm1 was immunoprecipitated and 
tested for interaction with SLIP1 by western blotting.  No change in the efficiency of 
SLIP1 co-precipitation indicates that the two proteins are found in an RNAse insensitive 
complex.    
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fused to GST and tested the interaction by GST pulldown with full length Lsm4.  N-
terminal fragments 1-68, 1-89 and 1-127 did not interact with Lsm4 (Figure 20D, lanes 
4, 6, 8), while the reciprocal fragments, Δ68, Δ91 and Δ127 bound Lsm4 (Figure 20D, 
lanes 3,5,7).  Neither the Δ165 deletion from the N-terminus, nor the Δ200 deletion, 
bound Lsm4 (Figure 20D, lanes 10 and 11).  C-terminal truncations extending to amino 
acid 165 interacted with Lsm4.  The RNA binding domain (RBD) extends from aa 127-
199, and these data suggest that the RNA binding domain of SLBP interacts with Lsm4, 
and that the N-terminal portion of the RBD contains amino acids (between aa 127 and 
165) that are necessary for binding to Lsm4. 
To determine whether the RBD is the only essential region for binding, and to further 
identify amino acids in SLBP required for binding to Lsm4, I took advantage of the fact 
that Xenopus contains two SLBPs, xSLBP1 the orthologue of mammalian SLBP, and 
xSLBP2 which functions to translationally silence histone mRNA during oogenesis 
(Wang et al., 1999; Sanchez and Marzluff, 2002).  We used chimeric SLBP proteins 
constructed from xSLBP1 and xSLBP2 that contain all possible combinations of the 
domains of SLBP.  The chimeric proteins have been described previously and were used 
to determine the region of xSLBP1 required for histone mRNA translation (Sanchez and 
Marzluff, 2002).  xSLBP2 has the same overall organization as xSLBP1, with a central 
RNA binding domain (domain 2), which is 62% identical (80% similar) with the xSLBP1 
binding domain, but has no similarity in the N-terminal (domain 1) or C-terminal 
(domain 2) domains of the protein (Figure 20E & G). Chimeric proteins are referred to 
by which domains they contain.  For example, 1-2-1 contains the N- and C-terminal 
domains of xSLBP1 and the RNA binding domain of xSLBP2.  Using the 6 constructs, 
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Figure 20.  Lsm4 interacts with the RNA binding domain of SLBP.  (A) 5 µg of 
recombinant GST or GST-SLBP was bound to glutathione sepharose resin for 2 hours at 
4oC followed by incubation with 8 µL of the indicated 35S-methionine labeled Lsm 
protein in reticulocyte lysate in a 100 ml total volume for 2 hours at 4oC.  Glutathione 
beads were washed with TEN100 buffer, and the proteins were eluted by boiling in SDS, 
resolved on a 12% SDS-PAGE gel, dried and visualized on a PhosphorImager.  (B) GST 
pulldowns were performed as previously described using GST-SLIP1  to test for 
interactions with indicated Lsm proteins.  (C) SLBP (top) or SLIP1 (bottom) labeled with 
35S-methinoine by in vitro translation were incubated with GST or GST-Lsm4 and 
analyzed as in panel A.  (D) 35S-methionine labeled Lsm4 was incubated with the 
indicated recombinant GST-SLBP N- and C-terminal truncations and the bound proteins 
were analyzed as in panel A. Top panel: PhosphorImage of bound Lsm4; Bottom: 
Coomassie stained gel (E) The diagram of the xSLBP1 and xSLBP2 proteins, with the N-
terminal domain (1,4), the RNA binding domain (2,5) or the C-terminal domains (3,6) 
indicated.  (F) All possible combinations of these three domains were created (Sanchez 
and Marzluff, 2002), and the six chimeric proteins were tested for their ability to interact 
GST-Lsm4. The indicated chimeric xSLBP proteins were labeled with 35S-methionine 
and incubated with GST or GST-Lsm4 and the bound proteins were analyzed as in panel 
A.  (G) Sequence comparison of regions of human SLBP, Xenopus SLBP1 and Xenopus 
SLBP2 purported to bind Lsm4.  Amino acids conserved in human SLBP and Xenopus 
SLBP1 but different in Xenopus SLBP2 are indicated in red.  (H) Indicated point 
mutations were made in human SLBP and in vitro translated in rabbit reticulocyte lysate 
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in the presence of 35S-Met.  GST pulldowns were performed with 5 µg of GST-Lsm4 as 
previously described.  
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we found that the three constructs that contained the RNA binding domain of xSLBP1 (1-
1-2, 2-1-1, 2-1-2) retained binding to Lsm4.  In contrast, the three proteins which 
contained the RNA binding domain of xSLBP2 (1-2-1, 2-2-1, 1-2-2) did not bind Lsm4 
(Figure 20F).  This result demonstrates that SLBP binds Lsm4 with high specificity and 
confirmed that the amino acids required for binding are found within the RNA binding 
domain, and include the small number of residues that differ in this domain between 
xSLBP1 and xSLBP2.   
Data from Lsm4 binding truncation mutants and Xenopus proteins suggested that 
the critical residues for Lsm4 binding to SLBP were contained between amino acids 127 
and 165 of SLBP and could be further narrowed down to those that are conserved in 
human SLBP and Xenopus SLBP1 but different in Xenopus SLBP2 (Figure 20G). 
Therefore, I created a set of human SLBP mutants in these amino acids so long as they 
also did not alter SLBPs ability to bind the stem-loop as these mutants would not be 
useful in future in vivo testing of the interaction.  Human SLBP was cloned into pxFRM 
and point mutants were generated by overlap PCR.  Proteins were synthesized by in vitro 
translation in rabbit reticulocyte lysate in the presence of 35S-methionine.  GST 
pulldowns were completed with GST-Lsm4.  Unfortunately, none of the tested mutants 
had any reduction in binding to Lsm4 (Figure 20H).  This suggested that more than one 
point mutation in SLBPs RNA binding domain is necessary to disrupt this interaction or 
it was one of the untested amino acids that would also interfere with binding to the 
histone stem-loop.   
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Amino acids in the unstructured C-terminal tail of Lsm4 are required for binding to 
SLBP 
 
Since determination of required amino acids required for binding in SLBP seemed 
as though it would not produce suitable proteins for further testing in vivo, I focused 
instead on the binding requirements in Lsm4. The 1st 100 amino acids of Lsm4 contain 
the Sm-fold and the C-terminal 40 amino acids of Lsm4 are predicted to be unstructured.  
This region contains a number of GRG repeats which are arginine methylation sites 
(Figure 21A; (Brahms et al., 2001).  The entire Lsm4 protein, including the C-terminal 
domain, is highly conserved in vertebrates (Figure 21A).  I expressed full length Lsm4 
and a truncation of Lsm4 with the C-terminal unstructured tail deleted (Lsm4 ΔC40) in 
vitro, labeled with 35S-methionine and tested their ability to interact with GST-SLBP.  
Full length Lsm4 interacted strongly with GST-SLBP (Figure 21B, top), but 
Lsm4(ΔC40) no longer interacted with SLBP (Figure 21B, bottom), demonstrating that 
the C-terminal tail is necessary for binding.  I then expressed a protein where just the C-
terminal 40 aa tail of Lsm4 was fused to GST, GST-Lsm4(100-139), and this protein 
bound SLBP with similar affinity as the full-length GST-Lsm4 (Figure 21C, lane 4).  
These data demonstrated that the C-terminal extension of Lsm4 is necessary and 
sufficient for binding to SLBP.   
To further define the binding site for Lsm4, I expressed and purified GST-Lsm4 (120-
139) which contained only the final 20 amino acids of Lsm4 fused to GST (Figure 21C, 
lane 5).  This protein did not interact with SLBP.  The failure to interact could be 
attributed to the terminal amino acids not being sufficient for binding or the close 
juxtaposition of the tail to the GST protein.  Therefore, I expressed and purified GST-
Lsm4(FL19/120-139), which contained only the last 20 amino acids of Lsm4, but  
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Figure 21.  The C-terminal extension of Lsm4 is required for binding to SLBP.  (A) 
Comparison of the sequence of the C-terminus of Lsm4 from several vertebrates.  (B) 
Full length Lsm4 or Lsm4 with the indicated deletions of the C-terminus were labeled 
with 35S-Met in reticulocyte lysate and tested for binding with recombinant GST-SLBP or 
GST as in panel 2A.  The stained gel is shown below the autoradiogram.  (C) SLBP 
labeled with 35S-methionine was incubated with GST fused with full-length length Lsm4, 
the final 40 amino acids of Lsm4 (GST-Lsm4(100-139), the final 20 amino acids of 
Lsm4 (GST-Lsm4(120-139) or GST fused to a 20 aa random flexible sequence replacing 
amino acids 100-119 of Lsm4 followed by amino acids 120-139 of Lsm4.  (D)  The 
indicated point mutations were introduced to the C-terminal tail of Lsm4, the proteins 
labeled with 35S-Met in rabbit reticulocyte lysate and then incubated with GST or GST-
SLBP.  (E) The results from three independent experiments were quantified using 
ImageQuant.  The amount of binding to WT-Lsm4 was normalized to 100 and statistical 
significance was determined by the student t-test.   
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separated them from the globular GST with a 19 amino acid flexible linker.  This protein 
also did not bind SLBP (Figure 21C, lane 6).    
To more precisely determine which amino acids in the Lsm4 tail are required for 
binding, I made deletions from the C-terminus and tested for binding to SLBP. I found 
that deleting just the last 5 amino acids destroyed binding (Figure 23B), as did all larger 
deletions from the C-terminus.  I then made point mutations in the last 10 amino acids to  
define which the critical amino acids for binding.  Changing the final 5 amino acids to 
alanines (QAGKQ>AAAAA) reduced binding by 50%, while mutation of the 
penultimate 5 amino acids completely abolished binding to SLBP (KKPGR>AAAAA) 
(Figure 21D and E).  However, changing the 3 amino acids N-terminal of KKPGR 
(QPE>AAA) had no effect on binding to SLBP.  These data show that a distinct set of 
amino acids located at the most C-terminal region of Lsm4 are required for binding to 
SLBP, but that amino acids between 100 and 119 were also required for binding.  Note 
that this region of Lsm4 is conserved in all vertebrates (Figure 21A). 
3’hExo interacts with Lsm4 & Lsm6. 
The 3’ to 5’ exonuclease, 3’hExo (also termed Eri1) was isolated about a decade 
ago based on its ability to bind the histone stem-loop (Dominski et al., 2003).  Both 
SLBP and 3’ hExo can bind the stem-loop simultaneously to form a stable ternary 
complex (Yang et al., 2006; Tan et al., 2013), and the 3’ hExo trims 2-3 nts off the 
processed histone mRNA to form the mature cytoplasmic mRNA (Hoefig et al., 2013).  
SLBP blocks further degradation by the 3’ hExo (Yang et al., 2006).  In mouse cells that 
have 3’hExo deleted, histone mRNAs are degraded more slowly when DNA replication 
is inhibited, demonstrating that the 3’hExo also plays an important role in histone mRNA 
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degradation (Hoefig et al., 2013).  3’hExo is also predominantly found on polysomes 
(Figure 22A and (Ansel et al., 2008), consistent with a role in mRNA metabolism.   
Since 3’hExo is able to bind uridylated stem-loop (Figure 15D & E), I  
investigated the possibility that the Lsm1-7 ring may form direct interactions with 3’hExo 
as well.  I expressed full length his-tagged GST-3’hExo in E. coli and purified it over Ni-
NTA resin. The protein was tested for interaction with all seven members of the Lsm1-7 
ring that were expressed in rabbit reticulocyte lysate in the presence of 35S-methionine.  I 
found that, similar to SLBP, GST-3’hExo interacts directly with Lsm4, and in addition, 
there is also a strong interaction in vitro with Lsm6 (Figure 22B).  Using the same 
deletions and mutations I used to characterize the SLBP:Lsm4 interaction,I determined 
the regions of Lsm4 required to bind to 3’hExo.  The 3’hExo bound to the last 40 aa of 
Lsm4 as well as it bound the full-length proteins (Figure 22C, lanes 3 and 4).  The 
3’hExo, like SLBP, did not bind to the last 20 amino acids fused to GST or to the last 20 
amino acids fused to GST through a 20 amino acid flexible linker, indicating that, like 
SLBP, amino acids 100-119, were also necessary for binding to 3’hExo. 
Deletion of the last 10 amino acids of Lsm4 abolished binding of 3’hExo (not shown) and 
also abolished binding of SLBP.  I tested the three point mutants in the last 13 amino 
acids I used to define SLBP binding in Figure 21.  However different point mutants in the 
last 10 amino acids affected 3’hExo and SLBP binding (Figure 22D).  Mutation of the 
last five amino acids, QAGKQ, to alanines abolished 3’hExo binding, but only reduced 
SLBP binding (Figure 21D), while mutations of the adjacent five amino acids, KKPGR, 
to alanines had no effect on 3’hExo binding (Figure 22D), but abolished binding of 
SLBP (Figure 21D).  The mutation of amino acids 127-129 (QPE) to alanines,  
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Figure 22. 3’hExo directly interacts with the C-terminal tail of Lsm4.  (A) 
Exponentially growing Jurkat cells were separated into nuclear, free cytoplasmic and 
polysomal fractions.  Equal cell equivalents of each fraction were analyzed by Western 
blotting for 3’hExo and SLBP.  (B) The Lsm proteins were each labeled with 35S-
methionine and incubated with recombinant GST or GST-3’hExo and analyzed as in 
panel 2A.  (C) The 3’hExo was labeled with 35S-methinoine and incubated with the GST 
proteins fused to the different Lsm4 C-terminal fragments used in Fig. 3C.  The bound 
proteins were analyzed as in panel 2A. (D and E) Full-length Lsm4 and the 3 mutants in 
the C-terminal amino acids described in Fig. 3D were labeled with 35S-methionine and 
incubated with GST-3’hExo.  The bound proteins were analyzed as in panel 2A.  The 
results of three independent experiments were quantified in panel E. (F) The probes used 
for mobility shift assays in panels G and H are shown.  (G and H) Increasing amounts of 
3’hExo (0.1, 1 and 10 pmoles) were incubated with 10 femtomoles of each probe. 
Complexes were analyzed on a 6% polyacrylamide gel.  The results are quantified in 
panel H.    
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did not affect either 3’hExo (Figure 22D) or SLBP binding (Figure 21D).  Thus the 
same general region of Lsm4 is required for binding both SLBP and 3’hExo, the last 40 
amino acids. Although the last 10 amino acids at the 3’ end of Lsm4 were essential for 
3’hExo and SLBP binding, the last 20 amino acids of the Lsm4 tail are not sufficient for 
binding either protein since inserting a different amino acid sequence in the first 20 aa 
after the Sm-domain, but keeping the C-terminus intact, also abolished binding of both 
proteins.  Both proteins require elements in the C-terminal 10 amino acids for binding, 
although the precise amino acids essential are distinct for 3’hExo and SLBP.  Thus it is 
likely that the C-terminal of Lsm4 interacts with the ternary complex at the 3’ end of 
histone mRNA, contacting both SLBP and 3’hExo. 
I showed above that 3’hExo interacts with the oligouridylated 3’ end of histone 
mRNA (Figure 15D & E), which also binds Lsm1-7.  3’hExo has weak affinity for the 
histone pre-mRNA containing 36 nts downstream of the cleavage site (Dominski et al., 
2003)  I compared the affinity of 3’hExo for a stem-loop containing 10 random nts 
following the stem-loop to the uridylated stem-loops terminating 10 nts downstream of 
canonical 3’ cleavage site (SLWT + 10nts, Figure 15A).  The results show that the 
3’hExo can interact with either RNA, but that it has a higher affinity for the 
oligouridylated RNA, suggesting that the 3’ hExo might interact directly with the 
oligo(U) tail.  It is likely that 3’hExo is bound together with SLBP and Lsm1-7 at the 3’ 
end of oligouridylated histone mRNA resulting in the initiation of histone mRNA 
degradation.  
Mutants in the C-terminal tail of Lsm4 assemble into the Lsm1-7 complex 
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To investigate whether the SLBP:Lsm4 interaction is required for efficient 
degradation of histone mRNA in vivo, I first determined whether a tagged mutant Lsm4 
would be incorporated into the Lsm 1-7 complex.  Of several tags tested on wild-type 
Lsm4, only the Lsm4 constructs with a single FLAG tag at the N-terminus were 
incorporated into the Lsm1-7 ring.  I constructed Flag-Lsm4 constructs which were wild 
type Flag-Lsm4(WT) or had the final 10 amino acids truncated (Flag-Lsm4(ΔC10).  To 
test whether the FLAG-tag would interfere with proper assembly of Lsm4 into the Lsm1-
7 ring, I transfected the construct transiently into 293T cells.  Two days after transfection, 
Flag-Lsm4 was immunoprecipitated using anti-Flag and the immunoprecipitates were 
probed for the presence of Lsm1.  The anti-Flag antibody immunoprecipitated substantial 
amounts of the Lsm1 indicating that the Flag-Lsm4 is able to incorporate into some of the 
Lsm1-7 rings in the presence of endogenous Lsm4 protein.  The Flag-Lsm4(ΔC10) 
mutant was also incorporated into the Lsm1-7 ring (data not shown).   
Based on these results, I constructed stable HeLa cell lines expressing FLAG-
Lsm4 (Figure 23A) and FLAG-Lsm4(ΔC10) and the FLAG-Lsm4(KKGPR) mutant.  
The stable cell line expressed similar amounts of FLAG-tagged Lsm4 as endogenous 
Lsm4 (Figure 23A).  Deletion or mutation of the last 10 amino acids greatly reduced the 
ability of the Lsm4 antibody to detect the FLAG-Lsm4 protein.  Note that the Lsm4 
(ΔC10) protein migrates identically with the endogenous Lsm4, also preventing 
unambiguous detection of the FLAG tagged protein with the Lsm4 antibody (see Figure 
23C).  However, the Western signal for the FLAG-tagged proteins was similar in the 
three cells lines, indicating there were similar expression levels in all three cell lines. I 
determined how many of the Lsm1-7 rings containing FLAG Lsm4 by 
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immunoprecipitation with anti-FLAG and Western blotting for Lsm1.  In the stable cell 
lines only a small fraction (2-5%) of the Lsm1-7 complexes contained FLAG-Lsm4 
(Figure 23B). The FLAG-tagged proteins did not compete effectively with the 
endogenous Lsm4 for incorporation into the Lsm1-7 ring.  
To increase the percentage of Lsm1-7 complexes containing FLAG-Lsm4, I 
knocked down the endogenous Lsm4 with a lentivirus expressing a shRNA directed 
against the 3’ UTR of the Lsm4 mRNA.  This resulted in a dramatic increase in the 
fraction of Lsm1-7 complexes that contained the FLAG-Lsm4 (cf. Figure 23B and 23D).  
The knockdown of the endogenous Lsm4 was efficient (Figure 23C, lane 2) and these 
cells grew very slowly compared to cells with Lsm1 knocked down and died 7 and 14 
days post infection.  The cells expressing the FLAG-tagged wild-type and mutant Lsm4 
proteins survived and continued to proliferate.  Thus the mutant Lsm4 proteins support 
the essential function of Lsm4, which likely includes formation of a functional Lsm2-8 
ring in the nucleus.  The shRNA treatment knocks down both Lsm1-7 and Lsm2-8 
complexes, and knockdown of the Lsm2-8 complex, required for splicing, has a more 
deleterious effect on the cell.  In the Lsm4 knocked down cells expressing FLAG-Lsm4 
the great majority of the Lsm4 protein was the FLAG-tagged protein (Figure 23C, lane 
3), and most of the Lsm1-7 complexes contained FLAG-Lsm4 (Figure 23D, lane 1 and 
3).  Since the knockdown isn’t complete there will be a percentage of wild-type Lsm1-7 
rings in the cells. Thus I were able to create a healthy cell line expressing a mutant Lsm4 
that is incorporated into a substantial fraction of the Lsm1-7 (and presumably also Lsm 2-
8) rings, allowing us to determine the effect of this mutation on histone mRNA 
degradation.   
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Figure 23. Flag-Lsm4 proteins are incorporated into the Lsm1-7 complex. (A) HeLa 
cells were transfected with Flag-Lsm4 and stable cells lines selected with G418.  Proteins 
were resolved by SDS-gel electrophoresis and analyzed by Western blotting with anti-
Lsm4.  The bottom panel is a loading control (cross-reacting band with anti-Lsm4).  (B) 
Equal amounts of lysate from cells stably transfected with Flag-Lsm4 (lanes 1-3) or the 
FLAG-Lsm(DC10) (lanes 4-6) were incubated overnight with 1.0 µg of either anti-Flag 
or anti-HA antibody and the immunoprecipitates collected and analyzed by Western 
blotting for Lsm1.  2.5% of the input was analyzed in lanes 1 and 4.  (C) The same cells 
were treated with viruses encoding an shRNA targeting the Lsm4 3’ UTR and stably 
selected with puromycin. 10 mg of total cell protein from lysates of untransfected cells 
and the stably transfected cells expressing FLAG-Lsm4(WT), FLAG-Lsm4(ΔC10) or 
FLAG-Lsm4(KKPGR) were resolved by SDS-gel electrophoresis and analyzed by 
Western blotting with anti-FLAG (top) and anti-Lsm4 (middle). The FLAG-tagged 
Lsm4(DC10) protein comigrates with Lsm4 (lane 4), and reacts poorly, if at all, with the 
Lsm4 antibody.  The Lsm4(KKPGR) mutant also reacts weakly with the Lsm4 antibody 
(lane 5).  (D) Lysates from cells transfected with FLAG-wild-type Lsm4 (lanes 1-3) or 
FLAG-Lsm4(ΔC10) (lanes 4-6) and with endogenous Lsm4 knocked down were 
incubated with anti-HA (lanes 2 and 5), anti-FLAG (lanes 3 and 6) as in panel B, and the 
immunoprecipitates probed with anti-Lsm1.  2.5% of the input lysate was analyzed in 
lanes 1 and 4.  (E) Lysates from cells transfected with FLAG-Lsm4(WT) and treated 
shRNA against endogenous Lsm4  were immunoprecipitated with anti-FLAG, and the 
immunoprecipitates probed with various antibodies to degradation factors both without 
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(Lane 3 & 7) and without (Lane 4 & 8) RNAse A treatment.  Treatment was done with 
(Lanes 5 – 8)  and without (lanes 1 – 4) HU treatment of cells for 15 minutes before lysis.   
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I also tested the ability of Flag-Lsm4 to association with Lsm1 and other RNA 
degradation proteins after treatment with RNAse A.  As expected Flag-Lsm4 was able to 
immunoprecipitate Lsm1 independent of RNA further confirming that Flag-Lsm4 is 
stably incorporated into Lsm1-7 ring (Figure 23E).  This interaction was also 
independent of HU treatment.  I asked if Flag-Lsm4 interacted with Upf1, an NMD factor 
that is also required for histone RNA degradation.  Flag-Lsm4 was able to 
immunoprecipitate Upf1; however, this interaction was mediated by RNA as the 
interaction is lost after RNAse treatment.  I was surprised to find that this interaction was 
not dependent upon HU (cf. Figure 23E, top panel, lane 3 & 7).  This was the same 
pattern of immunoprecipitation seen for CBP80 and Upf2, a member of the cap-binding 
complex that is required for NMD and that may be associated with histone mRNAs 
during degradation (Figure 23E, 3rd  panel).  These data further confirm that Flag-Lsm4 
is incorporated into the Lsm1-7 complex, but also suggests that Lsm1-7 may play a wider 
role in degradation of other mRNAs. 
Interaction of SLBP and Lsm4 is required for efficient histone mRNA degradation 
I tested the effect of expressing the mutant Lsm4 proteins on histone mRNA 
degradation.  To determine the kinetics of histone mRNA degradation, exponentially 
growing HeLa cells were treated with 5 mM hydroxyurea (HU) to inhibit DNA 
replication and trigger histone mRNA degradation.  Total cell RNA was prepared 0, 20 
and 40 minutes after addition of HU.  I have previously shown that knockdown of Lsm1 
reduces the rate of histone mRNA degradation (Mullen and Marzluff, 2008).  I knocked 
down either Lsm1 or Lsm4 in HeLa cells using siRNAs (Figure 24A).  Each knockdown 
resulted in a decreased rate of histone mRNA degradation  (Figure 24B,C).  I carried out 
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a similar analysis in cells expressing the FLAG-Lsm4(WT) and FLAG-Lsm4(ΔC10), 
which had the endogenous Lsm4 knocked down.  In cells depleted of Lsm4 that were 
expressing the Flag-Lsm4(WT), the histone mRNAs were degraded at similar rates as the 
untransfected cells, indicating that the FLAG-Lsm4(WT) restored histone mRNA 
degradation.  In contrast, cells depleted of Lsm4 that were expressing FLAG-
Lsm4(ΔC10) histone mRNAs were degraded at a much slower rate, indicating that the 
mutant Lsm4(ΔC10) did not restore histone mRNA degradation (Figure 24D and E).    
Since Lsm4(ΔC10) does not bind either SLBP or 3’hExo, these data show that the 
interaction between Lsm4 and the complex at the 3’ end of histone mRNA is necessary 
for efficient histone degradation.      
 
Discussion 
Degradation of histone mRNA requires the assembly of a complex of factors on 
the 3’ end of the mRNA, resulting in oligouridylation of the 3’ end of the mRNA 
followed by binding of the Lsm1-7 complex to the oligo(U) tail and subsequent 
degradation of the histone mRNA via both 5’ to 3’ and 3’ to 5’ pathways (Mullen and 
Marzluff, 2008). The 3’hExo is essential for the initial step of degradation of the histone 
mRNA after oligouridylation (Hoefig et al., 2013).  The 3’ end of the cytoplasmic, 
translationally competent histone mRNA likely is a ternary complex of SLBP and 3’ 
hExo bound to the stem-loop at the 3’ end (Yang et al., 2006;Tan et al., 2013).  Since 
addition of the oligo(U) tail does not evict SLBP or 3’ hExo from the histone 3’end, 
recruitment of other factors, such as Lsm1-7, likely precedes disassembly of the mRNP. 
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Figure 24.  The interaction of Lsm4 with SLBP and 3’hExo is necessary for 
degradation of histone mRNA after inhibiting DNA replication.  (A) HeLa cells were 
treated with a control siRNA (lane 6), a siRNA targeting Lsm1 (lane 7) and a siRNA 
targeting Lsm4 (lane 8) as previously described (Mullen and Marzluff, 2008).  Total cell 
lysates were prepared and analyzed by western blotting for Lsm1 (top), Lsm4 (middle) 
and polypyrimidine track binding protein (PTB, bottom).  Dilution series of lysate from 
untreated HeLa cells were used to determine loading.  (B and C)  The cells in panel A 
(exponentially growing) were treated with 5 mM HU and RNA was harvested before HU 
treatment and 20 and 40 min after HU treatment (HU).  Total cell RNA was purified and 
1 µg of whole cell RNA was resolved on 8M Urea-6% polyacrylamide gels and histone 
H2a mRNA and 7SK RNA detected by Northern blotting and visualized with a 
PhosphorImager.  The RNA samples were also analyzed by gel electrophoresis and 
stained with ethidium bromide for 28S rRNA (bottom).  The PhosphorImager images 
were analyzed by ImageQuant (panel C).  (D and E) Exogenous Flag-Lsm4 with a wild-
type C-terminal tail or FLAG-Lsm4(DC10) were stably expressed in HeLa cells.  
Endogenous Lsm4 was knocked down by an shRNA targeting the 3’UTR of endogenous 
Lsm4 (Fig. 5C).  Histone mRNA degradation was initiated by treating exponentially 
growing cells with 5 mM HU, and the total cell RNA analyzed as in panel B.  The results 
of three independent experiments were quantified in panel E and statistical significance 
was determined by student t-test.  
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The Lsm1-7 ring also plays a critical role in degradation of polyadenylated 
mRNAs (Parker and Song, 2004).  Following deadenylation, it binds to the short (<15 
nts) oligo(A) tail of the mRNA resulting in the recruitment of factors that inhibit 
translation and activate degradation.  The Lsm 2-7 proteins are shared as part of a second 
complex, Lsm 2-8, which is associated with the oligo(U) tail on the 3’ end of U6 snRNA 
in the nucleus where it is essential for splicing (Pannone et al., 2001;Mayes et al., 1999).  
How the relative amounts of the two different Lsm complexes is controlled is not 
understood, but the Lsm2-7 proteins are components of two critical complexes, one 
involved in pre-mRNA splicing in the nucleus and the other in mRNA degradation in the 
cytoplasm.   
Specific roles for individual Lsm proteins in these complexes have not been 
identified.  The complex consists of a ring of proteins which interact through their Sm 
domains.  Each of the members of the ring has additional sequences at the N and C-
termini which may be available for interacting with specific factors.  Some of these tails 
are likely essential for assembly of the Lsm 1-7 ring.  These sequences are highly 
conserved among vertebrates suggesting that they have specific functions.  The Lsm1-7 
ring interacts with Rck/p54, Pat 1, Hedls, and hEdc3, although whether regions of the 
Lsm1-7 ring directly contact all these factors is not known (Ozgur et al., 2010;Fenger-
Gron et al., 2005).  
Lsm4 plays a specific role in histone mRNA degradation. 
My finding that a specific site on Lsm4 directly binds with both proteins at the 3’ 
end of the histone mRNP suggests that recruitment of the Lsm1-7 ring to its target 
mRNAs may involve protein-protein contacts with the mRNP as well as recognition of an 
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unstructured oligo(A) or oligo(U) stretch.  Several lines of evidence support this 
conclusion.  The C-terminal tail of Lsm4 specifically interacts with the RNA binding 
domain of SLBP.  This interaction is conserved between frogs and humans, but the RNA 
binding domain of frog SLBP2, an SLBP that functions in storing histone mRNA in an 
inactive form in the oocyte, does not interact with Lsm4.  Lsm4 also interacts with 
another component of the histone mRNP, 3’hExo, suggesting that it forms a specific 
complex with the 3’ end of histone mRNP.  A mutant in Lsm4 that disrupts its binding to 
SLBP and 3’hExo specifically interferes with histone mRNA degradation.  
Since the Lsm proteins are small, any alterations in their structure may affect their 
ability to assemble into the Lsm1-7 ring.  I found many tagged wild-type constructs I 
made of either Lsm4 or Lsm1 would not assemble into the Lsm1-7 ring even after RNAi 
knockdown of most of the endogenous proteins.  Of a number of tags I tested only the 
singly N–terminally FLAG-tagged Lsm4 (and not a triple-tagged FLAG Lsm4) was 
capable of assembly into the Lsm1-7 ring in vivo.  N-terminally HA-, 3X Flag-, myc-, 
his- or C-terminally myc- and his-tags prevented exogenous Lsm4 from effectively 
incorporating into the Lsm1-7 ring as judged by co-precipitation with Lsm1.  Even this 
tagged protein did not compete effectively with the endogenous Lsm4, and <10% of the 
protein was incorporated into the Lsm1-7 ring in cells expressing the tagged Lsm4 
together in similar amounts with endogenous Lsm4. I were only able to assemble 
substantial amounts of tagged-Lsm4 into the Lsm1-7 ring by knocking down the 
endogenous Lsm4.  
Transitioning histone mRNAs from translation mRNPs to degradation mRNPs 
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Throughout the life cycle of the histone mRNA, SLBP interacts with the histone 
mRNA.  The SLBP:SL complex provides a scaffold which helps to coordinate different 
processes.  In the nucleus, during pre-mRNA processing SLBP interacts with the nascent 
histone mRNA.  Following the maturation of histone mRNAs, SLBP is essential for 
transport of the mRNA to the cytoplasm (Sullivan et al., 2009), likely by interacting with 
SLIP1 and/or CTIF (Choe et al., 2013;Kim et al., 2009) and Dbp5 (von Moeller H. et al., 
2013) to facilitate TAP-dependent mRNA export (Erkmann et al., 2005a).  During S-
phase in the cytoplasm, SLBP interacts with SLIP1 and/or CTIF (Choe et al., 2013) 
which in turn interact with the translation initiation complex at the 5’ end of the message.  
At the 3’ end of the histone mRNA there is likely a ternary complex of SLBP:SL:3’hExo 
(Yang et al., 2006;Tan et al., 2013). 
The rapid decrease in the half-life of histone mRNA when DNA synthesis is 
inhibited is mediated by the 3’ end of histone mRNA, which must be close to the 
terminating ribosome.  Previously data generated in the from the Marzluff lab have 
argued that the initial signal for histone mRNA degradation acts by reducing the 
efficiency of termination of histone mRNA translation (Kaygun and Marzluff, 2005b) 
which in turn results in recruitment of Upf1 as a critical factor required for histone 
mRNA degradation.  Upf1 interacts directly with SLBP (Kaygun and Marzluff, 
2005a)(S.Meaux and W.F.M., unpublished).  This data makes it likely that recruitment of 
Upf1 results in the subsequent recruitment of a TUTase which adds an oligo(U) tail to the 
histone mRNA.  Subsequent recruitment of Lsm 1-7 possibly promoted by the direct 
interaction of SLBP and 3’hExo with Lsm4, is essential for efficient histone mRNA 
degradation.  In cells lacking 3’hExo, the oligouridylated histone mRNA accumulates 
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(Hoefig et al., 2013), suggesting that one role of 3’hExo may be to remove the oligo(U) 
tail, and initiate degradation of the 3’ end of the histone mRNA.  A limiting step in 3’ to 
5’ degradation of the histone mRNA is likely removal of SLBP and any associated 
proteins from the 3’ end of the histone mRNA to allow 3’ to 5’ exonucleolytic digestion.  
The precise role of the Lsm4:SLBP interaction is not clear.  It may enhance the 
recruitment of limiting amounts of Lsm1-7 to the oligouridylated histone mRNA, or it 
may help in remodeling and eventually dissembling the SLBP:SL:3’hExo complex 
making the histone 3’ end available for degradation to the exosome, and it could 
participate in both functions. Since 3’hExo is responsible for the initial step in histone 
mRNA degradation, including probably the removal of the oligo(U) tail (Hoefig et al., 
2013), it is also possible that the C-terminal tail plays a role in promoting this reaction.  
An intermediate in histone mRNA degradation is partial degradation into the stem-loop, 
likely catalyzed by the 3’ hExo (Hoefig et al., 2013).  This intermediate is also uridylated 
and again binds Lsm1-7 presumably to recruit the exosome to promote degradation 
and/or recruitment of the decapping complex.  For histone mRNAs being degraded 3’ to 
5’, the rate limiting step in degradation may be the removal of SLBP from the 3’ end of 
the histone mRNA, allowing complete degradation of the mRNA from the 3’ end. 
Data presented in this chapter show for the first time that SLBP plays in integral 
role in histone mRNA degradation, further expanding its repertoire of roles.  Previously, 
members of the Marzluff lab have demonstrated that SLBP has district roles in regulating 
3’ end processing of histone mRNAs, nuclear export of histone mRNAs and translation 
of histone mRNAs.  In each of these cases, SLBP does not act directly on the histone 
mRNA, but rather acts as a scaffold for other proteins to interact with the mRNP.  For 3’ 
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end processing in mammals, SLBP interacts with ZFP100 to help recruit the U7 snRNP.  
In nuclear export, SLBP interacts directly with TAP, which in turn interacts ith 9G8 to 
promote export to the cytoplasm.  During translation, SLBP interacts with SLIP1 and/or 
CTIF to promote the formation of the closed-loop translation complex.  To this list, I can 
add that during histone mRNA degradation, SLBP interacts with the C-terminal tail of 
Lsm4 to promote degradation, perhaps by recruiting additional components of the 
degradation complex.   
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CHAPTER IV:  POLYADENYLATION OF A SUBSET OF HISTONE mRNAs IN 
NON-DIVIDING CELLS 
 
Introduction 
 In 1972, Darnell and collegues first determined that replication-dependent histone 
mRNAs in humans are not polyadenylated (Adesnik and Darnell 1972; Adesnik et al. 
1972).  Subsequently, histone mRNAs were shown not to contain poly(A) tails in sea 
urchin larvae (Nemer et al. 1975), mouse embryo (Jacob 1976), frog oocyte (Destree et 
al. 1977), brine shrimp larvae (Amaldi et al. 1978) and D. melanogaster (Burckhardt and 
Birnstiel 1978).  In each of these cases, the characterization of histone mRNAs as non-
polyadenylated occurred in rapidly proliferating cells such as cancer cells (HeLa), short-
lived species (D. melanogaster), or during development. 
 The regulation of histone mRNA biogenesis by effectors of the eukaryotic cell 
cycle has also been long established. (Harris et al. 1991a).  Phosphorylation of  p220NPAT 
by cyclin E/Cdk2 is required for entry into S-phase and transcription of histone mRNAs 
at the G1/S boundary (Zhao et al. 1998; Ma et al. 2000; Zhao et al. 2000).  The expression 
of NPAT is also dependent on the cell cycle effector E2F (Gao et al. 2003).  Furthermore,  
generation of properly cleaved stem-loop 3’ ends is dependent upon SLBP (Dominski et 
al. 2001; Sullivan et al. 2001; Dominski et al. 2002) and the expression of SLBP protein 
is constrained to S-phase (Whitfield et al. 2000a) through proteolysis triggered by 
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phosphorylation by Cyclin A/Cdk1 at the end of S-phase (Zheng et al. 2003b; Koseoglu 
et al. 2008b) and an unknown mechanism during G1 phase of the cell cycle. 
 An unresolved question is how and if histone mRNAs are expressed after cells 
have terminally differentiated and will no longer re-enter S-phase.  This is a particularly 
pertinent question for long-lived species like humans.  The half-life of histone protein in 
brain tissue is 19 days (Bondy 1971) and turnover likely occurs as a result of damage to 
existing histone proteins.  While some amount of cell division in brain tissue does occur 
at low levels in granule neurons of the adult dentate gyrus of the hippocampus (Kaplan 
and Hinds 1977), the brain is largely composed of mitotically quiescent cells (Rakic 
1985a; Rakic 1985b).  Additionally, the generation of a mature neuron can take up to six 
months (Kohler et al. 2011).  How, then, do cells such as these maintain proper levels of 
histone proteins, that are critical for genome stability and the regulation of gene 
expression? 
 Here, I will show that in terminally differentiated cells, a subset of histone 
mRNAs no longer end in the stem-loop that has been so meticulously characterized 
during development and in tissue culture cells.  Instead, they bypass the stem-loop and 
utilize downstream polyadenylation signals.  In certain cases, this poly(A) signal is 
downstream and reached by extending the 3’ UTR of the histone mRNA.  In other cases, 
the histone mRNA is spliced to reach a poly(A) signal located more than 5 kb 
downstream.  I suggest that the increased expression of polyadenylated histone mRNAs 
may be may be due to the reduction in the amounts of U7 snRNA and SLBP.   
Replacement histones are those that replace replication-dependent histones in 
nucleosomes that are lost due to chromatin rearrangements or due to natural turnover.  
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Two particularly well-studied replacement histones are H1o and H3.3.  H1o is an H1 
replacement histone that is specific to non-dividing, terminally differentiated tissues 
(Panyim and Chalkley 1969).  Initially discovered in mammalian tissues, H1o was later 
identified to be present in other species as well and shares homology with the avian 
histone H5, a histone protein that is specific to differentiated nucleated erythrocytes.  The 
mRNA expressing the H1o protein does not end in the stem-loop characteristic of 
replication-dependent histones, but rather, ends in a poly(A) tail.  This allows for H1o to 
be expressed independent of cell cycle controls.  A similar situation exists with the 
expression of the H3 replacement gene H3.3.  This too is expressed from a spliced and 
polyadenylated mRNA expressed independent of the cell cycle.  After differentiation, 
large amounts of the H3 protein in the cell is turned over to H3.3 protein (Urban and 
Zweidler 1983).  Other histone proteins do not have related genes that serve as 
replacements, and even in the case of histone H1, only a relatively small fraction of total 
H1 protein is H1o in differentiated cells.   
There must be a mechanism for synthesis of the other histone proteins in 
differentiated cells, because other variants, such as H2a.Z, have important functions and 
cannot replace histone H2a in bulk chromatin.  I show in this chapter that a subset of the 
replication-dependent histone mRNAs can exist as either stem-loop isoforms or 
polyadenylated isoforms.  Hist1H1c is a replication-dependent histone mRNA that ends 
in a stem-loop in actively dividing cells (Wang et al. 1997).  However, upon cell cycle 
arrest or through differentiation, Hist1H1c can be expressed as a polyadenylated isoform.  
This was not surprising since histone H1 proteins turn over much faster than core 
histones.  A similar situation is observed with the H2a.X gene.  During S-phase in 
	   151	  
actively proliferating cells, this gene produces mRNAs that end in a stem-loop.  
However, during cell cycle arrest or during G1, the H2A.X gene is capable of producing a 
polyadenylated mRNA by utilizing downstream poly(A) signals (Nagata et al. 1991).  
However, H2A.X is not a true replacement histone.  Rather, it is a specialized histone 
protein that the cell uses to specifically recognizes damaged DNA (Marzluff et al. 2008).  
The H1o, Hist1H1c and H3.3 genes provide replacement proteins for the H1 and 
H3 histones in non-dividing cells.  Here, I demonstrate that H3.3 is the sole replacement 
histone H3 gene in mouse tissues, as there is no expression of other H3 genes.  I also 
demonstrate that a subset of replication-dependent H2A, H2B and H4 genes are 
expressed as polyadenylated mRNAs after cells have exited the cell cycle.  These 
transcripts likely represent the replacement variant histones for these three protein 
classes, similar to the role of histone H1c for the histone H1 genes.  These data 
demonstrate that terminally differentiated cells have multiple mechanisms to produce 
histones outside of the confines of the cell cycle.  
 
Materials and Methods 
RNA extraction from mouse tissue 
 Post-natal day 1 (P1 mice) along with dissected mouse liver and brain were 
obtained from the lab of Dr. Ned Sharpless and kept at -80oC until use.  Sections of tissue 
were weighed and placed in mortar filled will liquid nitrogen and homogenized by hand 
with pestle.  Resulting tissue powder was transferred to 15-mL falcon tube.  One mL of 
trizol (Invitrogen) was added per 50 mg of tissue powder.  Trizol homogenate was 
transferred to eppendorf tubes and was centrifuged for at 12,000 x g for 10 minutes at 
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4oC.  If present, the layer of fat was removed from top of supernatant and the supernatant 
was removed to new tubes leaving behind tissue debris.  To each mL of trizol, 0.2 ml of 
chloroform was added and the tube was vortexed.  To separate phases, eppendorf tubes 
were spun at 12,000 x g for 15 minutes at 4oC.  The upper aqueous layer was transferred 
to a new eppendorf tube and RNA was precipitated by adding an equal volume of 100% 
isopropanol.  RNA was pelleted by spinning at 12,000 x g for 10 minutes at 4oC.  
Resulting pellet was air dried and resuspended in 300 µl of 0.3 M sodium acetate [pH 
5.6].  Resuspended pellet was phenol/chloroform extracted, ethanol precipitated, washed 
with 70% ethanol, dried and resuspended in 100 µl of dH2O.  Concentrations were 
checked on NanoDrop.  
Preparation of protein lysate from mouse tissues 
Mouse tissue frozen with liquid nitrogen were ground to a powder using a mortar and 
pestle and resuspended in 1 mL of NP-40 lysis buffer (150 mM NaCl, 50 mM Tris [pH 
8.0], 0.5% NP-40) per 100 mg of tissue.  Eppendorf tubes were rotated at 4oC for 20 
minutes.  Cell lysates were pelleted by centrifugation at 16,000 x g.  Supernatant was 
transferred to new tubes and protein concentration was determined by Bradford Assay.   
Extraction of Genomic DNA from NIH3T3 Cells 
 NIH3T3 cells were grown to 80% confluency, trypsinized, and counted.  Cells 
were pelleted and washed with ice cold PBS.  For each 3.0 x 107 cells, 300 µL of 
digestion buffer (100 mM NaCl, 10 mM Tris [pH 8.0], 25 mM EDTA [pH 8.0], 0.5% 
SDS, 0.1 mg/mL proteinase K) was added.  Cells were resuspended in digestion buffer by 
pipetting and vortexing.  Suspension was rotated overnight at 50oC.  The following day, 
DNA was extracted with phenol:chloroform.  The aqueous layer was precipitated with ½ 
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volume of 7.5 M ammonium acetate and 2 volumes of 100% ethanol.  DNA was pelleted 
by centrifugation, washed with 70% ethanol and, after air drying, resuspended in 300 µl 
of dH2O.  Resuspension was facilitated by incubation at 65oC.  SDS was added to a final 
concentration of 0.1% and RNAse A was added to a final concentration of 1 µg/mL and 
incubated at 37oC for 1 hour.  DNA was extracted with phenol chloroform and 
precipitated with ethanol.  DNA was resuspended in TE buffer and concentration was 
determined using a NanoDrop 2000 spectrophotometer.   
S1 Nuclease protection assay 
 The genomic MmuHist1H1c, MmuHist2H2aa1, MmuHist2H3c, MmuHist2H4a 
DNA was amplified by PCR and cloned into pUC19.  A minigene of the 
MmuHist1H2BC was created by cloning the promoter, 1st exon and 2nd exon, along with 
250 bps at the 5’ and 3’ ends of the intron, creating a 500 bp intron instead of the 
genomically encoded 5.6 kb intron.   
 For generation of 3’ S1 nuclease probes, 5 µg of these plasmids were first cut at a 
restriction site in the ORF of each gene allowing for the generation of a 5’ overhang 
containing a guanine in overhang.  Reactions were cleaned up using PCR cleanup kit 
(Fermentas) and eluted in 32 µL of dH2O.  To label the probe, the eluted DNA was 
incubated with 5 µL of α-[32P]-dCTP (3000 Ci/mmol), 5 µL of 10X Klenow buffer, 3 µL 
of Klenow (NEB), and 5 µL of 10 mM dATP, dGTP, dTTP (3.3 µM each).  The labeling 
reaction was incubated at 37oC for 30 minutes.  Unincorporated nucleotides were 
removes by running radiolabeled probes through a G-50 column (GE Lifesciences).  
Eluate was ethanol precipitated and resuspended in 20 µL of dH2O.  Radiolabeled 
plasmids were then cut at a 2nd restriction site downstream of the 3’ end to be analyzed.  
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Restriction enzymes used for each plasmid are found in Table 2).  Probes were then gel 
purified away from plasmid backbone using Fermentas gel purification kit and eluted in 
50 µL.  Counts per minute per µl of each probe was measure by scintillation counter and 
1000 cpm were used in each experiment. 
 For S1 mapping, various amounts of RNA were added to 1000 cpm of 
radiolabeled probe and dried in a speedvac.  The dried RNA and probe were then 
resuspend in 10 µl of S1 hybridization buffer (80% formamide, 40 mM PIPES [pH 6.4], 
500 mM NaCl, 1 mM EDTA), heated to 100oC for 5 minutes and then incubated 
overnight at 52oC.  The following day, RNA digestion was completed by adding 10 µL of 
10X S1 buffer (300 mM Sodium Acetate [pH 4.6], 10 mM zinc acetate, 50% (v/v) 
glycerol), 1 µL S1 nuclease (Promega) and 79 µL of dH2O and incubating at room 
temperature for 90 minutes.  Digested RNAs were then ethanol precipitated, resuspended 
in 20 µL of RNA loading dye and run on a 6% Urea-acrylamide gel.  Gels were dried and 
visualized by autoradiography. 
Selection of Poly(A)+ mRNA 
 The tip of a 1-mL pipette tip was cut off and stuffed with autoclaved glass wool.  
The pipette tip was then washed with 1 mL of 5 M NaOH.  25 mg of oligo(dT) cellulose 
(Gibco) was resuspended in 500 µL of 0.1 M NaOH.  This slurry was loaded into the 
pipette tip column and washed with 5 ml of dH2O.  The column was then equilibrated 
with 10 mL of loading buffer (0.5 M LiCl, 10 mM Tris [pH 7.5], 1 mM EDTA, 0.1% 
SDS).  At least 50 µg of whole cell RNA was heated to 65oC for 5 minutes and then 
passed through oligo(dT) column.  Eluate was saved and passed over column 2 additional 
times.  The final eluate was the poly(A)- fraction.  The RNA was precipitated with  
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Table 2. Polyadenylated replication-dependent histone mRNAs in mouse and 
human tissues 
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ethanol and resuspended in dH2O.  The column was then washed with 1 mL of loading 
buffer and the Poly(A)+RNA was eluted with 400 µl of 2 mM EDTA, 0.1% SDS.  
Sodium Acetate was added to eluate to a final concentration of 0.3M and the RNA was 
precipitated using ethanol.  RNA pellets were resuspended in dH2O. 
Northern Blotting 
For each tissue tested, 25 µg of whole cell RNA was ethanol precipitated and 
resuspended in RNA loading buffer.  RNA was heated denatured for 10 minutes at 65oC 
and run on a 6% Urea-Acrylamide gel until bromophenol blue ran off the bottom of the 
gel.  Separated RNAs were transferred to Nylon-P membrane (GE Amersham) by 
electroblotting.  Membranes were dried on the benchtop and RNAs were crosslinked to 
membrane by exposure to 460000 J of UV light.  Membranes were incubated while 
rotating with 25 ml of QuickHyb (Stratagene) at 42oC for 1 hour.  After denaturing by 
boiling for 5 minutes, 5 µl of end labeled oligonucleotide complementary to target 
snRNA was added to QuickHyb.  To generate these northern probes, 5 µl of 10 µM 
oligonucleotides ordered from IDT were incubated with 2 µL of T4 PNK buffer (NEB), 1 
µL of T4 PNK (NEB), 3 µL of γ-32P-ATP (3000 Ci/mmol) and 9 µL of dH2O.  
Unincorporated nucleotides were removed by passing the probe through G-25 column 
(GE lifesciences).  The following day, QuickHyb and northern probe was removed and 
blot was washed twice with 1X SSC/0.1% SDS at 48oC.  Blots were wrapped in saran 
wrap and exposed to a phosphor screen.   
Biotinylated RNA pulldown 
 Cellular lysates were prepared from mouse tissues and tissue culture cells as 
previously described.  Lysates were diluted to 1 mg/mL in NP-40 lysis buffer (150 mM 
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NaCl, 50 mM Tris [pH 8.0], 0.5% NP-40) and final concentration of EDTA was brought 
to 20 mM.  For each experiment, 100 µL of 1 mg/mL lysate was incubated with 10 µL of 
10 mM biotinylated stem-loop ordered from Dharmacon for 1 hour while rotating at 4oC.  
To each reaction, I added 50 µL of 1:1 streptavidin-agarose equilibrated in NP-40 lysis 
buffer and continued rotating at 4oC for an additional hour.  Beads were collected by 
centrifugation for 1 minute at 14,000 rpm at 4oC and 10% of supernatant was saved for 
analysis.  Beads were washed 4 times with 1 mL of NP-40 lysis buffer.  Protein 
complexes were removed from beads by boiling in 25 µL of SDS loading buffer and 
resolved on an 8% SDS-PAGE gel for western blot analysis. 
   
Results 
A subset of histone mRNAs are expressed in human tissue 
 I analyzed publically available RNA-seq data generated by Illumina using 
Integrated Genome Browser (IGV) from the Broad Institute (Harvard University & 
Massachusetts Institute of Technology) prepared from 16 different human tissue samples 
by cDNA synthesis by either random priming or using oligo(dT) primers.  These different 
tissues are: (1) Adipose, (2) Adrenal, (3) Brain, (4) Breast, (5) Colon, (6) Kidney, (7) 
Heart, (8) Liver, (9) Lung, (10) Lymph, (11) Prostate, (12) Skeletal Muscle, (13) Ovary, 
(14) Testes, (15) Thyroid, and (16) White Blood Cells. 
 Upon investigation of the Hist1 and Hist2 gene clusters, I determined that there 
were 12 of the 65 (18%) histone genes in these two clusters expressed in the tissues and 
that these transcripts were found in a polyadenylated form (Table 4).  Particularly 
striking was the observation that one half (6) of these genes encoded spliced mRNAs and,  
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Table 4. Polyadenylated replication-dependent histone mRNAs in mouse and 
human tissues 
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Figure 25. A subset of replication-dependent histone mRNAs are expressed in 
terminally differentiated tissues.  (A) RNA-Seq from human tissues showing 
expression of Hist1H1C gene.  Note that there is no expression of other genes in this 
region.  Hist1H1C is expressed as a polyadenylated isoform utilizing a polyadenylation 
signal downstream of the stem-loop (Wang et al. 1997). (B) RNA-seq from human 
tissues showing expression of the spliced Hist1H4H gene, but not other genes in this 
genomic region.  Schematic at bottom of figure indicates gene structure.  This gene is 
produces 3 mRNA isoforms, one stem-loop isoform and two different spliced and 
polyadenylated isoforms produced as a result of alternative polyadenylation.  (C) Core 
histones are expressed in mouse tissue as determined by RT-PCR.  Primers were 
designed that would detect each all mRNAs for a specific class histones.  cDNA 
synthesis was completed using random primers.  Histone mRNA was detected for each 
class in each sample tested.  However, expression was highest in tissue culture cells 
(NIH3T3).  Note that H3 expression also detects H3.3 mRNA.   
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in 4 genes, splicing led to the excision of the stem-loop from the mature RNA.  Hist1H1C 
was previously identified as expressing a poly(A) isoform in mouse tissues and upon 
arrest of MEL cells.  RNA-seq data confirms the expression of Hist1H1C in human 
tissues (Figure 25A).  A small fraction of this mRNA is expressed with an extended 3’ 
UTR which utilizes a downstream poly(A) signal, but the form that ends at the stem-loop 
is predominant as it is in mice.  Other histone genes surrounding Hist1H1C are not 
expressed in these tissues (Figure 25A).  Hist1H4H is also expressed as a poly(A) 
isoform (Figure 25B).  In this case, rather than simply extending the 3’UTR, the 3’ UTR 
is spliced and contains two different poly(A) signal in the 2nd exon, creating two different 
spliced and polyadenylated isoforms of this mRNA in a addition to the stem-loop isoform 
(Figure 25B, See diagram at bottom).  
 Do to the limitations of studying human tissues, I chose to continue the 
investigation of these RNAs in mouse tissues.  First, I had to confirm that similar 
phenomena were observable through deep sequencing.  Dr. Chris Burge at Massachusetts 
Institute of Technology gave us access to a RNA-seq data he had completed which 
subsequently has become publically available.  This library was prepared from 8 different 
mouse tissues: (1) Brain, (2) Colon, (3) Kidney, (4) Liver, (5) Lung, (6) Skeletal Muscle, 
(7) Testes, and (8) Spleen.  Unlike in human histone genes, the mouse core histone gene 
open reading frames are remarkably conserved at the nucleotide level which makes 
unambiguous alignment of short reads impossible.  There is less conservation in 3’ UTRs 
except for the stem-loop, which are predictably conserved, but this region is typically 
only 20 – 50 nts long.  Any short read is as likely to align to the gene from which it 
originated as it is to any other gene in the histone class.  Therefore, I was only able to  
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Figure 26.  Hist1H2bc is expressed as a spliced and polyadenylated mRNA in mouse.  
(A) RNA-seq of intron/exon boundaries and polyadenylation signal of the mouse 
Hist1H2bc gene.  Notable cis-elements are indicated at bottom of panel.  The stem-loop 
sequence is contained within the excised intron.  (B) Schematic of Hist1H2bc gene 
structure in mouse indicating the location of primers used in RT-PCR experiments.  (C) 
Expression of spliced isoforms of Hist1H2bc detected in P1mouse, liver and brain (Lanes 
1 – 3).  Stem-loop isoforms were also detected using stem-loop specific primers (Lanes 5 
– 7).  Due to differential cDNA synthesis, comparison between expression of stem-loop 
and spliced isoforms was not possible.  (D) S1 nuclease protection assay of using 
Hist1H2bc in mouse cultured cells and tissues.  Different amounts of whole cell RNA 
was added for each reaction in order to determine relative amounts of Hist1H2bc in 
mouse tissues.  Indicated bands correspond to stem-loop Hist1H2bc mRNA, spliced 
Hist1H2bc and other H2B genes.  Nearly all of H2B mRNA in the mouse liver is spliced 
(Lane 9).  (E) RNA from indicated tissues was poly(A) selected using oligo-d(T) 
cellulose.  S1 nuclease protection assay was performed on Poly(A)+, poly(A)- and whole 
cell (WC) RNA using Hist1H2bc S1 nuclease probe.  The spliced band observed in 
mouse liver fractionated with poly(A)+ mRNA (Lane 7) indicating that it was spliced an 
polyadenylated.  (F) NIH3T3 cells were arrested in Go by serum starvation and 
restimulated by the addition of 10% FBS  (G) Cell cycle arrest of NIH3T3 cells does not 
cause the production of the spliced-polyadenylated Hist1H2bc mRNA. 
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confidently identify expression of histone genes that I had already identified as being 
polyadenylated in humans, or that were spliced or had relatively long extended 3’ UTRs. 
Core histone mRNAs are expressed in the adult murine liver and brain     
 I extracted RNA from actively growing NIH3T3 cells, post-natal Day 1 mice (P1 
mouse), mouse liver and mouse brain (72 d).  RNA was resuspended in dH2O and 
quantified using NanoDrop.  RNA extracted from mouse cells and tissues was reverse 
transcribed using random hexamers and Superscript III (Invitrogen).  Due to conservation 
of mouse histone genes, I was able to design primer sets that would amplify most, if not 
all, of the mRNAs for each specific histone class (Table 3).  PCR was performed with 
these primer sets for each histone class.  I was able to detect histone mRNA expression in 
each sample for each class of histone.  This non-quantitative RT-asPCR was able to 
demonstrate qualitatively that there is less of each histone mRNA in mouse tissues when 
compared to tissue culture cells (Figure 25 C cf. NIH3T3 cells to mouse brain or liver 
samples).   
MmuHist1H2BC is the predominant H2B gene expressed in the murine liver and is 
exclusively polyadenylated 
 
 Analysis of the histone genes in RNA-seq of human tissues identified several 
RNAs that warranted further study.  In particular, Hist1H2BC was spliced and 
polyadenylated as it was in humans.  Interestingly, the 5’ splice site was located 5’ of the 
stem-loop.  The result of this splicing was that the stem-loop and HDE were excised as 
they were contained within a 5 kb intron (Figure 26 A & B).  In humans, this gene is 
found in an H2A-H2B pair with Hist1H2AC, which is also spliced and polyadenylated.  I 
was able to determine that Hist1H2BC had a similar gene structure in mice as was 
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described in humans (Figure 26 A & B). Immediately downstream of the stop codon and 
upstream of the stem-loop, there is a canonical GU splice donor.  Five kilobases 
downstream of this, there is a strong polypyrimidine tract followed by a canonical AG 
splice acceptor.  RNA-seq data demonstrates that this 2nd exon is 1 kb long and ends by 
utilizing a poly(A) signal (AAUAAA) followed by a GU rich sequence.  RNA-seq data 
from mouse tissue suggested that the other gene in the gene pair, Hist1H2AC, is 
expressed and polyadenylated as in humans.  However, polyadenylation here is due to an 
extended 3’ UTR and utilization of a downstream poly(A) signal.   
With the assistance of Clark Cunningham, an undergraduate, I analyzed the 
Hist1H2bc mRNA in mouse tissues.  The structure of Hist1H2BC allowed me to design 
primers that would specifically detect spliced, polyadenylated mRNAs and primers that 
would specifically detect Hist1H2BC mRNAs that end in a stem-loop (Figure 26B).  
Non-quantitative RT-PCR confirmed the RNA-seq data.  Spliced Hist1H2BC was readily 
detected in mouse liver, brain and also in the P1 mouse.  Further, I am confident that this 
amplification is from a spliced mRNA as it spans an intron that would otherwise have 
created a 5.6 kb amplicon.  I was also able to determine that there was some stem-loop 
Hist1H2BC mRNA present in each of these samples.  Due to the fact that the downstream 
primer used to detect stem-loop mRNA was located in the stem-loop and at the 3’ end of 
the mRNA where cDNA synthesis is inefficient, levels of stem-loop mRNA appear 
artificially low as compared to poly(A) mRNA (Figure 26C).  Therefore, quantitative 
comparison between the relative levels of poly(A) mRNA and stem-loop mRNA was not 
attempted possible using the RT-PCR this method.   
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I performed 3’ S1 nuclease protection assays to accurately measure the relative 
levels of each mRNA isoform.  I cloned a mini-gene MmuHist1H2BC from mouse 
genomic DNA containing an artificial 500 bp intron.  This intron contained 250 bps of 
DNA from the 5’ and 3’ ends of each side of the endogenous intron that was ligated 
following introduction of an XhoI site by PCR.  I also cloned 200 bps downstream of the 
purported poly(A) 3’ cleavage site and 300 bps upstream of the start codon.  This 
construct was cloned into pUC19 between BamHI and SalI. 
To generate 3’ S1 probes, the pUC19-MmuHist1H2BC mini-gene plasmid was 
digested in the ORF with NcoI and labeled with dCTP using Klenow and then excised 
from the plasmid using XhoI.  This results in a 406 bp S1 probe that will protect a 220 bp 
band if the mRNA is spliced and a 256 bp band if the mRNA terminates in a stem-loop.  
Also, due to the conservation between Hist1H2BC and other H2B genes in mice, the S1 
probe will protect a 201 bp band extending to the termination codon corresponding to the 
expression of all other H2B genes (Figure 26D). 
S1 nuclease assays were conducted with RNA from growing NIH3T3 cells, adult 
mouse brain and liver (Figure 26 D).  Dilution of NIH3T3 RNA demonstrated that there 
was <10% of the amount of H2B RNA in the mouse brain as compared to NIH3T3 cells 
(Figure 26D, c.f. Lane 5 & 7) and <2% in liver as compared to NIH3T3 cells (Figure 26 
D, c.f. Lane 5 & 9).  This is in agreement with non-quantitative PCRs shown earlier 
(Figure 25 C).  The major protected band by S1 in mouse liver was the spliced isoform 
(Figure 26 D, Lane 9) as indicated by the band with the slightly slower mobility than the 
ORF protected band.  More striking, Hist1H2BC appears to be the major H2B RNA 
transcript present in the mouse liver, since there is very little mRNA from other H2B 
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genes which would map to the termination codon, in contrast to NIH3T3 cells and mouse 
brain where the stem-loop Hist1H2BC comprises 5% - 10% of total H2B mRNA, 
consistent with the fact that Hist1H2BC is one of 16 H2B genes.   
In order to confirm that Hist1H2BC was the spliced polyadenylated mRNA, I 
poly(A) selected whole cell mRNA using oligo-d(T) cellulose. Whole cell RNA was 
compared against poly(A)+ and poly(A)- fractions.  The slightly slower migrating band 
did fractionate with poly(A)+ mRNA (Figure 26 E, Lane 7).  H2B RNAs from the 
NIH3T3 cells, brain and P1 mouse fractionated with Poly(A)- mRNA  and the protected 
fragment indicated that they end in the canonical stem-loop.  Surprisingly, the H2BC 
RNA from the brain also primarily ended at the stem-loop and gave a pattern similar to 
the P1 mouse and NIH3T3 cells suggesting at this relatively young age (72 days), there 
might still be a substantial number of dividing cells in the brain.  
Go Cells do not express polyadenylated histone mRNAs 
Switching from stem-loop to polyadenylated histone mRNA could be a 
consequence of a lack of progression through the cell cycle, thereby preventing 
expression of necessary cell cycle dependent histone factors, or a result of programmed 
cell differentiation.  To determine which was true, I arrested NIH3T3 cells by serum 
starvation (Figure 26 F), which arrests NIH3T3 cells in a G0 from which they can be 
released back into the cell cycle after restimulation with FBS.  Upon arrest by serum 
starvation, levels of Hist1H2BC and other H2B genes were drastically reduced to <1% of 
normal levels (Figure 26 G).  This was not accompanied by the appearance of the spliced 
and polyadenylated Hist1H2BC RNA seen in mouse liver samples.  Thus, I concluded 
that regulation of the polyadenylated forms of histone RNAs is not simply due to a loss of  
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Figure 27. Expression of Histone Specific factors in Mouse tissues.  (A & B) SLBP 
mRNA is expressed in both Human (A) and mouse (B) tissues.  This confirms previous 
data presented in Frank et al 1997. in human tissues.  (C) SLBP protein is not expressed 
in mouse tissues.  Western blotting of mouse tissues and NIH3T3 cells using antibody 
specific for endogenous SLBP.  Two alternative bands are detected using α-SLBP for 
western blotting in liver (*) and in the brain (**).  (D) Alternative band in liver (*) and 
brain (**) do not bind the histone stem-loop.  Biotinylated stem-loop was incubated with 
100 µg of indicated lysate and precipitated with streptavidin-agarose.  Precipitate was 
tested for he presence of bands detected in tissues by western.  SLBP was efficiently 
precipitated from NIH3T3 lysate.  Alternative bands in liver and brain do not bind the 
stem-loop suggesting that they are not tissue specific isoforms of SLBP, or if they are, 
they are incapable of binding the stem-loop. (E) U7 snRNA levels are reduced in the 
mouse liver.  For each tissue, 25 µg of whole cell RNA was ran of urea-acrylamide gel 
and transferred to nylon membrane.  Membranes were probed for U7 snRNA and 
visualized by exposure to phosphor screen.  Staining of 5S rRNA confirms equal loading. 
(F) Quantification of three independent northern blots for NIH3T3, P1 mouse, brain (72 
d) and liver (72 d) RNA.  Error bars indicate standard error.  For brain (14 d) and liver 
(14 d) samples, quantification represents a single experiment. 
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a histone processing factor as a consequence of failure to progress through the cell cycle.  
Instead, I believe that regulation of these mRNAs relies on an undefined cell programing 
event related to cell differentiation, which maintains activity of a subset of the histone 
gene promoters and activates a novel alternative splicing pathway for some genes.  
Expression of histone specific factors in mouse tissues 
 In order to address why some histone mRNAs were predominantly expressed as 
polyadenylated mRNAs that may or may not be spliced, I asked if the levels of the two 
histone specific factors required for stem-loop mRNA were altered in mouse tissues.  
Previously, Dr. Frank Martin in the laboratory of Dr. Dani Shümperli showed that human 
tissues sexpressed SLBP mRNA based on a tissue Northern blot, but did not determine if 
SLBP protein was present (Martin et al. 1997).  This is confirmed by analysis of human 
and mouse deep sequencing data sets (Figure 27A & B).  However, as SLBP is primarily 
regulated by proteolysis and translational regulation (Whitfield et al. 2000a) , it is 
possible that without the regulatory cell cycle machinery, SLBP protein could be absent, 
as it is in G1 cells.  Therefore, I prepared cell lysates from mouse tissues and tested for 
expression by Western Blotting using antibodies specific for SLBP (Figure 27C).  I was 
able to identify the band corresponding to SLBP in NIH3T3 cells as indicated in Figure 
27C.  There were two different prominent bands detected by the α-SLBP antibody in 
brain and liver lysate.  A slightly faster migrating band just below the SLBP band in 
NIH3T3 cells indicated by (*) in Figure 27C and a much slower migrating band in brain 
tissue indicated by (**) in Figure 27C. There was no SLBP signal at the molecular weight 
typical of SLBP in tissue culture cells in either tissue, suggesting that it is not expressed 
or expressed at levels below the detection limit of our antibody.   
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Alternatively, the faster migrating band in the liver tissue could be a modified 
version of SLBP.  Dr. Berndt Müller’s group has suggested that alternative splicing may 
alter some of the functions of SLBP during cell stress (Rattray et al. 2013).  Therefore, I 
wanted to ensure that the prominent bands in the brain and liver tissues were not able to 
bind stem-loop RNA.   To accomplish this, I prepared cell extract from NIH3T3 cells and 
tissues that I incubated with biotinylated stem-loop mRNA.  This RNA was recovered by 
precipitation with streptavidin-agarose beads.  The resulting precipitate was tested for the 
presence of SLBP by Western blotting with α-SLBP.  I found that the band that I had 
identified as SLBP in NIH3T3 cells was able to bind biotinylated stem-loop RNA, 
confirming that it is SLBP (Figure 27D, Lane 3).  The two other bands in brain and liver 
tissue were not able to bind the stem-loop RNA in this assay (Figure 27D, Lanes 6 & 9).  
In both cases, these proteins which are detected by α-SLBP antibody remain in the 
supernatant after precipitation.  This suggests that they are not tissue specific isoforms of 
SLBP.  The RNA –seq data indicated that there were not any novel transcripts from the 
SLBP gene in the tissues.  
 Another major histone specific factor required for histone mRNA cleavage at the 
stem-loop is the U7 snRNP, which base pairs with the histone downstream element 
(HDE) through the U7 snRNA.  Protein components of the U7 snRNP include some 
members of the spliceosomal Sm proteins in addition to two U7 specific Sm proteins, 
Lsm10 and Lsm11.  As the detection level of these proteins is typically below the limits 
of our antibodies for western blotting, I asked whether the levels of U7 snRNA were 
altered in mouse tissues.  I completed northern blotting using 25 µg of RNA extracted 
from different tissues and probed for U7 snRNA (Figure 27E).  Not surprisingly, levels 
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of U7 snRNA in the P1 mouse were high, particularly when compared to levels in 
NIH3T3 cells owing to the fact that cells are rapidly proliferating.  Levels of U7 snRNA 
in mouse tissues were dramatically reduced in comparison to either NIH3T3 cells or P1 
mouse RNA.  Markedly, expression of the U7 snRNA was reduced to nearly 0 in 72 day 
old mouse brain (Figure 27 E, Lane 3 & F).  This correlates well with the observation 
that mouse liver produces primarily polyadenylated and spliced Hist1H2BC mRNA and 
may indicate why these RNAs switch 3’ end processing mechanisms.  
 The tissue sequencing data also showed that the mRNAs for other protein 
components specific for hstone pre-mRNA processing (Lsm10, Lsm11, FLASH, and 
ZFP100) were expressed in adult tissues, as was the NPAT mRNA.  Thus, despite the 
fact that these cells have terminally differentiated, they continue to express proteins 
whose only known function is in replication-dependent histone mRNA metabolism.          
Polyadenylation status of other core histone mRNAs 
 Following the observation that mouse liver had significantly lower levels of U7 
snRNA when compared to that of NIH3T3 cells, P1 mouse or brain, I tested if mRNAs 
from other histone classes were polyadenylated in the mouse liver, using as probes, 
RNAs predicted to be polyadenylated from the tissue sequencing data.  I poly(A) selected 
RNA from liver and P1 mouse and prepared S1 probes from Hist2H4, Hist2H2aa1 and 
Hist2H3c.  
 Hist2H2aa1 encodes an H2a.2 protein.  The AscI restriction site used to prepare 
this S1 nuclease probe is unique to these proteins, so, only other H2a.2 mRNAs 
(Hist2H2ac & Hist2Hab) are mapped using this assay.  Surprisingly, S1 mapping of 
H2a.2 mRNAs showed that they fractionated with the poly(A)- RNA, suggesting that 
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Figure 28.  Expression of H2a and H3 mRNAs in mouse livers.  (A) S1 nuclease 
protection assay following poly(A) fractionation of mouse liver and P1 mouse RNA 
demonstrates that H2a.2 mRNAs are expressed predominantly as stem-loop isoforms in 
the mouse liver.  (B) S1 nuclease protection assay following poly(A) fractionation of 
mouse liver and P1 mouse RNA demonstrates that mouse liver does not express 
replication-dependent H3 mRNAs.   
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they terminate in stem-loops (Figure 28A).  This is in contrast to the H2B and U7 data 
showing that most H2B mRNAs in the mouse liver are polyadenylated (Figure 26E) and 
that U7 snRNA is reduced in the mouse liver (Figure 27E).  However, while reduced, U7 
snRNA is not completely absent.  The differential regulation of Hist2H2aa1 and 
Hist1H2BC could be attributed to their different locations in the genome, with 
Hist2H2aa1 being located in the Hist2 cluster on chromosome 3 and Hist1H2BC being 
located in the Hist1 cluster on chromosome 13.  The failure to map the open reading 
frames of mRNAs encoding other H2a.2 proteins suggests that this is the only expressed 
H2a gene in the Hist2 cluster.  This is in agreement with RNA-seq data.  
I also tested for expression of H3 mRNAs using a probe generated from the 
Hist2H3c gene.  This S1 probe protects both Hist2H3c and all other H3 ORFs as seen 
previously with S1 probes generated for Hist1H2BC.  For P1 mouse RNA, both 
Hist2H3c mRNA and all other H3 mRNAs fractionated with the poly(A)- RNA, 
indicating that they end in a stem-loop.  Analysis of the mouse liver H3 mRNAs 
indicated that no replication-dependent H3 mRNAs were expressed (Figure 28B).  This 
data agrees with RNA-Seq data in both mouse and human tissue samples that showed that 
there was no H3 gene expressed in the histone clusters.  The most likely interpretation of 
this data is that the H3 genes is that the H3.3 gene is a true replacement gene, and thus it 
is not necessary to express any other histone H3 protein in terminally differentiated cells.  
The loss of expression from replication-dependent H3 genes can be overcome by the 
continued expression of H3.3.  How this transcriptional silencing of the H3 genes is 
	   178	  
accomplished or how the expressed genes in the histone cluster are specifically activated 
is unknown.  
       
Discussion 
 I believe that these initial observations that as subset of replication-dependent 
histone mRNAs are differentially regulated in tissue culture cells as compared to adult 
tissues of longer-lived species will lead to a new line of study in this field and shed 
additional light on regulation of these RNAs and terminal differentiation in general.  It is 
very likely that continued production of histone protein to replace damaged histones as 
well as possibly part of DNA repair mechanisms is essential in non-dividing cells.  
Characterization of the phenomena presented here is only the first step in understanding 
how the expression of histone proteins is regulated in non-dividing cells.  Further 
experiments will surely be needed to understand the underlying mechanisms.  
Polyadenylation of histone mRNAs as a mechanism to allow for continued 
expression of histones outside of S-phase 
 
 As suggested by their name, expression of the replication-dependent histone 
mRNAs is constrained to S-phase of actively dividing cells (Marzluff et al. 2008).  Cell 
cycle regulation of these proteins is regulated by the histone stem-loop and SLBP, which 
is required to direct proper 3’ end cleavage, export from the nucleus, translation and 
degradation.  In continuously growing cells, there are small amounts of replication-
dependent histone mRNAs expressed in G1 cells and there is no expression of 
polyadenylated histone mRNAs except for histone H1c in some conditions (Wang et al. 
1997).  However, following terminal differentiation, the situation is different.  Since the 
histone proteins turnover slowly, it is necessary to replace them as they are lost.  In brain,  
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Figure 29. Phylogenetic analysis of promoter sequences of mouse histone promoters 
As the precise transcription start site is not well annotated for each histone gene, 500 base 
pairs upstream of the start codon of each gene was aligned using clustalW2 from which 
phylogenetic trees were compiled. 
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the half-life of histone proteins is about 19 days (Bondy 1971).  Inability to properly 
compact the genome into chromatin quickly leads de-repression of certain genes leading 
to aberrant transcription and genomic instability (Meeks-Wagner and Hartwell 1986; Han 
and Grunstein 1988; Kim et al. 1988).  This presents an obvious problem for longer-lived 
cell types. The average age of non-epithelial cells in the human body is 15.9 years 
(Spalding et al. 2005).  In the extreme, when the age of cortical neurons in individual 
humans were measured, the age of the neuron was equivalent to that of the age of an 
individual.  In these cells, there must be a mechanism to replace histones that turn over 
slowly to maintain genome integrity.  It is striking that different mechanisms are utilized 
for different histone proteins.  
One obvious mechanism to provide replacement histone is to utilize different 
genes to encode the replacement variant and this is the case for the histone H3 genes, but 
not the other core histone genes.  Previously, H3.3 (H3F3A) had been identified as a 
replacement histone that accumulates as a large fraction of the histone H3 in non-dividing 
cells over an extended period of time (months to years).  The H3.3 protein is expressed 
from genes that produces a spliced polyadenylated mRNA that is not linked to other 
histone genes.  Dr. Alfred Zweidler found that in large amounts of the H3 protein in 
terminally differentiated cells is H3.3 rather than the H3.1 or H3.2 from the replication-
dependent histones (Urban and Zweidler 1983).  Here, I demonstrate that this is due to 
near total loss of replication-dependent H3 RNA expressed as either a stem-loop isoform 
or polyadenylated isoform.  In this regard, H3.3 can truly be considered a replacement 
histone.  How and why the cell accomplishes the switch from expression of H3.1 or H3.2 
genes to H3.3 is unknown.  The promoters of the replication-dependent H3 genes do not 
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differ greatly from the promoters of other replication-dependent genes (Figure 29) and 
the consensus sequence for the H3 stem loop is nearly identical to the stem-loops found 
in H1, H2A, or H2B (Figure 12).  How the H3 genes are specifically turned off while 
interspersed within the two histone clusters remains to be determined. 
For the other 4 classes of histone genes, there are no replacement histone genes 
outside of the histone clusters from which they are expressed.  Histone H1 is a special 
case, since the H1 protein turns over more rapidly than the core histones.  The histone 
H1o protein accumulates in non-dividing cells, but functions to silence genes and the 
histone H1c protein (and mRNA) continues to be expressed in non-dividing cells.   As 
demonstrated in this chapter, these other classes of histones are expressed as both stem-
loop and polyadenylated isoforms from a subset of the replication-dependent genes 
expressed solely as stem-loop RNAs in rapidly growing cells. 
  In the liver, this formation of the polyadenylated isoforms correlates well with 
the loss of the U7 snRNA.  Although, it is not known if this is the primary or sole reason 
that allows the switch to polyadenylated histone mRNAs.  Clearly the splicing of the 
mRNAs that splice before the stem-loop must be regulated also.  Finally the data suggests 
that only a subset of the histone genes are transcribed in terminally differentiated cells.  It 
is possible that the unexpressed histone mRNAs are transcribed, but lack the downstream 
elements required to make a polyadenylated histone mRNA.  Failure to cleave and 
process these RNAs would lead to degradation of the nascent RNAs.  The inability to 
efficiently form stem-loop mRNAs due, perhaps, to reduced levels of histone specific 3’ 
end cleavage factors could lead to the preferential polyadenylation of those genes that 
harbor the correct signals.       
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Loss of U7 snRNA and SLBP in mouse liver leads to polyadenylation of histone 
mRNAs 
 
 Binding of the U7 snRNA to the histone downstream element is absolutely 
required for efficient histone 3’ end processing at the stem-loop.  In Drosophila, mutation 
of the U7 snRNA is not lethal, but does produce sterile flies due to disruption of 
oogenesis (Godfrey et al. 2006).  The ability of these flies to develop properly requires 
large maternal dose of U7 snRNA.  Indeed, this leads to the onset misprosessed histone 
mRNA later in development in U7 mutant flies as compared to SLBP mutants, which are 
lethal.  In U7 mutant flies, histones mRNAs are not cleaved after the stem-loop, but 
instead read through the HDE and utilize cryptic polyadenylation signals downstream of 
each of the fly genes.  In the study by Dr. Ashley Godfrey that created and characterized 
these mutants by P-element excision, she also showed that U7 snRNA levels were 
reduced during embryogenesis (Godfrey et al. 2006, Figure 4C). The observed 
phenomena in Drosophila development may be similar to this in mouse liver.  P1 mouse 
has the highest levels of U7 snRNA, with levels decreasing until it is nearly absent in the 
72 day old mouse liver and brain.  As Drosophila rarely survive to this point and are even 
more rarely studied in a laboratory setting at this age, it is impossible to say if histone 
mRNAs would become polyadenylated in this system in different fly tissues. 
 However, natural lack or reduction of U7 snRNA during an animal’s normal life 
span may lead to the polyadenylation of histone mRNAs.  Failure to efficiently recruit the 
U7 snRNP will lead to continued transit of Pol II until polyadenylation factors can utilize 
downstream polyadenylation signals.  Whether or not splicing is required or aids in this 
process is unknown.  As many of the observed polyadenylated histone mRNAs are not 
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spliced, it is conceivable that splicing of the Hist1H2BC gene is not required for 
polyadenylation. 
Expression of SLBP protein is tightly regulated by the cell cycle.  At the end of S-
phase, SLBP is bound and phosphorylated by CycA/Cdk1 and CK2 at threonine-60 and 
threonine-61 (Koseoglu et al. 2008a).  This phosphorylation triggers proteasome 
dependent proteolysis of SLBP.  As Cyclin A levels remain high throughout G2 newly 
synthesized SLBP protein is quickly degraded by proteolysis.  However, during G1 when 
CycA is absent, SLBP expression is regulated at the level of translation (Whitfield et al. 
2000a).  SLBP mRNA levels change little throughout the cell cycle and during G1 
translation of SLBP mRNA is repressed by an unknown mechanism.  It is not known how 
these processes would be affected during terminal differentiation.  Data presented here 
demonstrates that SLBP protein is not expressed in mouse tissues or is expressed at levels 
below the detection limit of our antibodies.  By northern blotting, the Shümperli lab has 
previously shown that SLBP mRNA is expressed in human tissues and, by RNA-seq, 
data presented here confirms that this is true for mouse tissues as well. The absence of 
detectable levels of proteins suggests extensive post-transcriptional regulation of the 
SLBP mRNA in terminally differentiated cells.  CycA/Cdk1 is not available to promote 
proteolysis via phosphorylation of Threonine-60 and 61.  Therefore, if SLBP were to be 
regulated by proteolysis, it would likely be targeted by a different region of the SLBP 
protein and a different ubiquitin ligase.  SLBP mRNA is also subjected to translational 
regulation during G1.  However, it is not known if this regulation is due to translational 
repression during G1 translational or activation during S-phase.  It is possible then that if 
the mode of translational regulation proves to be activation during S-phase, the key 
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factors required for this activation could be absent in terminally differentiated cells 
thereby preventing accumulation of SLBP protein.   
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CHAPTER V:  SUMMARY AND CONCLUSIONS 
 
 Post-transcriptional regulation of mRNA translation and degradation plays a 
major role in modulating gene expression.  This dissertation builds on the data that 
highlights different and disparate mechanisms that are required to faithfully express 
histone proteins in order to properly package chromatin.  Data from yeast to humans 
demonstrate that failure to regulate this process leads to catastrophic consequences for 
cells.  In metazoans, SLBP must specifically interact with the histone stem-loop 
immediately after transcription followed shortly thereafter by association of the U7 
snRNP and histone cleavage complex upon transcription of the histone downstream 
element.  Faithful recognition of these cis-acting elements is critical to formation of the 
mature histone mRNA and subsequent expression of histone proteins.  SLBP then plays 
critical roles in both histone mRNA translation and regulation of degradation   
In this chapter, I will summarize data presented in this dissertation that showed 
how both SLBP and 3’hExo recognize the histone stem-loop (Chapter 2) and how these 
two proteins help direct histone mRNA degradation by making specific contacts with the 
mRNA degradation machinery (Chapter 3), and extend the current model for histone 
mRNA degradation.  Finally, I will summarize current data showing how a subset of 
normally replication-dependent histone mRNAs are able maintain expression in  
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Figure 30. The SLBP interactome 
Schematic of domains of SLBP that have been demonstrated to form protein:protein or 
protein:RNA interactions.  For each, the protein partner and critical reference is 
indicated. 
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terminally differentiated cells (Chapter 4).  Further, I will discuss possible future 
directions these projects should take.      
The histone stem-loop and SLBP as a scaffold for directing histone expression 
through protein:protein interactions 
 
 Every post-transcriptional step in the biogenesis and expression of histone 
mRNAs is mediated through the action SLBP and the histone stem-loop (Harris et al. 
1991a).  Many of these post-transcriptional events are a result of proteins associating with 
SLBP through direct protein:protein interactions (Figure 30). SLBP first binds the 
histone stem-loop during transcription (Wang et al. 1996; Martin et al. 1997) and aids in 
the co-transcriptional cleavage of the mRNA by CPSF-73 (Dominski et al. 2001; 
Dominski et al. 2005).  In mammals, SLBP aids in the cleavage reaction by interacting 
with the U7 snRNP through direct contacts with ZFP100 (Dominski et al. 2002).  
Following cleavage, 3’hExo may also interact with the stem-loop and SLBP to trim the 
final 3 nucleotides (CCA) from the 3’ end of mRNAs (Dominski et al. 2003).  However, 
it is unclear when 3’hExo may perform this task, as it is also possible that 3’hExo is not a 
stable component of the histone mRNP until the initiation of degradation.  At the 
completion of 3’ end processing, SLBP interacts with TAP (Erkmann et al. 2005) and/or 
a complex of SLIP1 and Dbp5 to promote export from the nucleus to the cytoplasm (von 
Moeller et al. 2013).  To promote active translation through the formation of the closed-
loop translation complex, SLBP will interact with SLIP1 and/or CTIF to bridge the 3’ 
and 5’ ends of the RNA (Cakmakci et al. 2008; Choe et al. 2013).  To these examples of 
SLBP effecting histone mRNA metabolism by acting as a scaffold for other factors, I can 
add that SLBP directs histone mRNA degradation through its interaction with Lsm4.  The 
Lsm4 directed degradation is also mediated by interactions with 3’hExo.   
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 In order for SLBP to perform these functions, it must specifically recognize the 
histone stem-loop.  Paradoxically, together with Howard Chang’s lab, I found that SLBP 
is able to recognize and bind to a much wider variety of stem-loops than predicted by the 
remarkable conservation of the stem-loop in metazoans (Martin et al. 2012).  Despite this 
potential broader binding specificity, in cells, SLBP is only found in association with 
histone mRNAs.  As SLBP’s major function after binding the histone stem-loop is 
facilitating protein:protein interactions, perhaps alternative stem-loops, while permitting 
SLBP binding, distort SLBP structure in such a way that it is either not capable of 
binding any of number accessory factors (ZFP100, TAP, SLIP1, CTIF, Lsm4) throughout 
the histone mRNA life cycle or are able to bind the accessory protein, but positions in 
such a way that it is no longer able to effectively act upon the histone mRNA.  In vitro, 
binding studies demonstrating that SLBP illuminating as to the pliability of SLBP’s RNA 
binding domain, but do not answer why alternative stem-loops are not seen in nature.  
Additional in vitro and in vivo experiments could be particularly fruitful in explaining 
why there is not more variation in the histone stem-loop.  Reporter RNAs harboring 
mutant stem-loops that support binding could be expressed in cells and expression could 
be checked in comparison to reporters containing WT stem-loops.  Any potential defects 
in expression could be examined by studying the 3’ end processing of reporter RNAs in 
vitro by cleavage reactions or in vivo by S1 nuclease protection assays, the export of 
reporter RNAs by FISH, translation of reporter mRNAs by luciferase assays or decay of 
reporters by northern blotting.  In conjunction with the recently published crystal 
structure of SLBP in complex with the stem-loop, these studies indicate how SLBP and 
3’hExo interact with the histone stem-loop.   
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Figure 31. Current model for histone mRNA degradation.  
Possible pathways for degradation of histone mRNAs are shown. (A-C) The initial step is 
recruitment of Upf1 and oligouridylation of the 3’ end of histone mRNA.  Lsm1-7 binds 
to the oligo(U) tail, promoted by Lsm4 binding to the SLBP and 3’hExo.  (D-F) 
Subsequently there is partial degradation of the stem-loop by 3’ hExo and/or decapping 
of the histone mRNA.  This intermediate is uridylated and binds the Lsm1-7 ring (Hoefig 
et al., 2013). (F-H) Subsequently the histone mRNA can be degraded bidirectionally 
(Mullen and Marzluff, 2008). Panel (F), 3’ to 5’ (panel G), or 5’ to 3’ (panel H).  The 
relative importance of these three pathways is not known. 
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How might Lsm4 promote histone mRNA degradation? 
 I show in Chapter 3 of this dissertation that there is an interaction between the 
histone mRNP (SLBP and 3’hExo) and Lsm4 and that this interaction is necessary for 
efficient histone mRNA degradation.  This further extends our current knowledge of 
histone mRNA degradation (Figure 31).  Currently, our model starts with the closed-loop 
translation complex formed by interaction between eIF4G and SLBP mediated by SLIP1 
(Cakmakci et al. 2008) (Figure 31A).  However, it is also possible that the closed-loop 
translation complex is formed by interactions with CPB80 and SLBP mediated by CTIF 
(Choe et al. 2013) (Figure 4).  To initiate histone mRNA degradation, translation 
termination becomes inefficient which promotes the recruitment of Upf1 to the histone 
mRNA (Graves et al. 1987; Kaygun and Marzluff 2005b; Kaygun and Marzluff 
2006)(Figure 31B).  An unidentified TUTase adds an oligouridyl tail to the 3’ end of the 
histone mRNA(Mullen and Marzluff 2008).  The two most likely TUTases that perform 
this reaction are TUT3 (PAPD5) or TUT4 (ZCCHC11) (Schmidt et al. 2011).  Addition 
of the oligo(U) tail allows for association of Lsm1-7 with the histone 3’ end mediated 
through the C-terminal tail of Lsm4 (This thesis) (Figure 31C).  Lsm1-7 is known to 
interact with a complex of proteins including Pat1 and Rck that promote translational 
repression (Fenger-Gron et al. 2005).  Degradation of the mRNA can either proceed 3’ to 
5’ (Figure 31D), 5’ to 3’ (Figure 31E) or bidirectionally (Figure 31F).  Decay from the 
3’ end requires initial trimming into the stem by 3’hExo (Figure 31D).  Eventual removal 
of SLBP and 3’hExo from the stem-loop allows for processive degradation by the 
exosome (Figure 31G).   Decay from the 5’ end requires decapping mediated by Dcp2 
(Figure 31E) followed by exonucleolytic decay by Xrn1 (Figure 31H).  siRNA 
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experiments suggest the 3’ to 5’ pathway or bidirectional pathway is significant for a 
significant fraction of histone mRNAs, but certainly, all three pathways could be active.        
 The interaction between Lsm4 and both SLBP and 3’hExo is required for 
efficient histone mRNA degradation.  To this point, no data exists that indicates how this 
interaction promotes histone mRNA degradation.  There is also no data about how, or 
whether, the Lsm1-7 tails affect metabolism of any mRNAs, and it is possible that 
specific sequences on different Lsm tails play roles in degradation of other mRNAs.    
 One possible mechanism would involve stabilizing the interaction of Lsm1-7 on 
the oligouridylated histone mRNA, promoting recruitment of Lsm1-7 to histone mRNAs.  
Since a substantial fraction of histone mRNA is degraded 3’ to 5’, removal of SLBP and 
perhaps 3’hExo from the stem-loop is likely essential for degradation.  Until biochemical 
studies of the uridylation reaction using the histone stem-loop bound to SLBP can be 
completed, the length of the uridyl tail cannot be completely known without being 
confounded by exonucleolytic degradation by 3’hExo or the exosome.  However, 
currently, data has been presented that demonstrates that the uridyl tail found on RNAs in 
the cell are between 1 and 10 nucleotides long with the tail length distribution of skewing 
towards the shorter tails.  Optimal binding for Lsm1-7 requires oligo(A) or oligo(U) tails 
of at least 7 nucleotides (Figure 15H).  The relative affinity of mammalian Lsm1-7 for 
oligo(U) vs. oligo(A) tails is not known, and it is possible that Lsm4:SLBP interaction 
may provide additional stability to promote recruitment of Lsm1-7 to histone mRNA.  
 Another possible mechanism could involve the C-terminal tail of Lsm4 
performing a defined function in promoting degradation, possibly in helping remove 
SLBP from the mRNA.  I have shown that the Lsm4:SLBP interaction is mediated 
	   195	  
through amino acids found in the RNA binding domain of SLBP.  There are several 
amino acids in this domain that do not function in RNA binding.  In fact, some are found 
in helices outside binding pocket.  For example, ZFP100 binds to the B helix of the SLBP 
RNA binding domain.  The recently published crystal structure of SLBP bound to the 
stem-loop demonstrates that this helix is oriented perpendicular to the stem of the RNA, 
extending away from the binding site. (Tan et al. 2013).  Alternatively, interactions with 
amino acids located on the opposite face of an α-helix interacting with stem-loop RNA 
could also affect binding to the RNA. Therefore, there is no inherent conflict between the 
observations that Lsm4 interacts with the RNA binding domain with the possibility that 
this occurs as SLBP is bound to stem-loop.  But, it does make it possible that the C-
terminal tail of Lsm4 is involved in assisting in the removal of SLBP from the stem-loop 
by weakening the SLBP:SL interaction or in preventing SLBP from rebinding the stem-
loop after removal by Upf1.  
A major kinetic intermediate in histone mRNA degradation results from 3’hExo 
removing 2 – 3 nucleotides from the 3’ side of the stem and this intermediate is then 
oligouridylated allowing Lsm1-7 to bind to promote further degradation.  Presumably 
SLBP is still bound to this intermediate and prevents further exonucleolytic decay into 
the stem by 3’ hExo, until the SLBP is removed from the stem-loop.  
Therefore, in this model, Lsm4 could destabilize the SLBP:stem-loop interaction enough 
to allow for further degradation by 3’hExo or recruitment of the exosome which carries 
out the rest of the degradation of histone mRNA.  Following digestion of nucleotides in 
the stem by 3’hExo, SLBP would further lose affinity for the stem-loop allowing for 
processive exonucleolytic decay by 3’hExo or the exosome.  Alternatively,  
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Figure 32. Lsm4 may help remove SLBP from stem-loop RNA 
(A) Potential post-translational modifications of SLBP.  (B) GST-pulldowns 
demonstrating that stem-loop RNA interferes with binding of SLBP/3’hExo and Lsm4. 
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data presented from the Thapar lab suggests that dephosphorylation of SLBP by upon 
initiation of histone mRNA degradation could reduce SLBP’s affinity for the stem-loop 
(Krishnan et al. 2012).  In addition, preliminary data by Dr. Stacie Meaux suggests that 
after the initiation of histone mRNA degradation by treatment of cells with hydroxyurea, 
the occupancy of several post-translational modifications is altered on SLBP (Figure 
32A). If any of modification does not alter SLBP’s affinity for the C-terminal tail of 
Lsm4, it is possible that as SLBP has reduced affinity for the stem-loop, it could 
preferentially interact with Lsm4.  The interaction with Lsm4 could therefore serve to 
prevent reassociation of SLBP with the stem-loop, allowing for exonucleolytic decay.        
 In support of this model, I performed pulldowns testing the interactions between 
SLBP and 3’ hExo with Lsm4 after the addition of stem-loop RNA (Figure 32B, Lanes 4 
& 14).  Addition of this RNA, but not RS RNA, which cannot bind SLBP, inhibited 
binding between these SLBP and Lsm4.  I was not able to rescue the binding by 
formation of a ternary complex (Figure 32B, Lanes 5 & 15).  In contrast, binding of 
Lsm4 to 3’hExo has little effect on 3’hExo binding to the stem-loop RNA (Figure 32B, 
Lanes 9 & 10).  It is possible then, that following post-translational modification of SLBP 
that reduces its affinity for the stem-loop favors association with Lsm4 in order to prevent 
reassociation with stem-loop RNA.   
Potential Role for Lsm4 and oligouridylation in NMD 
 It is possible that Lsm4 is involved in other mRNA degradation pathways.  The 
current model for mRNA degradation in response to nonsense-mediated decay involves 
initial endonucleolytic cleavage of the mRNA by PIN domain of Smg6 (Figure 33) 
(Eberle et al. 2009).  Cleavage leaves an exposed 5’ phosphate on the 3’ fragment and an  
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Figure 33. Model of NMD including possible role for oligouridylation 
(A) During pioneer round of translation, CBP20/80 aids in the formation of the closed-
loop translation complex.  An EJC deposited in the 3’ UTR downstream of the premature 
termination codon (PTC) elicits the response of the SURF complex composed of the 
translocating ribosome, Smg1/8/9, Upf1 and eRF1/3.  Interaction between the EJC and 
SURF complex mediated by Upf2 creates the DECID complex that triggers degradation.  
(B) Smg6, a PIN domain containing endonuclease, is recruited to the NMD substrate and 
cleaves the mRNA exposing a 5’ phosphate on the 3’ fragment and a 3’ hydroxyl on the 
5’ fragment.  (C) The 5’ fragment may be oligouridylated to allow for binding of Lsm1-
7.  A similar mechanism is seen after cleavage directed by siRNAs.  (D) Xrn1 and the 
exosome complete degradation of each fragment.   
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exposed 3’ hydroxyl on the 5’ fragment (Gatfield and Izaurralde 2004).  Studies done in 
Drosophila demonstrate that the degradation of the 3’ cleavage product is dependent 
upon Xrn1, a processive 5’ to 3’ exonuclease.  This is the same nuclease that degrades 
RNAs following decapping.  Degradation of the 5’ fragment is dependent upon activity 
of the exosome and apparently does not require decapping.     
 I believe that data presented in chapter 3 of this dissertation suggests that 
degradation of the 5’ fragment may require an additional steps or an additional mRNA 
degradation pathway in the cell.  The ability of Flag-Lsm4 to co-immunoprecipitate 
Upf1, CBP80 and particularly Upf2 suggests that it may be involved in NMD.  As Upf1 
is absolutely required for histone mRNA degradation and CPB80 has been implicated as 
being required for histone mRNA translation and degradation, the presence of these two 
proteins in immunoprecipiatates of Flag-Lsm4 could be due to their interaction with 
histone mRNA degradation.  However, these same factors are also involved in NMD. The 
observation that hydroxyurea treatment does not alter the percentage of Upf1 or CPB80 
in complex with Lsm4, suggests not all of this complex is present on histone mRNAs.  
Additionally, the dependence of this interaction on RNA argues that it is not occurring on 
histone mRNAs, but likely on some other RNAs.  Data presented in chapter 3 
demonstrates that SLBP and Lsm4 exist in an RNAse insensitive complex.  Unpublished 
data from Dr. Stacie Meaux demonstrates that upon the initiation of histone mRNA 
degradation, Upf1 also makes direct contact with SLBP.  Were the interactions seen in 
the Flag-Lsm4 immunoprecipitate occurring on histone mRNAs, it is likely that they 
would not be sensitive to RNAse A as they would be mediated through SLBP 
interactions. 
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 The most striking evidence that the interactions seen in Figure 23E are 
interactions occurring during NMD and not during histone mRNA degradation is the 
presence of Upf2 in the immunoprecipitates.  Knockdown of Upf2 does not alter the half-
life of histone mRNAs upon inhibition of DNA synthesis and, while Upf1 is found in 
immunoprecipitates of SLBP after HU treatment, Upf2 is not.  This evidence suggests 
that the Lsm1-7 may have an undescribed role in NMD.  Data presented here cannot 
distinguish if Lsm1-7 is involved in the degradation of the 5’ or 3’ fragment following 
endonucleolytic cleavage and thus, several models are possible.  The initial steps of 
NMD could involve deadenylation of the mRNA as suggested by Lejeune et al. 2003.  
This work, done in the lab of Dr. Lynne Maquat, shows that the rate of degradation of 
NMD substrates is reduced following knockdown of PARN, a deadenylase that has 
affinity for both poly(A) mRNAs and for the 7-methylguanosine cap (Lejeune et al. 
2003).  Therefore, following deadenylation, could leave an oligo(A) tail that allows for 
Lsm1-7 to interact with to trigger decapping.  This study also showed that Xrn1 was 
required for degradation of NMD substrates.  They proposed that deadenylation followed 
by decapping led to degradation of the NMD substrate by either a 3’ to 5’ or a 5’ to 3’ 
mechanism.    
 This model is in conflict with recent data showing that NMD substrates are 
endonucleolyticly cleaved by Smg6 and each fragment is degraded independently 
berle(Eberle et al. 2009).  In this model, proposed by Elisa Izzauralde, the 3’ fragment is 
degraded by Xrn1.  This is in line with data from Lejeune et al. 2003 showing that Xrn1 
is required for NMD.  However, they show that the 5’ fragment is degraded by the 
exosome.  This model is currently more widely accepted in the field and if correct, I 
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propose that prior to degradation by the exosome, the 5’ fragment is uridylated and bound 
by Lsm1-7.  This would allow for Lsm1-7 to be found in an RNase sensitive complex 
with CBP80, Upf1 and Upf2.  A mechanism similar to this is not without precedent.  
Following siRNA directed mRNA cleavage in Chlamydomonas reinhardtii and 
Arabadopsis thaliana, the 5’ fragment is oligouridylated prior to degradation (Shen and 
Goodman 2004; Ibrahim et al. 2006).    
I propose that Lsm1-7 would help recruit the exosome to cleaved mRNA and 
facilitate 3’ to 5’ degradation (Figure 33C).  This would be analogous to the 3’ to 5’ 
degradation seen in histone mRNAs.  An oligo(U) tail is added to the 3’ end of the stem-
loop that is bound by Lsm1-7.  Following these events, in part, the mRNA is degraded by 
the exosome in a 3’ to 5’ direction.  I propose that Lsm1-7 may form additional 
protein:protein contacts with other members of the mRNA degradation machinery to 
promote degradation of proteins following deadenylation or addition of an oligo(U) tail.   
Function of the Lsm1-7 complex in degradation of polyadenylated mRNAs. 
A question that remains is whether Lsm1-7 must specifically recognize its proper 
RNA substrates with high affinity from a broad group of substrates that have similar 
features?  The mechanism by which Lsm1-7 is recruited to any RNA substrate is not well 
understood.  Lsm 1-7 has a higher affinity for oligo(A) or oligo(U) RNA at the 3’ end of 
mRNAs (Chowdhury et al., 2007;Chowdhury and Tharun, 2008) and the complex can 
also bind to oligo(A) stretches at the 5’ end of orthopox viral mRNAs (Bergman et al., 
2007), as well as internal oligo(A) sites in other viral mRNAs (Galao et al., 2010).  
Protein-protein interactions, such as those shown here with SLBP and 3’hExo, may 
provide additional specificity that allows for association of the Lsm1-7 complex 
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preferentially with RNAs being targeted for degradation.  All of the Lsm proteins contain 
a core Sm fold.  However, some of these proteins contain substantial N- or C-terminal 
extensions, particularly Lsm1, Lsm4 and Lsm8.  In yeast, the C-terminal domain of Lsm1 
was shown to have an additional function in binding RNA substrates that is distinct from 
the Sm core of the protein (Chowdhury and Tharun, 2008).  For mammalian histone 
mRNAs, the C-terminal domain of Lsm4 may play a similar role, functioning to provide 
additional specificity through interaction with the protein components of the mRNP in 
addition to Lsm1-7 ring binding the oligo(U) tail.  In yeast, Lsm4 also contains an 
unstructured C-terminal extension, although, there is no conservation between the 
vertebrate Lsm4 C-terminal extension with yeast, Drosophila or C.elegans.  However, 
other groups have presented data that this C-terminal extension may play a role is 
formation of P-bodies (Decker et al., 2007).  Our results suggest that there are likely to 
also be specific protein-protein interactions between proteins associated with poly(A) 
mRNPs and the Lsm1-7 complex, which may contribute to the half-life of specific 
poly(A) mRNAs following removal of the poly(A) tail.    
After binding of Lsm 1-7 to oligouridylated or oligoadenylated mRNA, one 
pathway that is activated is decapping of the mRNA, particularly in yeast.  Factors that 
assist in recruiting the decapping complex interact directly with the Lsm1-7 ring, 
resulting in decapping followed by degradation by the 5’ to 3’ exonuclease Xrn1 (Parker 
and Sheth, 2007).  In yeast growing in rich media, the major pathway of mRNA 
degradation is 5’ to 3’.  In mammalian cells the major pathway is less clear.  In 
cytoplasmic extracts prepared from tissue culture cells, 3’ to 5’ degradation is active, 
although it is impossible to extrapolate from the in vitro results what happens in vivo.   
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An attractive possibility is that many mRNAs are degraded both 5’ to 3’ and 3’ to 5’ 
(Murray and Schoenberg, 2007), either as individual mRNAs entering different 
pathways, or the same mRNA molecule being degraded simultaneously from the 5’ end 
and the 3’ end as we have found for some histone mRNAs (Mullen and Marzluff, 2008).  
A fraction of the histone mRNAs are certainly degraded by the 5’ to 3’ 
degradation pathway (Su et al., 2013;Mullen and Marzluff, 2008).  However after 
inhibition of DNA replication there is an increase in the fraction of the histone mRNAs 
that are degraded by the 3’ to 5’ pathway (Su et al., 2013), requiring the exosome 
(Mullen and Marzluff, 2008).  It seems likely that removal of the oligo(U) tail either by 
3’hExo or the exosome is initiated with Lsm1-7 bound to the tail, and indeed it is 
possible that Lsm1-7 plays a direct role in removal of the U-tail rather than simply 
protecting the tail from degradation.  The details of how the Lsm1-7 ring may direct the 
subsequent pathway of histone mRNA degradation await elucidation in the future.  
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